Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AC114490.2 ENSG00000284773 "Novel protein" 1 34974356-34985313 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 6 "Ductal cells: 14.3;Exocrine glandular cells: 7.4;monocytes: 5.2;Pancreatic endocrine cells: 9.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 1: Pancreatic cells - Digestion" 1.0 0.5 0.6 0.9 0.6 0.9 1.0 0.9 0.9 0.5 0.3 0.6 0.7 1.6 1.3 0.2 1.0 0.7 0.3 0.5 0.7 0.5 0.4 1.1 1.7 0.5 0.4 1.1 0.3 0.4 0.4 0.5 0.6 0.8 1.0 0.5 0.8 0.5 1.1 1.0 0.8 0.2 1.5 0.4 0.8 0.7 0.7 0.5 0.2 1.1 0.3 0.7 0.2 0.2 0.2 0.3 0.8 1.6 0.1 0.4 1.6 0.2 0.2 0.0 1.0 0.5 0.2 0.5 0.1 0.6 0.1 0.2 0.1 0.9 0.2 0.4 0.3 0.2 1.4 0.7 1.2 1.3 0.5 0.2 0.9 0.8 0.4 1.3 0.1 0.9 0.5 0.3 0.3 0.7 0.3 0.0 0.0 0.6 0.0 0.0 0.4 0.5 0.2 0.5 0.4 0.0 0.1 0.4 0.0 0.5 0.7 0.3 0.3 0.5 0.2 0.9 0.2 0.1 0.3 0.6 0.1 0.1 0.1 0.0 0.3 0.0 0.4 0.1 0.6 0.4 0.1 0.3 0.2 0.2 0.2 0.5 0.1 0.2 0.1 0.0 0.6 0.6 0.9 0.9 0.5 0.7 0.5 0.4 0.5 0.2 0.7 0.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.3 0.0 0.3 0.6 0.7 0.0 0.0 0.0 7.4 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.2 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ACTN1 ENSG00000072110 "Actinin alpha 1" P12814 14 68874128-68979440 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 524.5" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 351.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 364.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004303, HPA006035" Approved Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA 210000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane, Actin filaments, Focal adhesion sites" "CAB004303: AB_626633, HPA006035: AB_1078095" "unprognostic (4.40e-2)" "unprognostic (1.03e-3)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (6.19e-3)" "prognostic unfavorable (7.63e-5)" "unprognostic (3.62e-1)" "unprognostic (3.23e-2)" "unprognostic (3.16e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (9.08e-10)" "unprognostic (2.87e-2)" "unprognostic (2.00e-1)" "unprognostic (6.05e-3)" "prognostic unfavorable (8.00e-4)" 117.4 40.7 27.3 149.5 55.8 149.3 103.5 0.1 32.0 118.4 20.1 449.8 49.8 313.1 60.3 154.4 152.1 143.9 121.4 29.7 14.7 46.7 61.8 100.0 47.5 24.5 11.0 61.8 46.8 9.1 27.3 96.1 7.3 174.3 109.0 28.2 116.4 295.1 21.7 59.3 106.9 524.5 4.2 55.9 171.7 21.2 32.9 32.6 35.0 13.3 50.7 305.9 83.3 28.8 871.9 262.3 158.6 121.4 275.2 180.5 592.4 749.3 712.0 770.0 571.1 211.8 196.6 0.7 256.5 744.7 310.4 370.9 126.8 790.3 965.2 4.6 38.5 118.2 133.5 179.0 494.0 85.4 14.3 231.7 152.1 479.8 540.3 551.6 428.6 48.2 56.9 1.4 612.0 246.9 10.1 181.1 124.7 217.9 198.1 59.3 294.1 32.6 292.0 225.6 57.0 68.7 649.9 96.8 177.1 474.8 146.0 170.9 546.0 1085.2 432.8 126.9 662.5 113.8 47.8 3.9 314.4 115.7 584.4 64.6 67.5 137.1 5.7 28.8 7.1 0.1 22.7 12.4 45.5 0.2 103.9 92.2 364.2 4.5 8.9 2.0 9.6 89.2 27.3 55.8 0.1 32.0 29.7 14.7 24.5 11.0 7.3 4.2 32.9 28.8 44.7 38.5 25.1 19.6 4.0 119.3 154.9 137.4 82.0 74.7 88.6 157.6 60.3 51.5 36.0 42.3 246.0 155.3 3.0 17.2 3.9 186.8 34.0 65.8 112.8 135.5 38.5 21.9 102.7 144.9 351.8 88.9 34.1 90.2 7.6 15.9 129.5 96.6 79.5 18.5 29.7 57.3 59.0 100.9 82.1 10.7 35.8 96.4 30.2 34.7 105.1 6.0 4.1 9.0 4.3 203.7 28.0 245.6 0.6 132.6 2.4 15.3 47.8 80.8 177.5 30.0 270.6 19.4 18.4 51.8 59.8 66.9 22.7 20.9 47.0 67.1 ACTR1A "ARP1, Arp1A" ENSG00000138107 "Actin related protein 1A" P61163 10 102461881-102502712 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037193, HPA047443" Approved Approved Microtubules NA NA 560000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 1: Pancreatic cells - Digestion" Microtubules "CAB037193: AB_258253, HPA047443: AB_2680049" "unprognostic (9.64e-3)" "unprognostic (1.92e-2)" "unprognostic (8.34e-2)" "unprognostic (4.05e-2)" "unprognostic (2.57e-1)" "unprognostic (3.48e-1)" "unprognostic (2.20e-3)" "unprognostic (2.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.66e-2)" "unprognostic (7.77e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-1)" "unprognostic (3.10e-1)" "unprognostic (4.13e-1)" 59.4 58.8 98.3 39.4 100.6 36.8 51.5 101.9 108.4 50.9 78.4 90.0 37.8 61.8 37.5 61.6 47.4 36.1 93.0 101.9 108.0 49.0 40.4 58.5 33.7 116.3 105.9 36.9 41.9 56.5 54.7 45.3 116.9 53.0 41.7 41.9 46.4 51.9 174.3 65.1 49.1 69.0 97.4 48.7 56.2 40.4 104.0 56.8 41.2 127.0 42.2 74.8 51.2 104.4 80.5 95.8 113.5 117.1 138.0 109.2 45.5 100.3 177.3 154.4 142.4 52.7 63.3 54.4 75.2 149.5 76.2 78.3 109.9 123.7 106.5 70.7 75.8 72.9 53.4 77.9 99.6 56.9 65.0 112.4 89.6 141.2 100.7 155.7 201.6 88.7 60.5 53.5 154.6 67.1 103.5 97.9 45.4 62.5 86.2 78.5 146.0 35.0 125.2 43.9 40.5 88.8 60.1 35.4 75.1 98.3 130.0 38.9 147.0 74.7 71.5 83.6 102.1 54.0 58.8 63.3 78.7 98.3 45.9 32.2 40.7 44.3 31.1 51.8 25.5 18.8 22.0 30.4 40.6 17.6 18.0 20.7 31.2 23.9 57.0 20.8 33.6 39.2 98.3 100.6 101.9 108.4 101.9 108.0 116.3 105.9 116.9 97.4 104.0 104.4 40.0 57.7 41.0 10.1 23.4 33.8 24.0 42.3 13.1 26.6 22.1 17.1 51.6 14.3 34.8 27.6 16.7 54.9 23.8 52.4 54.8 75.5 53.0 15.3 21.0 45.2 39.6 45.9 14.9 77.5 63.3 36.9 23.4 19.3 32.3 27.3 34.6 24.1 73.9 26.9 15.5 24.4 46.8 37.6 38.2 53.9 33.2 44.5 51.6 5.6 70.3 31.5 38.1 10.1 15.3 92.0 36.8 36.1 30.0 26.7 40.9 45.6 26.5 24.5 46.0 17.1 48.5 61.9 14.0 27.3 32.4 104.7 28.2 32.9 24.2 26.6 ADH1C ADH3 ENSG00000248144 "Alcohol dehydrogenase 1C (class I), gamma polypeptide" P00326 4 99336497-99352746 "Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "intestine: 598.1;liver: 2062.2;stomach 1: 570.6" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 699.4;Gastric mucus-secreting cells: 611.2;Hepatocytes: 440.6;Undifferentiated cells: 420.5" "Cancer enriched" "Detected in many" 7 "liver cancer: 238.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.1;ASC TERT1: 3.6;HSkMC: 11.9;RPMI-8226: 2.1" "HPA047814, HPA060902" Supported Supported "Plasma membrane,Cytosol" NA NA 31000000 "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane, Cytosol" "HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (3.98e-2)" "unprognostic (9.88e-3)" "unprognostic (7.04e-2)" "unprognostic (1.90e-1)" "unprognostic (5.14e-1)" "unprognostic (1.57e-1)" "prognostic favorable (4.55e-4)" "prognostic favorable (2.99e-4)" "unprognostic (8.25e-2)" "unprognostic (8.89e-3)" "unprognostic (7.95e-2)" "unprognostic (2.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.21e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (9.37e-2)" 22.9 0.8 0.1 29.8 0.1 0.0 19.2 0.1 0.1 4.7 0.0 329.5 598.1 5.1 7.2 5.1 5.8 51.6 5.9 0.1 0.0 19.6 2062.2 2.9 0.6 0.1 0.1 4.0 16.7 0.1 1.6 0.1 0.1 9.4 191.9 0.0 19.3 6.2 23.9 0.7 190.7 16.3 0.1 0.7 570.6 0.8 0.1 0.5 2.9 31.1 0.5 5.9 3.6 0.2 0.0 2.1 0.0 0.0 1.4 3.6 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.2 1.1 0.3 11.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.8 0.2 0.0 0.1 0.1 0.8 2.1 0.8 0.0 0.3 1.1 0.5 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.3 0.1 0.1 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 2.1 3.2 7.3 0.7 1.3 0.0 4.0 0.0 25.0 0.0 0.1 0.3 1.0 64.3 24.8 29.5 0.0 0.0 0.1 108.4 0.0 159.5 2.3 1.3 0.8 1.2 21.6 29.5 0.3 699.4 0.0 21.1 611.2 1.3 0.0 0.0 13.2 440.6 0.0 0.0 0.2 86.3 0.0 13.2 0.0 1.0 10.5 0.8 0.0 0.0 2.0 0.0 0.0 0.5 0.1 66.3 120.8 0.0 0.6 3.1 59.4 1.4 43.7 0.0 0.0 1.3 2.0 0.0 0.7 10.6 0.0 0.0 1.8 1.6 420.5 3.6 AGTRAP ATRAP ENSG00000177674 "Angiotensin II receptor associated protein" Q6RW13 1 11736084-11754802 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 446.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 196.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044120 Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" Vesicles "Golgi apparatus" "HPA044120: AB_10960748" "unprognostic (1.08e-3)" "unprognostic (2.98e-3)" "unprognostic (6.10e-2)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (7.92e-3)" "prognostic unfavorable (6.57e-7)" "unprognostic (4.44e-2)" "unprognostic (7.96e-2)" "unprognostic (4.31e-2)" "unprognostic (1.61e-2)" "unprognostic (7.22e-2)" "unprognostic (1.61e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (2.33e-3)" "unprognostic (5.89e-2)" 44.1 50.3 26.6 30.2 28.5 132.3 44.3 27.1 32.4 34.6 44.0 29.3 11.2 24.7 47.7 53.6 48.3 25.2 37.0 24.5 30.5 65.8 29.5 62.3 23.4 37.3 28.8 26.9 67.3 25.7 31.2 22.0 31.3 79.1 9.3 3.4 39.0 21.0 54.3 38.8 25.7 20.3 28.4 83.4 33.7 24.7 31.8 11.3 40.8 12.4 13.3 43.9 43.3 31.1 55.9 66.7 16.7 36.9 27.5 34.9 30.5 28.6 49.0 34.8 30.2 42.0 129.7 5.4 126.7 35.4 87.3 45.8 27.9 135.3 10.7 3.1 61.5 1.6 38.4 51.8 84.9 27.6 64.3 34.6 105.4 112.9 59.2 42.4 46.9 17.3 73.8 52.8 19.8 44.6 13.7 80.9 29.7 24.0 67.3 4.6 15.0 27.5 56.7 5.2 14.6 22.0 52.5 26.4 48.4 22.3 59.8 57.4 26.0 44.1 30.8 70.3 30.9 19.6 24.2 33.3 111.7 196.1 20.7 483.4 844.2 694.6 185.7 442.7 90.4 47.0 66.9 109.8 312.2 38.2 72.0 93.5 756.8 73.0 385.2 25.5 90.8 577.4 26.6 28.5 27.1 32.4 24.5 30.5 37.3 28.8 31.3 28.4 31.8 31.1 46.2 22.4 27.4 3.9 12.1 11.6 30.7 112.4 16.5 1.0 54.8 56.0 12.0 32.9 41.6 36.8 6.2 15.7 60.1 6.9 9.8 95.5 20.6 75.3 30.8 36.1 7.2 21.0 0.2 446.7 92.4 45.3 11.2 41.1 88.0 19.1 42.1 7.7 118.3 3.3 0.2 12.3 20.3 143.5 18.9 23.4 37.9 97.8 28.4 1.9 107.4 19.4 122.6 0.5 7.0 96.9 22.5 27.1 8.6 66.5 8.6 55.3 78.5 5.6 13.1 13.0 23.8 3.5 36.1 34.4 13.5 13.1 45.0 50.4 18.2 25.2 AJUBA "JUB, MGC15563" ENSG00000129474 "Ajuba LIM protein" Q96IF1 14 22971177-22982551 "Cancer-related genes, Predicted intracellular proteins" "Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 61.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 47.5;Basal squamous epithelial cells: 35.3;Pancreatic endocrine cells: 33.8;Prostatic glandular cells: 34.2;Sertoli cells: 32.9;Suprabasal keratinocytes: 49.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 217.0;hTCEpi: 222.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA006171 Approved Approved "Nucleoplasm,Golgi apparatus" NA Yes "Cluster 11: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Golgi apparatus" "HPA006171: AB_1852044" "unprognostic (1.15e-1)" "unprognostic (2.99e-2)" "unprognostic (2.39e-1)" "unprognostic (1.24e-3)" "unprognostic (9.81e-2)" "unprognostic (1.49e-1)" "unprognostic (1.80e-3)" "unprognostic (2.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.47e-1)" "unprognostic (3.19e-3)" "unprognostic (2.94e-1)" "unprognostic (2.68e-1)" "unprognostic (9.35e-3)" "unprognostic (2.07e-1)" 4.8 3.0 2.3 1.4 1.8 0.5 6.7 2.0 2.2 14.4 9.2 3.2 1.5 12.1 8.5 18.3 7.5 4.9 6.3 2.2 1.5 17.7 43.4 15.2 2.6 2.5 2.1 12.2 11.6 7.2 2.0 19.3 1.6 10.6 2.5 3.7 8.2 15.9 1.9 61.7 1.9 8.4 2.2 3.8 4.2 5.5 1.9 8.2 10.9 2.3 5.5 7.6 15.5 2.7 46.9 54.1 71.0 27.6 6.8 12.2 57.4 44.9 58.5 102.6 91.4 116.0 47.3 1.2 45.5 92.9 70.8 146.2 54.9 217.0 124.6 4.5 5.0 3.5 90.8 131.4 78.9 4.9 3.1 38.9 222.3 42.9 164.3 72.7 40.0 8.3 1.9 2.8 96.2 37.3 4.5 5.7 4.5 86.6 73.9 12.7 59.0 1.2 103.9 71.3 0.2 6.2 135.5 39.4 8.8 57.4 55.3 4.5 36.1 44.2 88.4 7.3 43.6 0.4 1.3 0.5 7.0 4.2 20.6 0.7 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.5 0.1 0.2 0.3 0.2 0.5 0.5 0.2 0.2 0.0 0.1 2.3 1.8 2.0 2.2 2.2 1.5 2.5 2.1 1.6 2.2 1.9 2.7 2.1 19.2 6.4 0.7 0.0 47.5 13.0 27.6 35.3 0.1 3.7 9.7 4.5 20.0 10.2 7.3 0.0 10.0 0.1 0.3 5.9 14.3 5.8 13.0 2.5 4.0 0.0 0.0 0.0 14.9 9.8 3.4 0.0 4.4 0.0 12.8 2.5 17.1 1.7 0.0 0.0 0.4 2.0 0.0 2.2 5.0 3.7 0.6 3.6 0.0 0.0 8.1 0.0 0.5 0.0 33.8 0.1 0.7 1.2 34.2 0.3 21.0 8.3 0.2 32.9 2.7 14.0 7.0 2.7 14.2 49.6 4.0 0.5 1.6 0.8 18.0 AKR1C3 "DDX, HAKRB, HSD17B5, KIAA0119, PGFS" ENSG00000196139 "Aldo-keto reductase family 1 member C3" P42330 10 5035354-5107686 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 441.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 393.1;Exocrine glandular cells: 722.5;Proximal enterocytes: 576.9;Proximal tubular cells: 601.8" "Cancer enhanced" "Detected in all" "liver cancer: 83.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 244.0;gdT-cell: 102.6" "Group enriched" "Detected in many" 4 "granulocytes: 244.0;T-cells: 102.6" "Cell line enhanced" "Detected in many" "A549: 1615.1;ASC diff: 811.9;Hep G2: 699.6;OE19: 3025.3;RT4: 639.2" "CAB010874, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 19000000 "Cluster 38: Basophils - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB010874: AB_476751, HPA068265: AB_2685966" "unprognostic (4.20e-3)" "unprognostic (2.70e-2)" "unprognostic (8.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.41e-1)" "unprognostic (6.74e-2)" "unprognostic (5.08e-2)" "unprognostic (1.31e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (4.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.79e-3)" "unprognostic (4.24e-3)" 164.4 50.2 31.1 25.4 34.6 42.3 115.2 32.1 42.4 21.9 30.2 185.9 441.3 25.9 4.4 53.2 42.1 261.1 42.9 31.5 35.6 177.7 268.0 48.3 7.6 30.3 33.9 17.8 36.4 22.5 10.4 4.7 32.3 10.3 98.0 19.1 40.5 19.4 116.9 27.0 270.9 39.2 30.3 3.8 237.4 10.0 31.5 37.4 26.4 34.8 6.6 84.7 22.2 31.1 0.1 1615.1 1.1 413.0 811.9 292.2 1.0 0.0 21.4 0.4 1.4 47.6 24.5 0.2 78.7 19.4 45.0 11.5 1.5 28.8 1.1 3.0 0.5 3.2 438.4 699.6 4.3 0.7 0.2 160.9 57.1 20.0 0.7 25.8 28.1 3.4 10.8 0.0 42.6 3.8 9.8 2.6 0.7 3025.3 4.3 3.3 9.6 43.7 149.0 639.2 1.0 2.9 232.2 0.0 0.3 0.9 0.5 0.2 221.7 5.2 4.7 87.8 3.1 0.7 0.7 0.3 45.8 62.8 4.4 244.0 2.9 4.8 102.6 0.9 6.9 0.0 19.0 18.7 2.1 0.5 11.6 8.9 7.3 21.1 1.4 39.6 21.4 42.4 31.1 34.6 32.1 42.4 31.5 35.6 30.3 33.9 32.3 30.3 31.5 31.1 144.2 44.8 5.3 4.9 4.3 12.0 3.7 393.1 2.8 2.0 15.8 5.5 3.9 0.0 172.9 36.8 0.0 0.4 64.4 133.8 43.0 114.6 3.3 67.5 4.5 67.5 19.2 34.9 2.5 722.5 0.0 44.3 158.0 66.4 5.7 0.1 0.0 0.0 1.6 1.7 3.2 65.9 61.1 0.0 14.0 4.9 78.3 14.8 21.4 7.5 4.1 132.7 202.9 14.6 0.0 266.1 219.6 106.8 3.1 1.3 576.9 601.8 112.8 5.3 26.3 15.5 20.3 0.5 4.3 20.2 10.7 0.0 14.4 7.8 196.9 46.4 AMY2A AMY2 ENSG00000243480 "Amylase alpha 2A" P04746 1 103616811-103625780 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1983 "pancreas: 148689.6" "Cell type enriched" "Detected in some" 114 "Exocrine glandular cells: 1016.0" "Cancer enriched" "Detected in single" 2010 "pancreatic cancer: 200.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045394, HPA045399, CAB045960, HPA046980" Enhanced "Secreted to digestive system" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 1: Pancreatic cells - Digestion" "CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889" "unprognostic (3.27e-1)" "unprognostic (1.78e-3)" "unprognostic (3.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.13e-2)" 6.0 1.3 1.2 2.8 1.3 0.3 3.9 0.7 1.4 3.3 0.6 1.7 22.5 2.9 0.1 2.3 0.8 0.0 26.6 1.2 0.9 1.5 4.7 1.0 5.4 0.8 0.9 74.9 148689.6 0.1 1.5 8.3 0.8 2.1 0.0 0.6 30.0 0.0 1.5 1.4 10.7 0.0 0.7 1.7 2.2 1.2 0.9 0.0 1.1 0.0 0.0 0.5 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.7 1.4 1.2 0.9 0.8 0.9 0.8 0.7 0.9 1.0 0.1 0.0 0.0 2.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 0.0 0.0 0.2 0.0 0.0 1.3 1016.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 4.6 0.0 0.0 0.0 0.1 8.9 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.2 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.6 AMY2B AMY2 ENSG00000240038 "Amylase alpha 2B" P19961 1 103553815-103579534 "Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 122 "pancreas: 31246.7" "Cell type enhanced" "Detected in many" "Astrocytes: 56.2;Excitatory neurons: 61.2;Exocrine glandular cells: 148.0;Inhibitory neurons: 48.4;Oligodendrocytes: 41.8" "Cancer enriched" "Detected in many" 15 "pancreatic cancer: 25.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 5.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 9.8;EFO-21: 10.3" "HPA045394, HPA045399, HPA046980" Supported "Secreted to digestive system" NA NA 77000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 25: Pancreas - Digestion" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889" "unprognostic (8.69e-4)" "unprognostic (3.71e-3)" "unprognostic (6.41e-2)" "unprognostic (9.75e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-4)" "unprognostic (1.21e-2)" "unprognostic (1.63e-2)" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (1.07e-1)" "unprognostic (2.49e-2)" "unprognostic (7.41e-3)" "unprognostic (1.55e-2)" "unprognostic (5.74e-2)" "unprognostic (4.22e-1)" "unprognostic (3.12e-4)" 35.4 24.8 29.5 11.2 34.8 13.4 34.9 39.9 38.6 40.8 19.7 33.0 16.5 22.7 20.2 13.1 50.3 14.1 40.9 27.9 29.5 59.4 39.0 30.2 20.0 27.7 29.1 40.0 31246.7 14.9 36.8 6.9 27.1 35.3 11.9 69.8 256.2 14.6 63.7 42.6 31.7 9.8 26.3 34.8 18.1 5.2 30.6 12.6 63.5 25.2 13.8 29.3 25.8 30.0 0.0 0.5 1.1 0.0 5.6 9.8 1.1 0.8 0.8 0.6 1.5 0.0 0.2 1.0 10.3 0.3 0.0 1.2 0.1 1.3 1.4 1.3 1.6 1.9 4.5 0.8 0.8 2.5 2.6 6.7 6.7 0.8 1.2 1.8 0.2 3.0 0.0 3.2 0.9 0.0 1.9 0.5 0.1 0.1 1.4 0.5 0.0 4.7 5.7 2.0 2.8 0.6 2.4 1.1 0.8 1.8 0.1 1.4 0.8 0.3 0.9 0.5 0.7 3.5 0.1 0.3 1.9 1.8 0.2 0.0 5.0 1.0 0.4 2.5 0.3 1.0 0.1 0.2 1.6 0.9 0.6 0.2 1.2 0.1 2.2 0.5 0.2 1.2 29.5 34.8 39.9 38.6 27.9 29.5 27.7 29.1 27.1 26.3 30.6 30.0 2.8 12.8 20.1 56.2 3.2 4.7 4.2 1.4 0.6 11.7 2.9 2.7 7.2 2.8 11.2 1.8 33.3 0.4 2.4 3.6 0.0 1.3 7.3 1.1 0.6 2.7 4.9 1.3 61.2 148.0 0.4 3.2 2.0 0.7 3.8 0.5 2.2 6.5 1.6 10.1 48.4 2.5 0.0 9.4 3.5 2.7 2.5 3.4 5.4 11.2 4.0 3.1 2.1 22.1 41.8 1.3 2.7 1.9 1.4 1.5 4.3 0.8 14.6 15.4 0.0 1.0 2.5 1.5 0.9 0.4 3.0 0.3 1.7 0.4 2.2 1.6 ANKRD36C DKFZp667P0924 ENSG00000174501 "Ankyrin repeat domain 36C" Q5JPF3 2 95836919-95991831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 615.1;Gastric mucus-secreting cells: 498.9;Inhibitory neurons: 290.7;Pancreatic endocrine cells: 311.5;Urothelial cells: 411.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 30.9" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 6: Brain - Smell perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (2.21e-1)" "unprognostic (5.39e-2)" "unprognostic (6.32e-2)" "unprognostic (2.50e-1)" "unprognostic (1.83e-1)" "unprognostic (3.79e-3)" "unprognostic (1.29e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.44e-2)" "unprognostic (5.29e-3)" "unprognostic (5.35e-6)" "unprognostic (9.99e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" 2.0 1.5 5.3 2.1 9.3 16.3 6.1 24.0 8.9 2.6 1.5 2.8 1.2 3.8 2.3 2.3 3.1 4.8 1.4 4.2 9.3 1.2 0.6 2.6 3.5 9.4 5.9 6.0 1.8 1.6 1.6 1.5 11.3 1.9 2.6 10.6 14.6 1.5 0.7 3.6 1.6 1.9 2.6 2.9 5.4 12.0 9.7 6.5 1.6 0.9 2.9 3.2 1.9 25.8 8.4 1.6 3.3 2.3 2.1 5.7 1.3 1.9 1.4 2.5 3.3 1.9 1.9 8.3 2.5 1.4 2.5 1.9 3.0 1.5 3.2 4.8 4.1 3.2 4.5 2.4 0.5 9.9 2.4 1.7 1.2 2.0 1.0 2.5 4.3 11.7 3.3 10.2 2.8 1.2 7.7 3.7 0.7 0.4 30.9 4.0 2.5 3.3 1.3 1.6 3.0 2.7 1.3 2.1 1.3 1.2 1.0 2.3 4.8 3.1 3.4 2.4 2.4 3.8 3.4 8.9 0.9 6.7 1.3 48.0 3.3 2.8 20.8 0.5 13.4 17.1 16.7 13.9 2.5 19.5 14.5 14.2 0.2 12.6 1.0 35.0 15.6 1.3 5.3 9.3 24.0 8.9 4.2 9.3 9.4 5.9 11.3 2.6 9.7 25.8 32.3 38.5 19.9 123.1 26.9 10.7 53.4 33.6 11.4 84.4 38.4 20.8 29.1 4.3 91.0 9.2 79.2 0.3 47.2 23.5 0.0 226.3 118.4 42.6 28.7 25.8 21.0 27.1 227.9 615.1 0.8 26.3 498.9 25.8 34.1 41.3 15.4 1.5 8.3 33.7 290.7 70.2 12.2 7.0 14.7 17.7 32.6 15.9 14.2 46.9 27.4 15.8 50.4 147.8 177.7 311.5 8.4 36.5 48.7 145.8 7.7 0.9 82.3 72.9 19.7 56.1 31.0 178.7 22.4 7.7 7.4 0.3 47.5 13.1 22.0 411.9 ANXA4 ANX4 ENSG00000196975 "Annexin A4" P09525 2 69644425-69827112 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 569.9;pancreas: 356.8" "Cell type enhanced" "Detected in all" "Cholangiocytes: 2344.8;Ductal cells: 1469.8;Proximal enterocytes: 657.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 414.2;Hep G2: 456.9;RPTEC TERT1: 623.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005076, HPA007393, CAB017560" Enhanced Approved Cytosol NA NA 550000 "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 1: Pancreatic cells - Digestion" Cytosol "CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168" "prognostic unfavorable (8.55e-4)" "unprognostic (3.37e-2)" "unprognostic (4.82e-2)" "unprognostic (9.03e-2)" "unprognostic (1.62e-3)" "unprognostic (1.66e-1)" "unprognostic (3.57e-1)" "unprognostic (3.21e-1)" "unprognostic (4.52e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (7.23e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.79e-1)" "unprognostic (8.85e-2)" "unprognostic (3.60e-2)" "unprognostic (3.97e-2)" 48.2 21.6 14.5 33.6 15.4 30.8 45.9 14.9 18.9 62.4 52.4 101.7 271.3 50.9 30.3 43.0 68.6 569.9 26.1 14.4 15.2 104.0 120.9 81.6 21.1 15.6 15.1 38.8 356.8 78.0 11.9 52.7 15.8 46.3 92.3 30.0 39.2 52.1 17.2 61.0 232.4 52.0 15.7 24.2 108.2 9.7 15.2 23.0 43.6 20.4 24.0 61.3 50.2 16.6 69.6 249.4 3.4 31.0 185.0 158.3 11.3 66.0 101.5 27.1 38.0 37.9 121.7 22.8 414.2 109.5 78.9 104.7 23.8 108.1 27.6 65.2 20.3 35.0 20.5 456.9 131.2 12.5 43.0 95.9 104.8 36.5 87.3 62.9 71.1 11.0 2.0 20.1 74.7 63.8 18.3 22.8 6.1 280.0 34.3 19.4 6.8 28.3 623.2 99.1 5.1 22.9 72.9 99.5 103.8 35.6 33.3 156.3 100.9 49.2 23.8 65.5 37.7 8.2 9.7 1.3 75.8 59.7 34.1 80.4 34.7 29.6 23.1 42.5 17.5 40.6 11.7 17.5 50.6 46.7 2.0 12.5 4.9 9.5 58.7 15.5 14.5 24.2 14.5 15.4 14.9 18.9 14.4 15.2 15.6 15.1 15.8 15.7 15.2 16.6 66.4 205.1 154.8 47.3 27.3 74.2 98.5 148.2 68.9 8.2 36.8 36.4 10.6 2344.8 139.4 84.6 6.2 86.4 27.2 315.1 221.1 1469.8 14.6 257.9 79.0 49.1 18.6 12.6 29.9 344.4 370.1 103.6 196.7 488.8 111.5 24.3 33.9 68.5 227.6 8.4 17.7 193.8 240.1 46.1 80.4 11.2 64.7 54.5 92.5 63.7 87.2 48.7 45.3 17.6 106.0 245.7 268.6 92.2 6.9 55.6 657.1 400.4 230.2 59.9 6.6 27.6 64.6 15.8 3.7 61.3 79.6 439.6 32.5 19.1 174.1 96.9 ASCL5 bHLHa47 ENSG00000232237 "Achaete-scute family bHLH transcription factor 5" Q7RTU5 1 201113953-201127184 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "pancreas: 2.1" "Cell type enhanced" "Detected in single" "Oligodendrocyte precursor cells: 1.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.8;cerebral cortex: 2.1;hippocampal formation: 1.6" "Not detected" "Not detected" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (9.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.52e-2)" "unprognostic (6.32e-2)" "unprognostic (9.43e-2)" "unprognostic (8.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.37e-1)" "unprognostic (4.84e-2)" "unprognostic (9.50e-2)" "unprognostic (7.48e-2)" "unprognostic (9.82e-2)" "unprognostic (2.25e-7)" "unprognostic (2.95e-1)" "unprognostic (1.38e-1)" "unprognostic (4.70e-2)" "unprognostic (1.48e-2)" 0.0 0.1 0.5 0.0 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.8 0.8 0.0 0.0 0.1 0.1 0.2 0.1 0.3 2.1 0.0 0.2 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.6 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.5 0.8 0.8 0.2 0.1 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 ASPHD1 ENSG00000174939 "Aspartate beta-hydroxylase domain containing 1" Q5U4P2 16 29900375-29919864 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 138.6;choroid plexus: 79.3;pituitary gland: 36.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 27.1;Enteroendocrine cells: 29.4;Excitatory neurons: 25.1;Gastric mucus-secreting cells: 32.1;Inhibitory neurons: 22.6;Oligodendrocytes: 29.3;Pancreatic endocrine cells: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 61.7;Hep G2: 79.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045175 Uncertain NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 1: Pancreatic cells - Digestion" "HPA045175: AB_10959899" "unprognostic (1.58e-1)" "unprognostic (5.50e-2)" "unprognostic (4.74e-3)" "unprognostic (2.20e-3)" "unprognostic (1.34e-3)" "unprognostic (6.96e-2)" "unprognostic (5.75e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-2)" "unprognostic (8.37e-2)" "prognostic favorable (7.38e-4)" "unprognostic (5.55e-2)" "unprognostic (6.17e-2)" "unprognostic (1.97e-2)" "unprognostic (1.90e-1)" "unprognostic (2.97e-1)" "unprognostic (9.03e-2)" 5.5 5.1 113.3 0.7 119.8 0.1 0.8 106.3 138.6 1.3 79.3 1.3 2.5 3.0 0.1 0.4 1.3 14.8 0.8 108.6 101.7 4.4 0.7 1.1 0.2 113.3 113.9 1.3 9.1 0.8 36.4 0.2 111.9 1.5 0.9 2.3 4.9 0.5 0.2 0.3 1.7 1.4 110.4 0.3 20.9 5.9 110.1 0.0 0.1 0.2 0.2 0.8 0.4 117.6 3.3 14.5 0.0 16.7 0.0 2.4 0.9 15.8 5.1 18.0 12.9 35.1 61.7 6.2 39.4 10.5 13.0 2.4 2.0 4.2 3.4 1.0 2.4 3.1 50.9 79.1 29.1 0.7 40.5 18.3 3.9 26.7 2.7 19.4 0.7 11.3 0.2 13.1 4.3 32.1 0.9 0.6 23.0 13.7 13.8 1.2 0.0 2.5 18.4 0.4 47.3 19.3 0.2 26.1 5.2 0.3 10.0 11.9 1.2 7.5 13.2 0.4 4.5 1.1 0.4 0.6 23.7 41.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 113.3 119.8 106.3 138.6 108.6 101.7 113.3 113.9 111.9 110.4 110.1 117.6 0.7 0.0 5.1 4.9 0.1 0.6 4.8 2.5 0.0 19.2 4.3 3.9 0.3 27.1 0.5 1.8 4.2 0.0 0.0 2.6 1.9 17.3 1.9 0.7 9.4 0.9 29.4 0.0 25.1 20.2 0.4 7.8 32.1 1.4 1.3 0.5 0.0 0.2 4.0 6.7 22.6 4.2 6.1 0.0 0.3 1.2 0.3 0.9 1.8 5.6 0.0 1.7 0.0 9.0 29.3 29.3 0.3 0.7 0.1 8.1 1.7 3.7 0.3 10.2 0.0 0.2 2.5 1.2 1.0 0.0 0.6 0.3 0.2 4.8 4.2 2.8 BMF FLJ00065 ENSG00000104081 "Bcl2 modifying factor" Q96LC9 15 40087890-40108892 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 76.0" "Cell type enhanced" "Detected in many" "Ductal cells: 14.9;Exocrine glandular cells: 15.1;Kupffer cells: 18.7;Langerhans cells: 12.8;monocytes: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 43.3;HMC-1: 44.2;hTERT-RPE1: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010120 Approved Approved Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 63: T-cells - Adaptive immune response" "Cluster 20: HeLa - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA010120: AB_1845385" "unprognostic (2.94e-1)" "unprognostic (4.92e-3)" "unprognostic (7.63e-2)" "unprognostic (4.44e-1)" "unprognostic (1.89e-1)" "prognostic favorable (1.83e-4)" "prognostic unfavorable (6.32e-4)" "unprognostic (1.42e-2)" "unprognostic (4.26e-1)" "unprognostic (3.75e-1)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (7.06e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-2)" "unprognostic (2.35e-2)" 3.7 2.9 1.9 12.6 1.8 33.0 5.7 2.2 3.0 9.6 3.9 10.1 21.2 15.8 7.2 2.9 11.9 12.2 5.3 1.2 3.5 10.7 3.4 12.8 13.7 4.3 3.0 14.1 7.7 6.0 2.7 6.4 4.1 6.0 8.4 3.0 10.4 4.7 5.1 5.3 23.6 10.1 3.4 18.9 10.1 2.1 5.0 76.0 17.1 5.3 23.5 7.5 3.8 6.4 1.0 1.4 22.9 5.1 0.6 0.9 15.5 0.1 3.6 0.4 1.1 23.6 1.7 6.8 7.3 1.0 7.0 4.9 5.7 0.1 0.1 16.0 4.7 3.5 43.3 5.5 2.1 0.6 44.2 11.3 1.3 0.4 0.4 57.0 6.0 5.0 1.9 2.9 2.0 1.3 2.3 17.6 6.2 11.8 0.8 4.3 5.2 20.4 1.0 5.4 12.1 9.8 4.4 11.6 10.6 24.3 6.9 13.8 4.6 0.8 3.1 0.7 0.3 28.1 28.4 4.3 1.6 3.3 2.7 0.0 2.6 2.4 0.1 2.9 0.2 2.9 0.2 0.8 1.6 0.9 0.4 0.0 3.2 0.0 4.0 2.0 0.7 0.7 1.9 1.8 2.2 3.0 1.2 3.5 4.3 3.0 4.1 3.4 5.0 6.4 2.3 3.2 2.2 0.3 7.3 1.1 0.9 1.0 1.2 0.2 2.1 1.3 1.6 4.3 5.0 0.0 0.0 1.4 0.7 7.9 0.0 14.9 1.3 5.9 1.2 3.8 1.2 3.2 0.1 15.1 1.3 2.3 1.5 8.5 0.0 0.8 1.4 1.0 8.4 0.0 0.8 1.1 6.1 18.7 12.8 0.5 1.8 8.8 0.0 3.7 14.2 0.3 0.0 0.5 0.5 10.9 1.2 0.7 7.0 1.7 9.6 2.4 1.0 0.8 0.0 1.3 1.3 0.4 1.4 0.9 0.6 1.8 3.5 0.2 1.2 1.0 BRS3 "BB3, BB3R, BBR3" ENSG00000102239 "Bombesin receptor subtype 3" P32247 X 136487947-136493780 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "epididymis: 25.7" "Cell type enhanced" "Detected in single" "Spermatogonia: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "hypothalamus: 6.1" "Low region specificity" "Detected in many" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (1.49e-1)" "unprognostic (1.31e-1)" "unprognostic (2.07e-1)" "unprognostic (1.79e-2)" "unprognostic (3.73e-6)" "unprognostic (1.59e-1)" "unprognostic (1.86e-1)" "unprognostic (5.59e-2)" 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 25.7 0.0 0.8 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BSPRY FLJ20150 ENSG00000119411 "B-box and SPRY domain containing" Q5W0U4 9 113349541-113371233 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "parathyroid gland: 447.2" "Cell type enhanced" "Detected in many" "Breast glandular cells: 61.9;Ductal cells: 66.8;Exocrine glandular cells: 65.8;Pancreatic endocrine cells: 48.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 21 "plasmacytoid DC: 4.4" "Lineage enriched" "Detected in single" 21 "dendritic cells: 4.4" "Cell line enhanced" "Detected in many" "A-431: 41.8;CAPAN-2: 25.9;MCF7: 62.0;OE19: 70.9;RPMI-8226: 32.3;SK-BR-3: 29.9;T-47d: 30.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 3.8" "HPA042889, HPA077485" Approved Uncertain Nucleoplasm,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm Cytosol "HPA042889: AB_10795515, HPA077485: " "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "unprognostic (1.18e-1)" "unprognostic (2.20e-3)" "unprognostic (1.68e-1)" "unprognostic (2.10e-3)" "unprognostic (4.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (1.95e-2)" "prognostic favorable (4.56e-14)" "unprognostic (1.15e-3)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.70e-1)" 0.3 3.1 3.7 2.6 11.3 5.9 14.6 5.9 4.2 6.5 1.2 12.0 8.8 1.1 10.9 30.1 4.4 4.4 1.5 2.5 3.0 14.4 0.8 5.6 0.8 2.1 4.8 0.0 41.7 447.2 8.3 1.7 1.7 5.0 11.0 6.9 81.6 4.5 0.0 26.3 7.0 0.7 1.7 0.5 24.7 2.8 5.9 1.8 30.3 0.1 3.1 3.0 7.6 2.5 41.8 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 8.6 25.9 0.0 0.4 0.0 0.0 3.6 0.4 0.0 0.0 4.6 3.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 20.8 0.3 0.0 0.0 62.0 0.7 0.0 1.0 70.9 0.0 0.9 0.0 32.3 4.0 8.8 13.7 0.0 0.0 29.9 0.0 1.7 30.3 4.3 0.0 0.0 0.0 0.1 0.0 9.7 13.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.4 0.0 0.0 3.7 11.3 5.9 4.2 2.5 3.0 2.1 4.8 1.7 1.7 5.9 2.5 0.3 6.4 6.9 0.0 2.5 1.0 2.0 4.4 0.0 1.8 61.9 31.2 2.8 17.2 9.5 27.6 6.2 9.2 9.9 20.8 39.2 66.8 0.5 11.3 1.6 0.9 20.4 15.6 1.0 65.8 1.1 0.7 21.4 17.3 3.8 1.5 0.0 0.8 1.4 0.0 3.2 19.1 12.2 0.3 0.3 0.6 0.0 0.5 10.6 0.0 1.0 0.8 3.1 0.5 0.2 48.6 14.5 0.0 2.5 13.8 13.5 21.2 9.7 12.1 0.0 0.0 1.7 0.6 4.3 26.4 14.2 6.7 1.3 0.1 24.9 17.7 BX255925.3 ENSG00000284976 "Novel RING finger protein" 9 137217452-137219361 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Breast glandular cells: 10.3;Endometrial ciliated cells: 9.0;Exocrine glandular cells: 24.4;Glandular and luminal cells: 10.1;Pancreatic endocrine cells: 33.7;Theca cells: 17.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 1: Pancreatic cells - Digestion" 3.5 8.2 14.7 5.9 15.9 14.6 3.3 13.9 19.8 3.1 11.9 6.8 13.4 2.8 3.2 14.8 4.3 4.1 3.5 13.7 13.6 2.9 2.1 3.9 7.9 16.8 15.2 1.7 11.7 3.3 2.7 15.5 7.1 3.1 3.3 13.3 4.3 3.5 15.5 11.7 2.2 14.3 6.7 17.5 8.8 15.5 6.6 2.5 1.3 5.8 3.1 18.2 11.8 18.8 10.9 14.2 5.0 4.9 42.7 13.5 7.2 13.7 9.8 17.5 13.2 17.1 9.3 4.8 10.3 41.7 6.9 9.8 2.9 19.0 19.5 10.0 52.0 15.9 8.3 14.7 32.0 6.5 9.0 15.7 4.2 3.7 6.4 16.3 24.9 14.0 4.8 32.9 13.1 42.3 19.0 26.4 64.6 32.8 14.8 20.0 5.9 11.5 14.2 16.2 12.0 14.4 11.0 3.9 37.3 22.8 7.8 21.1 24.0 34.3 16.9 11.2 20.4 14.8 12.0 16.8 16.1 0.0 0.8 1.8 0.7 1.0 1.1 0.6 0.5 0.4 0.5 0.7 0.3 0.3 1.4 0.9 0.5 2.1 0.6 2.4 14.7 15.9 13.9 19.8 13.7 13.6 16.8 15.2 15.5 14.3 15.5 18.2 1.5 6.4 2.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 10.3 8.9 0.0 0.0 0.6 3.7 0.0 0.0 1.6 0.0 5.9 5.8 0.0 9.0 3.0 0.9 0.0 0.0 0.0 24.4 0.0 0.7 0.0 10.1 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 7.7 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.1 17.8 0.0 0.0 C11orf53 MGC50104 ENSG00000150750 "Chromosome 11 open reading frame 53" Q8IXP5 11 111245726-111286401 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "stomach 1: 3.4;testis: 5.5" "Cell type enhanced" "Detected in some" "Cholangiocytes: 14.3;Early spermatids: 38.1;Exocrine glandular cells: 56.6;Late spermatids: 12.4;Respiratory ciliated cells: 9.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "OE19: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA056128, HPA073101" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm Vesicles "HPA056128: AB_2683046, HPA073101: " "unprognostic (3.51e-2)" "unprognostic (3.60e-2)" "unprognostic (4.84e-2)" "unprognostic (5.84e-2)" "unprognostic (1.94e-1)" "unprognostic (8.07e-3)" "unprognostic (5.60e-3)" "unprognostic (3.09e-1)" "unprognostic (2.50e-1)" "unprognostic (9.95e-2)" "unprognostic (8.66e-2)" "unprognostic (3.52e-2)" 0.9 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.1 0.0 1.4 0.9 0.9 0.0 0.0 0.9 1.4 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.5 0.6 1.3 0.4 0.7 0.0 0.3 1.0 0.0 2.1 0.0 1.8 0.0 1.2 0.0 0.0 0.0 3.4 5.5 0.0 0.4 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 0.1 0.1 14.3 3.3 0.0 0.0 0.0 0.1 1.5 0.0 1.9 38.1 0.0 1.4 0.0 7.7 0.0 0.1 56.6 0.1 1.9 3.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 3.0 8.2 0.0 0.0 12.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.4 0.2 0.3 4.0 0.0 9.9 0.0 0.0 0.1 0.6 1.0 1.1 0.0 0.0 0.0 0.0 0.0 1.7 4.4 CCDC192 LINC01183 ENSG00000230561 "Coiled-coil domain containing 192" P0DO97 5 127703389-127941634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 12.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.5;Ductal cells: 1.0;Exocrine glandular cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.3;U-266/70: 1.2" "Low region specificity" "Detected in many" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 12: NES - Nervous system development" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (2.64e-1)" "unprognostic (4.24e-2)" "unprognostic (9.22e-2)" "unprognostic (1.09e-2)" "unprognostic (2.44e-2)" "unprognostic (3.01e-2)" "unprognostic (4.07e-5)" "unprognostic (2.46e-2)" "unprognostic (9.34e-2)" "unprognostic (8.18e-2)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "unprognostic (1.52e-6)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (1.98e-1)" 1.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.2 1.0 0.0 0.2 0.0 0.6 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.3 0.2 0.0 0.4 0.1 0.1 0.1 0.0 2.9 0.3 0.2 0.0 0.0 0.1 0.2 12.9 0.0 0.0 0.2 0.7 0.0 0.3 0.5 0.0 0.0 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 CCDC9B "C15orf52, FLJ43339" ENSG00000188549 "Coiled-coil domain containing 9B" Q6ZUT6 15 40331452-40340967 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 12.8;Alveolar cells type 2: 10.0;Collecting duct cells: 20.2;Ductal cells: 30.0;Pancreatic endocrine cells: 18.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "basophil: 4.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.3" "Cell line enhanced" "Detected in many" "HaCaT: 122.5;hTERT-RPE1: 110.8;WM-115: 138.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040484, HPA041834" Approved Approved Nucleoplasm,Cytosol NA NA 77000 "Cluster 38: Basophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 17: WM-115 - Nervous system development" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "HPA040484: AB_10794742, HPA041834: AB_10795643" "unprognostic (5.57e-3)" "unprognostic (1.85e-1)" "unprognostic (2.60e-3)" "unprognostic (2.33e-2)" "unprognostic (1.48e-2)" "unprognostic (2.68e-1)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-1)" "unprognostic (7.06e-3)" "unprognostic (1.51e-2)" "unprognostic (2.50e-1)" "unprognostic (1.04e-3)" "unprognostic (1.55e-1)" "unprognostic (3.48e-1)" "unprognostic (1.50e-2)" "unprognostic (9.68e-2)" 4.9 10.3 9.5 7.7 13.1 2.8 8.1 10.9 10.7 12.0 15.0 73.4 9.9 23.9 7.3 33.2 10.8 12.0 53.0 9.0 12.7 10.2 5.0 12.3 3.3 13.1 12.6 4.0 25.3 11.3 10.2 3.9 12.7 16.2 12.5 4.3 28.3 22.7 67.4 15.4 18.1 24.2 11.6 5.6 22.3 8.3 12.7 1.3 45.2 65.1 5.9 25.9 16.7 12.6 50.0 6.8 0.0 0.4 1.1 4.6 2.5 14.8 14.6 16.1 15.6 0.5 44.7 0.3 20.1 47.8 58.6 122.5 0.2 40.4 15.1 0.0 0.3 14.9 64.4 4.7 8.5 0.2 2.8 5.7 9.0 6.9 20.3 110.8 11.6 0.8 0.1 0.7 27.9 0.0 0.5 0.0 0.2 23.1 12.7 0.0 4.2 0.2 48.0 2.8 0.1 3.6 8.8 19.1 8.4 0.2 1.9 2.3 62.1 29.7 47.2 7.9 39.8 0.0 0.1 0.6 36.2 2.8 138.3 4.3 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.5 0.4 0.1 0.2 0.0 0.2 9.5 13.1 10.9 10.7 9.0 12.7 13.1 12.6 12.7 11.6 12.7 12.6 2.7 12.8 10.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.5 3.0 0.0 0.0 1.3 20.2 0.0 0.0 0.2 0.0 1.9 30.0 0.0 1.8 0.4 0.6 0.0 0.0 0.0 3.7 0.1 0.6 0.0 2.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 CCND1 "BCL1, D11S287E, PRAD1, U21B31" ENSG00000110092 "Cyclin D1" P24385 11 69641156-69654474 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation" "Cyclin, Repressor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 499.7;Ductal cells: 504.0;Pancreatic endocrine cells: 622.1;Urothelial cells: 412.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-266/70: 874.2;WM-115: 1239.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000024, HPA027802" Uncertain Supported Nucleoplasm Yes No "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 18: Non-specific - Mitochondria" "Cluster 17: WM-115 - Nervous system development" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "CAB000024: AB_563678, HPA027802: AB_2672390" "unprognostic (4.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.62e-2)" "unprognostic (1.39e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.38e-1)" "unprognostic (2.53e-2)" "unprognostic (9.46e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (4.39e-2)" "unprognostic (2.61e-3)" "unprognostic (4.38e-3)" "unprognostic (1.16e-1)" "unprognostic (6.40e-3)" "unprognostic (2.57e-1)" 55.6 29.2 12.1 10.0 14.6 1.5 40.2 15.0 11.9 17.0 33.4 19.8 22.7 14.8 27.6 72.9 30.8 19.5 64.9 10.8 14.6 32.2 107.3 61.1 10.5 17.5 15.5 4.6 86.3 82.7 25.7 63.7 18.3 53.3 17.2 3.2 30.4 50.4 3.6 120.3 16.0 23.3 15.9 37.2 52.7 3.2 21.7 9.9 45.5 5.2 19.0 29.5 43.9 24.0 467.3 183.0 59.5 1.8 178.3 186.7 127.4 717.5 264.9 82.1 47.6 206.9 349.9 0.1 317.6 375.5 137.2 332.1 6.5 195.2 146.0 1.2 36.5 0.3 46.7 211.7 43.3 3.3 6.7 106.5 37.9 116.0 44.0 192.5 142.1 0.2 0.6 1.3 654.2 197.1 0.4 26.6 109.0 190.7 198.3 1.2 187.9 11.3 379.4 282.8 10.0 231.4 9.2 167.7 458.4 143.5 102.6 9.5 600.4 399.5 111.0 176.1 496.2 874.2 559.4 1.5 341.6 5.9 1239.0 0.2 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.0 1.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.1 14.6 15.0 11.9 10.8 14.6 17.5 15.5 18.3 15.9 21.7 24.0 84.6 182.7 115.6 0.3 8.3 202.5 234.7 499.7 133.1 2.3 163.4 140.0 80.0 92.9 271.6 125.0 2.1 10.9 2.4 44.8 31.3 504.0 0.4 104.2 23.5 141.0 56.5 2.5 0.5 142.6 1.2 67.6 127.4 199.5 29.1 0.0 98.2 165.2 75.0 0.0 2.2 42.6 75.3 18.8 61.9 2.0 4.1 23.6 51.6 17.8 2.4 79.1 0.0 49.8 0.3 622.1 118.0 57.6 0.5 262.0 19.4 57.1 85.9 3.1 131.5 13.0 184.8 0.5 23.4 292.3 351.1 2.5 8.8 3.4 82.2 412.6 CD151 "PETA-3, RAPH, SFA-1, TSPAN24" ENSG00000177697 "CD151 molecule (Raph blood group)" P48509 11 832887-839831 "Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Blood group antigen" "Deafness, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 716.2;Exocrine glandular cells: 636.7;Pancreatic endocrine cells: 736.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002428, HPA011906" Supported NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "CAB002428: AB_564129, HPA011906: AB_1846245" "unprognostic (1.50e-1)" "unprognostic (1.12e-2)" "unprognostic (5.47e-2)" "unprognostic (5.45e-3)" "unprognostic (4.10e-3)" "unprognostic (2.45e-2)" "prognostic unfavorable (5.58e-4)" "prognostic unfavorable (9.46e-4)" "unprognostic (5.47e-2)" "unprognostic (2.41e-1)" "unprognostic (1.02e-3)" "unprognostic (3.31e-1)" "unprognostic (4.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.24e-1)" "prognostic favorable (6.92e-4)" "unprognostic (7.83e-2)" 332.4 159.5 54.0 79.7 53.5 25.0 277.8 52.5 67.6 181.6 66.1 219.7 140.6 264.6 103.0 97.5 184.3 132.4 345.8 54.2 65.3 194.3 145.3 240.1 35.4 64.5 57.4 116.2 278.3 85.9 81.1 110.1 60.5 182.9 99.8 9.6 243.5 194.2 113.1 107.0 149.4 255.2 58.3 94.8 187.3 44.8 58.6 15.0 133.5 77.0 30.6 203.1 151.3 58.0 380.0 475.3 71.8 256.3 1088.7 422.8 110.4 587.1 400.4 285.0 241.2 252.6 677.2 0.2 224.0 943.5 388.4 358.4 71.1 498.4 96.1 135.0 236.6 112.8 139.1 193.4 366.7 90.2 157.4 388.6 328.2 164.5 367.8 1089.2 348.8 16.4 135.1 56.3 485.9 196.1 1.9 99.5 48.0 232.9 569.4 20.0 173.7 106.4 642.8 102.1 99.5 111.8 578.9 371.5 121.5 81.6 145.8 102.4 600.0 462.6 209.3 147.5 352.9 62.0 66.5 4.5 437.5 89.7 265.8 24.6 19.1 15.2 5.7 19.3 6.8 3.0 4.7 5.0 11.9 2.0 1.9 3.0 7.3 8.2 24.1 1.8 2.9 10.8 54.0 53.5 52.5 67.6 54.2 65.3 64.5 57.4 60.5 58.3 58.6 58.0 294.4 208.3 79.1 13.1 12.8 70.6 143.2 328.2 60.9 16.6 180.9 203.7 180.0 133.0 159.8 248.3 4.2 222.6 15.6 542.3 19.6 716.2 2.6 60.8 114.6 214.8 127.6 28.6 10.0 636.7 423.8 173.8 236.5 143.7 81.3 103.7 265.2 54.0 130.0 37.0 5.5 388.5 138.4 59.3 70.4 11.3 123.6 81.8 128.1 15.9 75.6 94.8 23.7 3.5 0.7 736.6 477.9 283.2 26.6 307.1 440.6 124.6 52.2 17.0 210.4 96.6 310.3 5.6 13.6 73.4 54.4 185.7 29.7 61.1 289.8 199.6 CD2BP2 "LIN1, PPP1R59, Snu40, U5-52K" ENSG00000169217 "CD2 cytoplasmic tail binding protein 2" O95400 16 30350773-30355308 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041508, HPA061309" Enhanced Enhanced "Nuclear speckles,Cytosol" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" "Nuclear speckles" Cytosol "HPA041508: AB_2677523, HPA061309: AB_2684476" "unprognostic (5.66e-2)" "unprognostic (7.50e-3)" "unprognostic (1.47e-1)" "unprognostic (2.82e-2)" "unprognostic (1.65e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.71e-2)" "unprognostic (1.16e-1)" "unprognostic (9.76e-2)" "unprognostic (2.30e-2)" "unprognostic (7.47e-2)" "unprognostic (2.09e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-2)" "unprognostic (1.75e-1)" "unprognostic (1.66e-1)" 31.1 49.3 38.9 34.0 39.7 23.9 32.9 38.0 41.5 39.6 34.0 39.3 29.9 45.0 24.9 35.3 41.0 22.0 35.2 39.9 41.2 42.8 27.3 32.8 38.8 41.4 39.8 36.9 40.7 42.5 42.7 24.4 39.1 38.3 23.7 16.2 30.0 35.5 46.9 33.6 35.2 31.6 39.0 46.4 36.9 24.0 41.6 35.7 42.5 26.6 43.7 37.0 30.1 42.0 55.4 65.7 54.4 49.4 44.3 41.9 46.0 60.0 71.5 66.8 71.3 50.6 64.9 84.6 72.3 65.5 61.4 59.4 57.0 70.3 53.6 50.6 66.6 35.9 67.7 60.3 63.6 51.3 63.4 45.2 58.7 74.2 47.3 45.6 70.3 62.1 41.4 63.2 67.7 132.1 71.6 43.6 73.8 42.9 38.5 104.2 45.3 64.3 54.2 54.7 44.7 85.1 40.2 69.9 42.0 44.7 66.4 41.1 50.6 76.3 53.3 38.9 53.1 105.0 82.3 78.5 52.5 47.2 64.0 107.4 61.7 116.6 71.3 76.3 56.8 87.5 57.3 66.7 55.8 97.3 47.6 58.9 121.9 74.5 102.7 67.1 94.4 79.6 38.9 39.7 38.0 41.5 39.9 41.2 41.4 39.8 39.1 39.0 41.6 42.0 38.1 32.1 29.0 7.2 39.5 28.8 49.6 58.4 31.9 29.8 33.2 29.6 26.5 45.8 41.2 36.8 20.9 61.0 57.0 50.5 60.7 83.6 19.9 41.7 30.7 42.8 33.0 22.3 6.7 97.5 58.1 36.4 28.1 45.2 47.6 33.4 28.2 13.9 69.7 11.8 7.1 32.7 36.7 38.3 23.6 14.2 35.4 34.0 39.2 8.4 84.1 47.6 97.9 3.5 10.7 87.8 64.9 35.7 52.7 40.7 60.3 81.5 46.3 29.0 39.5 30.5 44.6 38.5 40.1 27.4 30.4 88.7 41.9 38.9 31.6 50.7 CD44 "CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1" ENSG00000026508 "CD44 molecule (Indian blood group)" P16070 11 35138882-35232402 "Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Blood group antigen, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 504.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 1650.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000112, CAB000316, HPA005785" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 1200000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane" "Golgi apparatus" "CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467" "unprognostic (5.33e-2)" "unprognostic (1.85e-1)" "unprognostic (4.97e-2)" "unprognostic (9.90e-3)" "unprognostic (3.50e-3)" "unprognostic (1.46e-2)" "unprognostic (1.56e-2)" "unprognostic (8.12e-2)" "unprognostic (1.57e-1)" "unprognostic (4.18e-2)" "unprognostic (1.51e-3)" "unprognostic (4.63e-2)" "prognostic unfavorable (1.78e-8)" "unprognostic (6.41e-2)" "unprognostic (4.14e-2)" "unprognostic (3.93e-2)" "unprognostic (7.98e-2)" 143.7 42.4 29.2 218.0 33.9 308.1 164.7 63.0 25.1 146.0 16.8 91.1 53.0 200.4 20.1 227.8 69.0 129.7 30.4 33.0 116.5 31.3 31.0 214.1 108.8 114.9 102.3 11.7 263.2 6.0 8.1 74.1 118.3 87.3 111.5 38.0 504.2 57.0 17.1 433.3 60.8 175.8 114.3 83.8 61.5 6.6 62.8 64.2 76.2 27.7 188.7 235.2 193.4 114.9 493.0 448.6 4.3 1.2 252.6 691.5 1.6 962.2 740.3 521.3 288.2 30.4 150.4 0.7 126.5 1350.2 1065.4 820.1 9.9 1013.9 716.4 110.3 6.2 18.9 198.3 0.3 262.3 254.6 1124.3 315.4 778.3 693.2 552.7 1650.0 184.3 0.1 4.0 157.9 518.9 3.0 25.6 166.9 9.8 8.7 136.4 1.4 89.3 7.5 777.4 138.1 2.0 1.4 185.2 5.5 462.8 38.6 25.7 15.1 547.3 646.6 120.0 815.8 1006.0 281.6 327.7 3.7 980.4 145.1 969.8 127.4 403.0 35.4 140.6 257.8 196.5 122.5 210.1 186.5 229.0 90.0 179.7 153.6 92.6 322.3 356.1 79.9 309.7 437.3 29.2 33.9 63.0 25.1 33.0 116.5 114.9 102.3 118.3 114.3 62.8 114.9 41.0 96.1 361.8 54.5 250.1 999.7 297.7 335.3 228.2 0.6 139.6 71.2 8.6 27.1 125.6 20.2 2.1 4.5 257.0 14.0 1.9 992.1 41.3 43.6 395.4 50.9 100.1 94.4 0.4 869.6 3.6 282.2 39.8 196.9 763.2 25.2 13.2 3.6 226.6 0.0 0.4 93.3 30.5 474.3 1934.2 24.3 22.4 523.9 604.7 8.4 594.2 29.6 62.8 0.5 11.2 813.1 10.9 0.4 216.3 386.7 6.0 1.6 18.8 2.0 157.8 197.2 227.9 0.4 0.4 279.3 1024.9 17.9 430.8 1.0 79.1 330.7 CD47 "IAP, MER6, OA3" ENSG00000196776 "CD47 molecule" Q08722 3 108043091-108091862 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 589.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016055, HPA044659" Approved Supported "Vesicles,Plasma membrane" NA NA 49000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane" Vesicles "CAB016055: AB_627086, HPA044659: AB_2679040" "unprognostic (3.54e-2)" "unprognostic (4.74e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (4.49e-2)" "unprognostic (2.14e-1)" "unprognostic (2.05e-3)" "unprognostic (8.77e-3)" "unprognostic (7.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.69e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (7.37e-2)" "unprognostic (3.78e-1)" "prognostic favorable (7.29e-5)" "unprognostic (1.83e-1)" 51.8 64.9 39.2 116.4 47.9 232.2 89.3 64.4 63.5 57.4 30.4 89.0 74.6 53.0 92.4 93.9 100.5 86.7 59.5 47.2 41.9 44.4 71.4 154.6 137.9 53.1 40.5 46.1 41.5 27.2 34.6 80.1 48.5 122.2 99.3 285.7 105.3 55.7 57.9 59.8 79.3 55.4 50.9 100.1 104.2 59.0 49.2 79.1 91.2 22.8 161.7 110.1 52.4 76.4 303.3 49.9 108.0 62.1 130.3 122.6 147.9 106.0 139.4 70.8 126.0 2.1 159.1 129.6 180.0 90.7 216.5 201.0 52.2 98.7 91.7 81.5 35.8 311.6 45.9 3.9 73.8 227.4 467.6 85.7 58.1 71.6 53.6 118.5 73.4 132.6 85.1 323.6 108.5 148.1 268.5 77.0 46.7 298.4 133.6 154.2 69.3 187.8 185.3 115.8 69.7 37.9 63.6 111.7 124.4 56.5 227.4 85.8 76.5 210.9 40.9 120.7 79.4 124.2 100.8 208.0 131.5 119.8 65.6 185.2 119.2 232.8 178.1 244.2 155.6 191.6 209.7 192.0 181.6 188.7 149.2 169.0 145.4 232.6 339.2 133.3 334.5 296.9 39.2 47.9 64.4 63.5 47.2 41.9 53.1 40.5 48.5 50.9 49.2 76.4 72.3 368.6 157.4 98.6 192.9 165.3 311.7 504.4 101.3 102.9 119.0 93.1 51.9 110.1 205.7 93.8 95.9 169.9 218.6 36.5 15.6 589.6 81.5 157.2 17.0 76.5 63.8 112.6 219.2 412.5 85.5 119.1 36.2 120.4 57.7 250.0 83.6 34.2 186.4 122.8 129.3 70.8 148.5 79.6 200.7 52.2 34.2 121.5 117.4 39.4 100.5 51.7 219.4 107.1 150.4 344.7 92.6 48.5 143.8 439.0 53.7 16.3 162.2 229.7 65.7 47.1 85.4 111.5 19.6 97.1 140.1 121.2 160.8 80.6 94.3 321.3 CDC42EP1 "Borg5, CEP1, MSE55" ENSG00000128283 "CDC42 effector protein 1" Q00587 22 37560480-37569405 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 245.6;Exocrine glandular cells: 226.0;Pancreatic endocrine cells: 266.2;Urothelial cells: 161.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 7.3;intermediate monocyte: 1.9;myeloid DC: 2.4" "Group enriched" "Detected in many" 10 "dendritic cells: 2.4;monocytes: 7.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006379, HPA076536" Approved Supported "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA006379: AB_1078486, HPA076536: " "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.44e-1)" "unprognostic (3.79e-3)" "unprognostic (5.82e-2)" "unprognostic (4.06e-2)" "unprognostic (4.38e-2)" "unprognostic (5.57e-2)" "unprognostic (9.45e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.85e-2)" "unprognostic (3.81e-2)" "unprognostic (1.09e-3)" 76.3 91.2 55.7 16.7 107.5 1.6 58.0 89.9 73.3 68.2 17.6 43.7 31.1 70.7 4.1 93.1 61.0 40.8 53.8 55.9 67.3 50.2 133.1 65.2 11.3 102.8 104.5 60.9 161.6 16.5 18.8 31.8 97.4 41.5 14.4 2.6 102.7 23.9 13.1 71.2 32.7 19.6 70.2 26.2 155.9 23.6 87.5 2.7 33.7 11.1 10.4 38.4 69.6 151.5 125.2 35.4 15.1 67.9 23.7 40.2 73.3 69.9 41.0 78.9 54.3 87.8 15.9 0.2 24.2 81.4 25.4 95.0 17.8 35.1 26.0 15.5 60.7 0.5 33.9 53.6 167.7 0.3 0.6 74.9 52.1 65.0 61.5 63.1 59.2 0.1 78.9 0.7 33.0 42.6 0.3 0.5 13.6 96.5 79.6 0.4 27.5 2.4 27.9 1.9 0.4 2.6 51.2 112.3 112.4 20.6 50.3 11.0 91.6 163.9 98.2 80.0 98.6 0.2 0.8 0.3 65.3 0.7 135.6 0.4 7.3 0.0 0.1 1.9 0.1 0.0 0.1 0.1 2.4 0.3 0.0 0.2 0.2 0.4 0.1 0.3 0.0 3.4 55.7 107.5 89.9 73.3 55.9 67.3 102.8 104.5 97.4 70.2 87.5 151.5 62.4 6.4 19.5 2.3 1.8 46.9 87.2 51.4 21.1 0.1 59.2 31.8 3.5 134.4 41.1 12.9 0.0 98.2 2.0 41.6 1.9 245.6 3.7 4.3 20.0 54.7 11.5 0.0 0.1 226.0 110.3 32.1 133.0 9.0 2.5 1.7 69.7 35.6 13.2 1.7 0.2 66.6 30.5 5.9 29.3 1.7 39.4 5.3 21.4 4.7 8.9 12.8 0.0 2.0 42.7 266.2 45.8 35.3 0.6 122.4 17.5 11.4 14.7 0.3 39.5 22.8 49.5 2.0 0.6 55.9 52.0 112.2 2.2 7.0 61.1 161.3 CELA1 ELA1 ENSG00000139610 "Chymotrypsin like elastase 1" Q9UNI1 12 51328442-51346679 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 2.2;pancreas: 6.6" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 16.6;Extravillous trophoblasts: 2.9;Kupffer cells: 7.9;NK-cells: 3.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "basophil: 12.4;naive CD4 T-cell: 12.3" "Group enriched" "Detected in many" 8 "granulocytes: 12.4;T-cells: 12.3" "Cell line enriched" "Detected in some" 4 "BEWO: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Secreted - unknown location" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 25: Pancreas - Digestion" "Cluster 28: BEWO - Transcription regulation" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (3.54e-2)" "unprognostic (1.64e-1)" "unprognostic (4.73e-2)" "unprognostic (2.73e-1)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (1.13e-1)" "unprognostic (3.59e-2)" "unprognostic (3.83e-3)" "unprognostic (2.52e-1)" "unprognostic (1.46e-1)" 0.0 2.2 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 6.6 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 12.4 1.6 0.1 1.0 0.8 0.4 0.3 2.7 0.8 1.0 0.0 12.3 5.9 0.2 0.2 1.0 0.0 0.3 1.2 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 16.6 2.9 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.8 0.0 0.1 0.0 0.0 7.9 0.0 0.0 0.0 1.4 0.0 0.0 1.8 0.0 3.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.5 1.4 0.2 0.0 0.0 CELA2A ELA2A ENSG00000142615 "Chymotrypsin like elastase 2A" P08217 1 15456728-15472091 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Diabetes mellitus, Disease variant, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2325 "pancreas: 162732.5" "Cell type enriched" "Detected in some" 34 "Exocrine glandular cells: 7828.2" "Cancer enriched" "Detected in single" 3818 "pancreatic cancer: 463.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.2" "Secreted to digestive system" NA NA 2700000 "Cluster 25: Pancreas - Digestion" "Cluster 3: HMC-1 - Innate immune response" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (9.78e-2)" "unprognostic (3.33e-2)" "unprognostic (5.60e-2)" "unprognostic (5.27e-2)" "unprognostic (3.63e-3)" "unprognostic (2.35e-1)" "unprognostic (4.14e-1)" "unprognostic (1.96e-2)" "unprognostic (1.38e-1)" "unprognostic (2.48e-1)" "unprognostic (3.94e-9)" "unprognostic (4.10e-2)" "unprognostic (3.42e-1)" "unprognostic (3.55e-2)" 7.9 5.5 0.0 2.6 0.0 1.1 4.4 0.2 0.1 3.9 0.0 2.0 18.5 2.1 0.0 2.3 1.1 0.0 26.9 0.0 0.0 1.6 5.8 1.2 4.3 0.0 0.0 70.0 162732.5 0.0 1.3 10.2 0.0 2.7 0.0 0.0 28.0 0.0 1.6 2.2 8.7 0.0 0.0 2.2 15.4 2.0 0.0 0.0 1.1 0.0 0.0 0.9 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.8 0.1 0.3 0.3 0.3 0.0 0.0 1.1 7828.2 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 20.7 0.0 0.0 0.0 0.1 227.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 CELA2B "ELA2B, RP11-265F14.2" ENSG00000215704 "Chymotrypsin like elastase 2B" P08218 1 15465909-15491395 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1672 "pancreas: 20446.9" "Cell type enriched" "Detected in some" 73 "Exocrine glandular cells: 1227.6" "Cancer enriched" "Detected in single" 574 "pancreatic cancer: 69.9" "Group enriched" "Detected in some" 4 "cerebellum: 2.0;cerebral cortex: 3.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-138 MG: 3.9" "Secreted to digestive system" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 25: Pancreas - Digestion" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (4.36e-3)" "unprognostic (5.45e-2)" "unprognostic (6.66e-2)" "unprognostic (5.31e-3)" "unprognostic (4.47e-3)" "unprognostic (1.37e-3)" "unprognostic (4.66e-2)" "unprognostic (6.32e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-1)" "unprognostic (2.94e-1)" "unprognostic (3.85e-2)" "unprognostic (1.22e-6)" "unprognostic (2.47e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-1)" "unprognostic (7.80e-2)" 1.1 3.0 0.0 0.5 0.0 1.0 0.6 2.0 3.2 0.4 0.0 0.2 3.7 0.4 0.1 0.3 0.1 0.6 4.5 0.3 0.6 0.2 0.6 0.3 1.2 0.2 0.2 12.2 20446.9 0.0 0.1 1.2 0.0 0.3 0.0 1.7 3.4 0.0 0.3 1.0 2.4 0.0 0.0 0.3 1.2 0.7 0.4 0.0 0.8 0.0 0.0 0.1 0.1 0.3 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.5 0.8 0.4 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.2 0.3 0.6 0.2 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.0 1.4 1227.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.1 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 CELA3A "ELA3, ELA3A" ENSG00000142789 "Chymotrypsin like elastase 3A" P09093 1 22001657-22012542 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2216 "pancreas: 262614.2" "Cell type enriched" "Detected in some" 56 "Exocrine glandular cells: 34710.4" "Cancer enriched" "Detected in some" 2497 "pancreatic cancer: 1481.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 28 "MOLT-4: 24.9" "HPA028086, HPA045650" Supported Approved Cytosol "Secreted to digestive system" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA028086: AB_2672482, HPA045650: AB_2679407" "unprognostic (1.27e-1)" "unprognostic (2.71e-1)" "unprognostic (1.79e-1)" "unprognostic (6.32e-2)" "unprognostic (2.67e-1)" 20.0 4.5 0.0 3.0 0.0 2.8 11.6 0.0 0.0 12.9 0.0 4.5 21.3 4.1 0.0 7.4 3.0 0.1 44.6 0.0 0.0 4.1 13.5 3.0 6.0 0.0 0.0 118.5 262614.2 0.0 6.9 14.9 0.0 8.8 0.0 0.0 44.0 0.0 3.9 5.2 12.2 0.0 0.0 6.3 47.7 3.2 0.0 0.3 3.1 0.0 0.0 2.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 25.5 40.7 0.1 0.0 0.6 0.0 0.0 0.1 34710.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 197.1 0.3 2.4 0.0 0.0 94.0 0.0 0.0 0.0 0.0 619.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CELA3B "CBPP, ELA3B" ENSG00000219073 "Chymotrypsin like elastase 3B" P08861 1 21977022-21998642 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2088 "pancreas: 49621.1" "Cell type enriched" "Detected in some" 45 "Exocrine glandular cells: 14881.1" "Cancer enriched" "Detected in single" 1218 "pancreatic cancer: 408.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028086, HPA045650" Supported Approved Cytosol "Secreted to digestive system" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA028086: AB_2672482, HPA045650: AB_2679407" "unprognostic (2.89e-1)" "unprognostic (4.01e-3)" "unprognostic (6.53e-3)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (6.40e-2)" 9.0 1.8 0.0 0.6 0.0 0.8 4.5 0.0 0.0 4.4 0.0 1.8 6.2 1.6 0.1 2.6 1.2 0.0 8.4 0.0 0.0 1.6 5.0 1.2 1.1 0.0 0.0 23.7 49621.1 0.0 2.2 3.4 0.0 3.1 0.1 0.0 9.5 0.0 1.6 1.9 2.6 0.0 0.0 2.3 17.2 2.4 0.0 0.0 1.2 0.0 0.0 1.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 10.4 78.6 0.3 0.0 0.6 0.0 0.0 0.2 14881.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 309.9 0.9 0.9 0.0 0.0 60.4 0.0 0.0 0.0 0.2 325.6 16.0 0.7 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 CFB "BF, BFD, H2-Bf" ENSG00000243649 "Complement factor B" P00751 6 31945650-31952084 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 2613.2" "Cell type enhanced" "Detected in many" "Ductal cells: 873.6;Exocrine glandular cells: 197.3;Hepatocytes: 284.0;Pancreatic endocrine cells: 318.0;Proximal enterocytes: 139.7" "Cancer enhanced" "Detected in all" "liver cancer: 78.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 15.0;ASC TERT1: 23.0;EFO-21: 25.1;fHDF/TERT166: 14.1;HSkMC: 19.1;U-87 MG: 10.1" "Low region specificity" "Detected in all" "HPA000951, HPA001817, HPA001832, CAB016381" Supported Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" "Secreted to blood" NA NA 879000000 120000000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Endoplasmic reticulum, Vesicles" "Cell Junctions" "CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778" "prognostic favorable (2.76e-5)" "unprognostic (1.02e-1)" "unprognostic (1.44e-1)" "unprognostic (7.94e-2)" "unprognostic (1.82e-2)" "unprognostic (8.56e-2)" "unprognostic (8.08e-3)" "unprognostic (8.81e-2)" "unprognostic (3.51e-1)" "unprognostic (2.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.57e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (1.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-2)" "unprognostic (3.68e-2)" 143.7 18.0 3.6 32.8 3.6 0.1 28.5 3.4 9.9 16.3 3.9 22.3 28.1 8.2 14.2 24.1 53.7 0.8 42.6 3.7 3.4 58.7 2613.2 39.2 4.2 4.1 3.7 9.9 51.8 0.2 17.7 5.0 3.8 60.3 14.5 1.4 43.3 0.0 3.0 7.7 73.1 48.3 3.4 12.9 54.5 2.1 3.7 1.9 15.5 0.7 6.7 17.8 9.2 3.6 0.5 1.9 0.1 0.0 15.0 23.0 0.1 0.0 0.2 1.1 0.0 0.1 8.6 0.1 25.1 14.1 0.6 6.0 0.0 1.8 1.2 1.0 0.3 0.7 0.4 0.5 0.0 1.0 0.4 19.1 0.4 0.6 0.5 1.3 0.2 0.1 0.3 0.7 0.1 0.2 0.1 0.3 0.4 0.0 0.4 0.3 0.3 1.3 1.7 0.5 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.2 0.0 3.4 1.2 0.4 0.4 0.7 2.1 1.0 10.1 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.6 3.6 3.4 9.9 3.7 3.4 4.1 3.7 3.8 3.4 3.7 3.6 1.0 0.0 16.9 0.0 2.6 0.8 0.9 64.8 11.4 0.3 4.9 0.9 0.4 44.3 127.3 5.5 0.0 0.1 0.0 3.7 3.9 873.6 0.0 1.9 0.4 3.9 2.4 16.0 0.2 197.3 0.2 34.6 20.9 1.2 0.0 0.0 11.7 284.0 1.0 0.0 0.2 8.5 18.3 19.7 1.0 0.0 2.8 1.1 0.0 5.6 18.1 0.4 0.0 0.0 0.0 318.0 10.6 0.0 0.1 8.6 139.7 17.1 75.4 0.7 0.0 1.0 12.6 0.1 0.1 3.9 1.8 1.6 1.6 0.0 12.4 4.5 CFTR "ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR" ENSG00000001626 "CF transmembrane conductance regulator" P13569 7 117287120-117715971 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Isomerase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 54.6;intestine: 42.7;pancreas: 210.7" "Group enriched" "Detected in many" 4 "Ductal cells: 485.4;Ionocytes: 252.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.9;pancreatic cancer: 28.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "CACO-2: 29.5;MOLT-4: 98.9;U-266/70: 49.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB001951, HPA021939, HPA079652" Enhanced NA NA "Cluster 25: Pancreas - Digestion" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 1: Pancreatic cells - Digestion" "CAB001951: , HPA021939: AB_1846578, HPA079652: " "unprognostic (6.38e-3)" "unprognostic (9.55e-2)" "unprognostic (1.77e-2)" "unprognostic (1.44e-2)" "unprognostic (8.74e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (9.44e-4)" "unprognostic (3.20e-3)" "unprognostic (1.13e-1)" "unprognostic (8.89e-2)" "unprognostic (1.55e-2)" "unprognostic (2.14e-2)" "unprognostic (4.78e-3)" "unprognostic (1.24e-1)" "unprognostic (2.58e-1)" "unprognostic (9.08e-2)" "unprognostic (6.64e-2)" 0.4 0.0 0.5 4.7 2.0 0.0 0.4 0.7 1.3 8.5 0.0 42.7 36.2 1.1 1.1 0.8 2.2 54.6 0.1 0.3 0.7 2.1 1.6 8.2 0.0 1.1 0.7 0.0 210.7 0.2 0.1 0.6 0.7 2.2 40.7 0.0 21.5 0.5 0.0 1.9 19.9 2.0 1.7 0.0 3.1 1.7 1.0 0.1 0.1 0.0 0.3 0.7 0.0 2.9 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 98.9 0.1 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 49.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.7 1.3 0.3 0.7 1.1 0.7 0.7 1.7 1.0 2.9 0.0 6.4 65.6 0.0 0.5 0.0 2.0 2.6 0.0 0.5 0.5 0.0 2.4 55.8 17.8 0.0 0.0 0.0 0.0 45.8 0.0 485.4 3.2 9.6 1.2 0.4 7.2 0.0 2.2 4.5 0.0 0.3 4.1 19.8 1.3 0.1 0.0 0.4 0.0 0.0 1.1 13.9 252.3 0.0 0.0 2.6 0.3 0.1 0.0 1.0 6.7 0.5 0.0 0.5 23.8 14.8 86.4 0.0 0.0 4.0 8.6 0.0 5.6 0.0 0.0 0.0 1.6 2.2 0.5 0.0 0.0 0.0 0.3 0.1 87.3 5.8 CHAC1 MGC4504 ENSG00000128965 "ChaC glutathione specific gamma-glutamylcyclotransferase 1" Q9BUX1 15 40952962-40956512 "Enzymes, Predicted intracellular proteins" "Apoptosis, Neurogenesis, Notch signaling pathway, Unfolded protein response" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 68.6;skeletal muscle: 68.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 35.2;Exocrine glandular cells: 27.8;Gastric mucus-secreting cells: 33.6;Pancreatic endocrine cells: 19.3;Plasma cells: 21.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 109.5;HHSteC: 80.7;hTCEpi: 130.8;SK-MEL-30: 95.0;U-266/70: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042708, HPA043505" Approved Approved Mitochondria NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 1: Pancreatic cells - Digestion" Mitochondria "HPA042708: AB_2678125, HPA043505: AB_2678518" "unprognostic (6.04e-3)" "unprognostic (2.81e-2)" "unprognostic (7.47e-2)" "unprognostic (2.84e-3)" "unprognostic (6.57e-3)" "unprognostic (2.00e-2)" "unprognostic (5.59e-2)" "unprognostic (2.43e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" "unprognostic (3.11e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.23e-7)" "unprognostic (1.37e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-2)" "unprognostic (3.91e-2)" 9.1 0.6 12.3 1.4 12.0 1.8 0.9 11.1 30.7 2.1 7.1 1.9 2.0 0.7 1.5 23.3 1.7 1.8 2.4 11.4 16.6 4.0 11.5 2.0 0.9 13.0 14.5 0.7 68.6 1.4 1.9 0.8 16.9 1.3 0.8 1.1 5.1 1.0 68.4 1.6 1.4 0.8 12.6 0.9 14.8 0.7 17.6 0.5 1.5 11.7 3.0 4.3 3.7 16.6 9.1 6.0 1.5 27.2 4.3 3.2 11.1 53.5 109.5 5.8 15.5 15.1 2.2 2.8 4.1 4.8 17.2 6.0 12.0 4.4 4.1 10.4 2.5 2.5 1.6 0.0 80.7 7.3 0.1 36.1 130.8 17.1 23.2 1.8 5.4 62.3 7.7 12.5 4.8 5.5 5.3 0.1 4.9 31.0 21.3 4.8 0.1 12.8 3.0 3.5 5.3 7.9 1.6 9.5 95.0 3.3 3.6 51.1 1.8 1.3 16.1 1.5 9.4 81.1 19.0 11.0 4.8 10.3 12.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 12.3 12.0 11.1 30.7 11.4 16.6 13.0 14.5 16.9 12.6 17.6 16.6 6.2 0.0 2.0 0.3 3.1 2.8 3.8 11.5 3.4 2.6 2.2 2.4 4.6 4.3 6.5 0.0 2.1 0.3 2.6 8.0 35.2 6.4 0.1 1.8 0.4 2.7 3.5 3.2 1.3 27.8 0.3 0.6 33.6 2.1 0.0 0.4 1.8 0.7 0.4 0.0 1.5 8.0 6.1 0.3 1.5 0.0 0.3 0.8 5.4 0.0 1.0 0.5 0.0 0.5 0.2 19.3 2.3 0.0 21.4 6.5 0.8 0.3 3.3 0.4 0.0 0.3 3.2 1.1 1.1 1.5 4.3 3.4 1.6 0.5 4.8 14.6 CHMP4C "MGC22825, Shax3, VPS32C" ENSG00000164695 "Charged multivesicular body protein 4C" Q96CF2 8 81732448-81759515 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.8" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 71.6;Pancreatic endocrine cells: 78.7;Proximal enterocytes: 80.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 37.2;CAPAN-2: 41.5;hTCEpi: 51.4;hTERT-HME1: 41.6;OE19: 73.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA023763, HPA023799" Enhanced Approved "Microtubules,Cytokinetic bridge" Yes NA "Cluster 48: NK-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "Microtubules, Cytokinetic bridge" "HPA023763: , HPA023799: AB_1846670" "unprognostic (3.98e-2)" "unprognostic (6.75e-3)" "unprognostic (1.58e-1)" "unprognostic (5.19e-2)" "unprognostic (3.12e-2)" "unprognostic (2.45e-2)" "unprognostic (5.75e-2)" "prognostic unfavorable (9.33e-5)" "unprognostic (7.54e-2)" "unprognostic (8.08e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.99e-2)" "prognostic favorable (1.96e-6)" "unprognostic (3.29e-3)" "unprognostic (4.95e-1)" "unprognostic (2.67e-1)" "prognostic favorable (6.45e-4)" 1.7 5.8 1.2 2.1 1.3 1.2 16.6 1.6 1.3 7.5 2.8 16.2 41.8 2.3 5.8 22.6 8.7 8.0 3.6 1.1 1.0 13.9 7.7 7.2 0.5 1.5 1.4 0.5 20.1 15.8 10.1 5.8 1.5 10.0 14.8 0.2 28.1 7.6 0.2 29.1 31.7 0.8 1.1 8.5 23.7 1.1 1.4 1.9 17.5 0.5 5.2 9.7 14.2 2.0 37.2 7.6 0.0 0.2 0.0 0.0 16.6 1.9 2.2 0.1 0.0 14.3 41.5 0.1 28.8 0.0 6.4 22.1 0.2 15.7 0.0 0.0 17.9 0.7 9.9 13.6 0.8 0.1 0.1 0.0 51.4 0.0 41.6 15.3 0.0 0.0 10.0 12.4 0.0 18.4 0.1 0.3 0.1 73.1 14.9 0.1 0.0 8.3 36.3 22.0 7.9 0.1 9.9 16.3 0.1 8.5 23.9 0.2 0.0 0.1 8.9 0.1 0.2 6.5 4.3 0.2 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.9 0.0 0.1 0.0 0.1 1.2 1.3 1.6 1.3 1.1 1.0 1.5 1.4 1.5 1.1 1.4 2.0 5.3 25.6 21.5 0.0 3.2 4.6 35.4 17.1 18.2 0.0 27.2 29.3 4.1 21.5 22.4 5.5 0.0 40.2 0.6 42.0 25.4 47.4 0.4 18.6 2.9 4.0 9.1 1.7 0.1 71.6 38.9 1.0 25.5 31.0 1.3 6.5 4.2 7.6 4.4 0.0 0.1 36.4 12.2 0.3 0.7 1.3 0.0 0.9 8.8 1.0 0.0 0.0 1.0 0.0 0.1 78.7 52.8 0.0 5.7 28.9 80.4 22.6 19.1 0.0 0.0 0.2 7.0 0.3 0.7 25.0 17.5 44.5 1.3 0.1 34.4 33.6 CLPS ENSG00000137392 Colipase P04118 6 35794982-35797344 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Digestion, Lipid degradation, Lipid metabolism" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1696 "pancreas: 262086.0" "Cell type enriched" "Detected in some" 17 "Exocrine glandular cells: 23175.0" "Cancer enriched" "Detected in many" 188 "pancreatic cancer: 1726.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA010512 Enhanced "Secreted to digestive system" NA NA 1600000 "Cluster 15: NK-cells - Transcription" "Cluster 25: Pancreas - Digestion" "Cluster 1: Pancreatic cells - Digestion" "HPA010512: AB_1846979" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (8.12e-3)" "unprognostic (2.47e-1)" "unprognostic (1.33e-1)" "unprognostic (1.61e-1)" 30.4 6.1 0.9 5.8 1.8 9.0 17.8 0.1 0.7 13.4 0.2 6.8 40.2 6.0 5.6 9.9 3.8 0.0 46.3 1.2 0.1 5.5 17.7 4.1 10.5 0.2 0.2 154.4 262086.0 0.0 6.3 11.9 0.3 7.9 0.0 0.0 41.7 0.0 5.8 8.1 24.0 0.0 0.1 7.9 27.7 4.0 0.6 0.0 3.8 0.0 0.0 3.3 5.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.9 1.8 0.1 0.7 1.2 0.1 0.2 0.2 0.3 0.1 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.6 0.0 0.0 0.0 1.1 11.9 0.0 0.0 23175.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 130.8 0.0 0.0 0.0 0.0 1331.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLPSL1 "C6orf127, dJ510O8.6" ENSG00000204140 "Colipase like 1" A2RUU4 6 35781019-35793675 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 90 "epididymis: 607.6;pancreas: 178.4" "Cell type enriched" "Detected in some" 4 "Exocrine glandular cells: 39.0" "Group enriched" "Detected in some" 6 "breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4" "Group enriched" "Detected in many" 4 "amygdala: 1.1;basal ganglia: 2.5;cerebral cortex: 2.3;hippocampal formation: 2.9;white matter: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "T-47d: 8.4" HPA073155 Enhanced "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 6: T47d - Mammary gland" "Cluster 1: Pancreatic cells - Digestion" "HPA073155: AB_2686576" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (4.75e-1)" "unprognostic (2.54e-1)" "unprognostic (3.10e-2)" "unprognostic (2.13e-1)" "unprognostic (1.97e-1)" "unprognostic (6.60e-2)" "unprognostic (7.06e-3)" 0.1 0.3 1.1 0.0 2.5 0.0 4.3 0.3 2.3 0.0 0.2 0.0 0.0 0.0 607.6 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.3 0.4 0.1 178.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.5 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 8.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.5 0.3 2.3 2.9 0.3 0.3 0.4 0.3 0.3 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 39.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 CLPSL2 "C6orf126, dJ510O8.5, UNQ3045" ENSG00000196748 "Colipase like 2" Q6UWE3 6 35776594-35779552 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 102 "epididymis: 532.1" "Group enriched" "Detected in some" 4 "Breast glandular cells: 3.4;Breast myoepithelial cells: 2.2;Enteroendocrine cells: 1.8;Exocrine glandular cells: 4.0;Pancreatic endocrine cells: 2.1;Spermatogonia: 2.2" "Cancer enhanced" "Detected in some" "breast cancer: 2.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "T-47d: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA051655 Approved "Secreted in male reproductive system" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 6: T47d - Mammary gland" "Cluster 1: Pancreatic cells - Digestion" "HPA051655: " "unprognostic (2.38e-1)" "unprognostic (3.65e-1)" "unprognostic (6.39e-3)" "unprognostic (9.38e-2)" "unprognostic (4.03e-2)" "unprognostic (2.47e-1)" "unprognostic (4.85e-3)" "unprognostic (8.69e-2)" "unprognostic (3.17e-2)" "unprognostic (3.95e-2)" "unprognostic (1.49e-1)" "unprognostic (1.13e-1)" "unprognostic (2.37e-1)" 0.0 0.0 0.3 0.0 0.4 0.1 0.4 0.2 0.8 0.0 0.2 0.0 0.0 0.0 532.1 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.2 0.4 0.0 5.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.7 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.2 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.7 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.3 0.0 0.1 6.3 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.4 0.2 0.8 0.6 0.4 0.2 0.4 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 2.2 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 1.8 0.0 0.2 4.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 CPA1 CPA ENSG00000091704 "Carboxypeptidase A1" P15085 7 130380339-130388114 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2326 "pancreas: 237498.3" "Cell type enriched" "Detected in some" 19 "Exocrine glandular cells: 10133.0" "Cancer enriched" "Detected in some" 639 "pancreatic cancer: 1377.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AN3-CA: 11.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA021836, CAB025197, HPA052215" Enhanced "Secreted to digestive system" NA NA 110000000 "Cluster 25: Pancreas - Digestion" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 1: Pancreatic cells - Digestion" "CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764" "unprognostic (8.41e-2)" "unprognostic (9.24e-4)" "unprognostic (5.22e-2)" "unprognostic (1.76e-1)" "unprognostic (3.97e-1)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.15e-2)" "unprognostic (1.35e-1)" "unprognostic (1.34e-6)" "unprognostic (4.99e-1)" "unprognostic (1.67e-1)" "unprognostic (2.16e-1)" "unprognostic (4.37e-2)" 27.9 4.8 0.2 5.6 0.2 4.7 13.6 0.1 0.2 11.9 1.2 4.5 33.6 5.0 0.1 6.9 3.7 0.2 43.5 0.2 0.3 4.6 12.9 3.3 8.7 0.1 0.1 102.1 237498.3 0.0 5.0 18.4 0.1 6.9 0.0 0.2 39.5 0.1 4.7 6.6 20.8 0.4 0.2 7.7 21.3 5.4 0.2 0.1 3.0 0.4 0.0 2.8 4.0 0.4 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.7 0.0 0.2 0.0 1.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.2 0.3 0.1 0.1 0.1 0.2 0.2 0.4 0.1 3.2 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.9 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.9 12.0 1.9 0.0 0.1 0.1 0.0 0.0 0.0 10133.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.9 1.2 0.0 1.0 44.5 2.1 0.0 0.0 0.0 527.2 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.1 0.0 16.2 2.7 0.9 5.5 0.0 0.0 1.6 0.0 2.5 0.0 0.1 CPA2 ENSG00000158516 "Carboxypeptidase A2" P48052 7 130266863-130289798 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 416 "pancreas: 45360.2" "Cell type enriched" "Detected in some" 10 "Exocrine glandular cells: 4973.8" "Cancer enriched" "Detected in many" 60 "pancreatic cancer: 411.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.2;CACO-2: 3.8;RH-30: 3.0;SCLC-21H: 1.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA020342, HPA021317" Enhanced Approved "Golgi apparatus" "Secreted to digestive system" NA NA 1500000 "Cluster 25: Pancreas - Digestion" "Cluster 39: CACO-2 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" "HPA020342: AB_1846007, HPA021317: AB_1846008" "unprognostic (1.12e-1)" "unprognostic (3.97e-1)" "unprognostic (4.21e-2)" "unprognostic (1.82e-2)" "unprognostic (1.38e-1)" "unprognostic (6.76e-2)" "unprognostic (4.65e-2)" "unprognostic (1.08e-1)" "unprognostic (1.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.66e-1)" "unprognostic (3.84e-5)" "unprognostic (7.52e-2)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (8.48e-2)" 5.5 1.0 0.3 0.7 0.8 0.4 2.6 1.0 0.9 1.9 0.2 1.3 17.4 0.8 0.1 1.5 0.7 0.0 8.4 0.3 0.6 0.9 2.6 0.7 1.4 2.8 1.3 19.7 45360.2 0.0 1.4 3.2 2.5 1.5 0.4 0.8 7.8 0.0 0.8 1.1 30.6 0.0 1.2 1.2 108.9 2.2 1.1 0.1 0.6 0.0 0.0 0.5 0.8 3.1 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.8 0.0 0.0 0.5 0.0 0.3 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 3.0 0.0 0.0 0.3 1.6 0.0 0.1 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.6 0.4 0.3 0.0 0.4 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 1.0 0.9 0.3 0.6 2.8 1.3 2.5 1.2 1.1 3.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.6 1.9 8.1 4.3 0.0 0.0 0.9 0.0 0.0 0.1 4973.8 0.0 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 10.5 0.3 0.5 0.0 0.0 13.9 4.6 0.0 0.5 1.0 471.3 52.9 0.0 0.0 0.0 9.9 0.0 0.0 0.3 0.0 0.0 1.3 0.4 2.0 0.0 0.1 0.3 0.0 0.2 1.5 0.2 CPA4 CPA3 ENSG00000128510 "Carboxypeptidase A4" Q9UI42 7 130293134-130324180 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.6;skin 1: 57.1" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 17.7;Basal respiratory cells: 23.7;Exocrine glandular cells: 54.1;Fibroblasts: 11.5;Suprabasal keratinocytes: 31.0" "Cancer enhanced" "Detected in many" "cervical cancer: 10.0;head and neck cancer: 9.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 140.1;hTERT-RPE1: 261.0;LHCN-M2: 284.2;U-2 OS: 151.0;U-87 MG: 272.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA021030 Approved Nucleoplasm,Centrosome,Cytosol "Secreted in other tissues" NA Yes 390000 "Cluster 31: Skin - Epidermis development" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "Centrosome, Cytosol" "HPA021030: AB_1846010" "unprognostic (7.60e-3)" "unprognostic (4.00e-2)" "unprognostic (1.59e-3)" "unprognostic (3.63e-3)" "unprognostic (2.24e-2)" "unprognostic (2.91e-2)" "unprognostic (2.78e-2)" "unprognostic (4.36e-3)" "unprognostic (3.23e-1)" "unprognostic (5.79e-2)" "unprognostic (2.37e-3)" "unprognostic (6.49e-2)" "unprognostic (6.21e-10)" "unprognostic (2.39e-1)" "unprognostic (1.67e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (1.31e-4)" 5.0 4.4 0.4 0.4 0.4 0.1 3.5 0.5 1.7 15.3 0.5 0.0 0.0 0.2 0.3 21.6 0.4 0.1 1.1 0.6 2.1 0.6 0.1 0.4 0.2 1.1 0.7 0.1 12.7 0.0 0.5 2.0 1.1 0.2 0.0 0.2 6.7 0.0 0.3 57.1 0.2 0.8 0.6 3.3 0.4 0.3 1.2 0.8 0.0 0.0 0.9 0.0 12.6 1.1 95.3 5.0 0.3 0.3 0.7 1.5 0.1 74.6 140.1 74.9 18.5 0.7 8.1 0.1 14.3 31.9 75.2 5.5 0.0 41.3 76.7 0.4 0.3 0.0 33.3 2.1 1.8 0.3 0.2 1.0 65.2 6.7 9.4 261.0 0.3 0.1 0.0 0.2 284.2 0.2 0.0 0.0 0.8 0.4 11.1 0.3 75.4 0.1 34.5 4.0 0.2 0.0 49.9 23.3 0.5 28.0 0.5 0.4 57.3 18.1 151.0 6.2 7.4 0.2 0.2 0.1 272.7 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.5 1.7 0.6 2.1 1.1 0.7 1.1 0.6 1.2 1.1 0.0 3.2 0.5 0.0 0.0 17.7 0.5 23.7 0.6 0.0 4.2 2.8 0.3 0.0 8.5 0.0 0.0 5.6 0.1 0.0 0.0 0.5 0.4 0.4 0.2 0.3 0.0 0.0 0.4 54.1 1.2 11.5 0.0 2.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.2 0.2 0.0 0.3 3.6 1.0 0.6 0.0 0.0 0.0 0.5 7.9 0.0 0.0 0.0 0.9 0.0 0.1 2.9 0.0 0.0 1.3 0.4 0.1 0.7 10.0 31.0 9.4 0.1 0.0 0.0 1.6 CPB1 ENSG00000153002 "Carboxypeptidase B1" P15086 3 148791102-148860187 "Enzymes, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1970 "pancreas: 226925.8" "Cell type enriched" "Detected in some" 12 "Exocrine glandular cells: 7306.0" "Group enriched" "Detected in some" 312 "breast cancer: 293.8;pancreatic cancer: 641.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 1.0;U-2 OS: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026158, HPA038069, HPA046340" Enhanced "Secreted to digestive system" NA NA 88000000 "Cluster 17: Basophils - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628" "unprognostic (6.90e-2)" "unprognostic (3.79e-2)" "unprognostic (3.34e-2)" "unprognostic (2.64e-2)" "unprognostic (5.58e-2)" "unprognostic (3.27e-2)" "unprognostic (6.26e-4)" "unprognostic (1.90e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" "unprognostic (7.59e-2)" "unprognostic (4.51e-2)" "unprognostic (5.50e-8)" "unprognostic (3.08e-1)" "unprognostic (1.60e-1)" "unprognostic (4.93e-2)" 15.7 83.0 0.4 5.1 1.7 2.5 78.3 0.6 1.4 6.0 0.1 2.6 31.2 4.7 0.3 3.5 1.8 0.1 40.8 0.6 0.8 2.0 7.1 1.7 8.1 1.0 1.2 115.1 226925.8 0.0 2.1 13.7 1.1 4.7 4.5 0.0 36.3 0.0 2.2 2.8 17.2 0.0 0.4 19.2 28.3 2.9 1.2 0.1 1.6 0.0 0.0 1.4 2.0 3.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.9 0.2 0.0 0.0 0.0 4.0 0.3 0.5 1.3 0.4 0.9 0.4 0.5 1.1 0.1 0.7 0.3 1.4 1.9 1.4 0.5 0.5 0.3 0.4 0.4 1.7 0.6 1.4 0.6 0.8 1.0 1.2 1.1 0.4 1.2 3.3 2.2 0.0 0.0 1.0 0.0 0.6 0.5 0.0 0.0 0.0 8.7 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.6 11.2 0.0 0.1 1.1 164.9 1.3 0.3 7306.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.2 0.0 0.0 1.0 2.5 0.6 1.5 0.0 0.0 18.1 0.0 0.0 0.0 29.8 590.0 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 4.2 2.5 0.0 1.1 0.1 0.3 0.3 0.3 1.1 0.2 0.2 CTRB1 CTRB ENSG00000168925 "Chymotrypsinogen B1" P17538 16 75218988-75226338 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2384 "pancreas: 133851.7" "Cell type enriched" "Detected in some" 21 "Exocrine glandular cells: 31269.6" "Cancer enriched" "Detected in some" 1905 "pancreatic cancer: 962.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;HDLM-2: 1.6" "Secreted to digestive system" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (1.76e-1)" "unprognostic (2.62e-1)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (5.22e-2)" "unprognostic (4.43e-3)" "unprognostic (2.96e-1)" "unprognostic (1.17e-2)" 25.5 5.1 0.2 2.1 0.2 1.0 9.5 0.5 0.3 10.4 0.0 4.3 16.6 4.2 0.5 6.8 3.0 0.0 22.3 0.0 0.0 4.4 13.2 2.9 2.6 0.1 0.1 56.1 133851.7 0.0 7.2 6.5 0.1 5.6 0.0 0.0 22.3 0.2 3.8 5.8 8.9 0.0 0.0 11.7 7.6 3.4 0.1 0.0 2.8 0.1 0.0 2.4 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.1 0.1 2.0 0.0 0.0 0.1 31269.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 151.9 0.0 0.0 0.0 0.1 1430.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 CTRB2 ENSG00000168928 "Chymotrypsinogen B2" Q6GPI1 16 75204103-75207161 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2443 "pancreas: 98661.0" "Cell type enriched" "Detected in some" 9 "Exocrine glandular cells: 53114.3" "Cancer enriched" "Detected in single" 1696 "pancreatic cancer: 540.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.4;U-2 OS: 5.8;U-251 MG: 1.6;U-266/84: 1.8;U-698: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to digestive system" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (9.41e-4)" "unprognostic (2.20e-1)" "unprognostic (1.28e-2)" "unprognostic (2.10e-1)" "unprognostic (2.92e-2)" "unprognostic (2.77e-1)" "unprognostic (5.95e-2)" "unprognostic (9.56e-2)" "unprognostic (3.54e-3)" "unprognostic (7.06e-2)" "unprognostic (2.17e-1)" "unprognostic (7.57e-2)" 27.8 4.8 0.2 1.5 0.2 1.8 9.1 0.4 0.3 8.2 0.0 4.4 9.1 4.7 0.1 6.6 3.7 0.2 13.7 0.1 0.2 4.5 12.8 3.1 2.8 0.2 0.1 40.3 98661.0 0.0 5.7 5.6 0.2 11.8 0.0 0.0 16.7 0.1 3.7 5.2 6.6 0.0 0.1 7.2 8.1 3.7 0.2 0.0 3.1 0.0 0.0 2.8 4.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.8 0.0 1.6 0.0 1.8 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 108.8 2.0 0.3 0.0 1.5 0.0 0.0 0.0 53114.3 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.3 6.0 0.0 0.0 215.5 0.0 0.0 0.0 0.0 5324.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 30.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 CTRC "CLCR, ELA4" ENSG00000162438 "Chymotrypsin C" Q99895 1 15438442-15449242 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 3927 "pancreas: 25708.5" "Cell type enriched" "Detected in some" 9 "Exocrine glandular cells: 6566.4" "Cancer enriched" "Detected in some" 168 "pancreatic cancer: 236.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046920 Enhanced "Secreted to digestive system" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 1: Pancreatic cells - Digestion" "HPA046920: AB_2679865" "unprognostic (2.62e-2)" "unprognostic (2.58e-1)" "unprognostic (1.34e-1)" "unprognostic (2.81e-1)" "unprognostic (8.60e-2)" "unprognostic (1.06e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (2.94e-2)" "unprognostic (7.60e-2)" "unprognostic (3.34e-1)" "unprognostic (2.00e-1)" "unprognostic (9.55e-11)" "unprognostic (4.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.50e-1)" "unprognostic (5.99e-3)" 6.5 1.2 0.2 0.2 0.2 0.7 2.9 0.7 0.3 2.7 0.2 1.2 1.1 1.3 0.1 1.9 0.8 0.0 2.3 0.3 0.1 1.2 3.5 1.0 0.3 0.1 0.1 5.6 25708.5 0.0 1.5 0.7 0.2 1.8 0.0 0.1 2.1 0.0 1.0 2.1 1.7 0.0 0.0 2.0 2.3 1.0 0.2 0.0 1.0 0.0 0.0 0.6 1.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.0 0.2 0.2 0.7 0.3 0.3 0.1 0.1 0.1 0.2 0.0 0.2 0.2 0.2 0.0 0.5 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 17.3 0.0 0.6 1.0 0.7 0.0 0.0 0.2 6566.4 0.1 0.2 0.0 2.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.0 1.1 1.8 0.0 24.3 0.0 1.0 0.0 0.0 673.8 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.0 1.3 3.5 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.3 CTRL ENSG00000141086 "Chymotrypsin like" P40313 16 67927640-67932365 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1154 "pancreas: 7481.6" "Group enriched" "Detected in some" 20 "Exocrine glandular cells: 224.2;Pancreatic endocrine cells: 58.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034504, HPA034505" Enhanced "Secreted to digestive system" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 1: Pancreatic cells - Digestion" "HPA034504: AB_2674196, HPA034505: AB_10602212" "unprognostic (3.03e-5)" "unprognostic (3.53e-3)" "unprognostic (3.46e-2)" "unprognostic (1.37e-1)" "unprognostic (9.66e-2)" "unprognostic (2.00e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (6.83e-3)" "unprognostic (6.41e-2)" "unprognostic (1.88e-1)" "unprognostic (3.20e-4)" "unprognostic (6.69e-2)" "unprognostic (2.79e-1)" "unprognostic (2.63e-1)" "unprognostic (1.29e-3)" 1.2 0.7 2.9 1.1 3.1 6.1 0.9 3.8 4.2 1.1 2.1 0.8 1.8 0.6 0.2 0.5 0.7 0.7 1.7 3.0 2.8 0.8 1.0 1.7 2.5 3.5 3.0 6.4 7481.6 0.0 1.7 0.7 3.7 1.2 0.5 0.3 1.1 0.2 0.6 1.0 1.7 0.4 2.8 3.5 1.0 0.6 3.3 1.9 0.7 0.7 1.0 0.7 0.7 3.5 0.4 2.1 0.6 0.2 0.1 0.0 0.9 0.3 0.4 0.7 1.0 1.9 1.0 0.5 0.3 0.4 0.6 0.7 4.1 0.7 2.0 0.8 4.6 0.5 0.9 1.9 0.2 0.3 1.4 0.7 0.1 2.5 0.7 0.3 0.0 1.0 1.0 1.1 0.3 0.7 0.4 2.2 4.1 1.1 1.9 2.0 0.3 3.1 0.0 0.8 1.9 1.1 0.7 0.7 0.4 0.4 0.9 2.5 0.9 0.1 1.4 0.2 1.0 3.8 1.7 2.2 0.1 0.7 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.0 2.9 3.1 3.8 4.2 3.0 2.8 3.5 3.0 3.7 2.8 3.3 3.5 0.6 0.0 0.0 1.6 0.2 0.5 0.0 0.0 2.2 0.0 0.2 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.3 0.8 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 1.3 224.2 0.0 0.5 1.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 1.7 0.4 2.0 1.2 0.3 0.0 0.0 0.5 0.0 1.0 2.1 0.0 0.0 0.5 1.6 58.5 1.4 0.0 0.2 0.1 0.3 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.3 0.0 0.6 6.9 0.5 0.1 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832158-122846175 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1631 "pancreas: 2414.2" "Cell type enriched" "Detected in some" 6 "Exocrine glandular cells: 266.9" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 1.9;U-937: 1.2" "Not detected" "Not detected" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles No No "Cluster 25: Pancreas - Digestion" "Cluster 30: Epithelial cell lines - Translation" "Cluster 1: Pancreatic cells - Digestion" Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663" "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.4 0.2 0.2 0.2 0.3 0.8 0.4 0.2 0.5 0.6 0.2 0.6 0.5 0.4 0.4 0.5 0.4 0.0 0.4 0.3 0.2 0.9 0.2 0.5 0.2 0.2 0.2 1.0 2414.2 0.0 1.4 0.1 0.4 0.7 0.0 0.4 0.5 0.0 0.1 0.7 0.9 0.0 0.2 1.1 0.4 1.0 0.2 0.3 0.5 0.0 0.0 0.5 0.5 0.3 0.3 0.5 0.1 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.7 0.0 0.1 0.1 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.9 0.1 0.2 0.3 0.3 0.3 1.0 0.1 0.4 0.3 0.4 0.4 0.0 0.0 0.4 0.0 0.4 0.1 0.4 0.2 0.3 0.0 0.3 0.5 0.4 0.6 0.5 0.0 0.5 0.2 0.0 0.0 0.4 0.8 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.5 0.3 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.7 0.2 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.9 2.8 0.1 0.1 0.1 0.0 0.4 0.0 266.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 5.0 0.0 0.1 0.0 0.3 0.3 6.7 0.3 0.1 0.0 0.0 3.7 0.1 0.0 0.0 0.0 43.6 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.4 0.1 0.7 0.2 0.0 0.1 0.0 0.7 0.1 0.2 0.1 CXCL11 "b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B" ENSG00000169248 "C-X-C motif chemokine ligand 11" O14625 4 76033682-76041415 "Human disease related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Basal prostatic cells: 2.6;Basal respiratory cells: 2.9;Distal enterocytes: 2.7;Exocrine glandular cells: 3.6;Macrophages: 4.3;Prostatic glandular cells: 3.7;Proximal enterocytes: 2.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 3.4;BJ hTERT+ SV40 Large T+: 5.1;BJ hTERT+ SV40 Large T+ RasG12V: 5.3;GAMG: 1.4" "Region enhanced" "Detected in single" "spinal cord: 1.2" CAB009921 Uncertain "Secreted to blood" NA NA 187000 "Cluster 3: T-cells - Adaptive immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 1: Pancreatic cells - Digestion" "CAB009921: AB_2088137" "unprognostic (2.00e-1)" "unprognostic (3.62e-1)" "unprognostic (6.94e-3)" "unprognostic (1.87e-2)" "unprognostic (9.95e-2)" "unprognostic (5.85e-2)" "unprognostic (1.89e-1)" "unprognostic (1.04e-1)" "unprognostic (1.73e-1)" "prognostic favorable (4.31e-7)" "prognostic unfavorable (8.18e-5)" "unprognostic (2.90e-1)" "prognostic unfavorable (3.29e-6)" "unprognostic (1.53e-1)" "unprognostic (4.17e-2)" "unprognostic (4.48e-2)" "unprognostic (5.32e-2)" 1.6 0.4 1.5 11.1 1.3 0.3 3.7 1.1 3.5 2.5 1.0 1.7 0.8 1.5 0.2 1.0 1.6 1.2 1.2 1.2 1.2 1.3 2.4 6.0 11.9 2.3 1.4 0.5 8.9 0.1 0.3 3.6 2.2 5.2 4.3 0.0 3.1 0.3 0.3 0.3 1.2 1.7 1.6 5.8 6.3 0.9 2.0 6.3 1.2 0.0 1.4 4.6 0.6 1.3 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.4 5.1 5.3 0.0 0.1 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 1.1 3.5 1.2 1.2 2.3 1.4 2.2 1.6 2.0 1.3 0.5 3.2 0.0 0.0 0.2 0.1 2.6 2.9 0.0 0.0 0.2 0.3 0.2 1.5 0.2 0.0 0.0 0.0 0.0 2.7 0.0 2.0 0.0 0.7 0.9 2.2 0.0 0.0 0.0 3.6 0.0 0.5 0.0 1.6 0.0 0.0 0.4 0.2 1.8 0.0 0.0 0.1 0.0 2.1 0.3 0.0 0.0 4.3 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.7 2.8 0.0 0.8 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.2 0.0 1.2 1.4 DAPK3 "ZIP, ZIPK" ENSG00000167657 "Death associated protein kinase 3" O43293 19 3958453-3971123 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation, Translation regulation" "Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028569 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" Cytosol Nucleoplasm "HPA028569: AB_10794319" "unprognostic (5.72e-2)" "unprognostic (3.28e-2)" "unprognostic (3.34e-3)" "prognostic favorable (2.01e-5)" "unprognostic (1.83e-1)" "unprognostic (2.37e-1)" "unprognostic (7.72e-3)" "unprognostic (2.16e-1)" "unprognostic (2.46e-2)" "unprognostic (4.95e-2)" "unprognostic (1.84e-3)" "unprognostic (7.64e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.92e-2)" "unprognostic (1.41e-1)" "unprognostic (5.48e-2)" "unprognostic (2.14e-1)" 49.9 25.4 15.0 29.0 15.2 18.9 47.2 14.3 27.9 58.3 18.9 92.2 30.9 85.0 8.2 37.0 55.4 36.0 106.2 16.8 13.9 27.6 30.4 72.5 21.2 16.2 15.4 48.4 36.4 19.0 38.5 31.9 18.8 53.3 11.0 9.0 41.3 39.3 113.6 51.2 44.4 36.6 11.9 29.6 61.4 42.6 17.4 15.4 31.0 21.1 11.3 59.5 45.3 17.3 79.2 61.1 37.5 47.6 27.5 30.9 57.8 106.0 84.5 84.7 55.5 113.4 23.3 43.4 50.8 93.8 59.6 61.7 36.9 60.3 30.7 64.0 61.2 17.5 76.7 65.9 87.2 42.7 63.1 70.6 73.6 77.0 44.0 50.8 71.2 29.2 56.3 73.2 52.5 51.0 42.4 31.9 58.5 31.8 48.6 52.5 55.3 40.5 51.0 60.9 59.1 41.1 71.4 84.9 61.1 43.8 61.4 33.1 134.8 108.3 49.3 98.1 134.5 81.1 72.4 50.7 86.3 44.0 59.0 32.5 18.0 32.5 23.0 20.3 16.7 15.9 17.8 21.6 16.2 16.6 13.1 12.9 29.8 24.3 14.3 18.6 23.6 14.6 15.0 15.2 14.3 27.9 16.8 13.9 16.2 15.4 18.8 11.9 17.4 17.3 24.1 25.6 10.5 6.5 17.0 100.7 99.7 84.1 27.9 15.2 23.9 15.6 29.2 24.3 35.0 11.0 2.1 50.5 14.5 69.2 17.6 90.3 40.3 27.9 28.2 38.3 27.4 7.0 9.6 88.2 79.1 27.8 40.8 37.5 20.3 24.8 21.4 7.9 22.9 11.8 7.1 48.2 48.8 13.6 22.8 23.6 22.7 16.6 37.4 8.4 25.7 12.8 30.9 6.0 6.7 117.7 49.9 22.6 13.3 46.1 59.6 14.3 18.8 10.7 32.9 19.9 53.0 34.6 15.7 24.4 71.7 93.2 15.1 26.2 29.7 46.3 DBNDD1 "FLJ12582, MGC3101" ENSG00000003249 "Dysbindin domain containing 1" Q9H9R9 16 90004871-90019890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 92.0;skeletal muscle: 48.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 22.8;Ductal cells: 16.0;Exocrine glandular cells: 18.8;Horizontal cells: 30.3;Pancreatic endocrine cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "naive B-cell: 12.9" "Lineage enriched" "Detected in many" 4 "B-cells: 12.9" "Cell line enhanced" "Detected in many" "MCF7: 139.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043018 Uncertain Approved "Nuclear speckles,Cytosol" No No "Cluster 21: B-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" "Nuclear speckles" Cytosol "HPA043018: AB_10794921" "unprognostic (1.07e-1)" "unprognostic (8.40e-2)" "unprognostic (8.70e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-2)" "unprognostic (4.18e-2)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.07e-2)" "unprognostic (9.52e-2)" "unprognostic (1.54e-1)" "unprognostic (2.86e-2)" "prognostic favorable (2.75e-7)" "unprognostic (1.03e-1)" "unprognostic (5.67e-1)" "unprognostic (2.44e-2)" "unprognostic (2.00e-2)" 1.8 7.4 47.1 2.5 35.3 0.3 4.4 27.5 60.6 4.1 11.6 2.9 1.6 0.9 10.0 28.2 3.6 3.8 4.6 35.2 40.7 13.3 6.5 3.5 4.7 50.6 55.3 3.1 19.5 9.6 7.7 0.1 50.8 3.8 1.4 7.4 15.5 3.1 48.0 6.0 1.7 1.3 30.3 1.2 7.7 1.0 92.0 1.4 5.2 4.8 5.1 1.7 7.3 38.6 22.8 34.7 3.5 44.7 0.9 0.4 24.7 4.9 6.6 10.5 5.3 32.1 19.7 0.0 2.7 1.1 10.2 24.0 41.3 1.2 10.7 0.1 65.4 0.0 4.4 58.6 1.5 0.3 4.7 1.0 3.3 18.8 0.1 25.2 47.3 0.8 6.7 0.4 4.1 139.7 0.1 33.5 59.5 18.6 13.9 14.5 32.3 0.6 64.2 4.5 51.2 53.0 5.6 5.3 44.8 10.2 34.6 4.8 36.2 7.4 15.1 0.4 24.1 0.3 0.3 0.4 3.5 3.9 20.1 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.6 0.5 0.0 12.9 2.9 0.5 0.0 0.0 0.0 0.1 0.0 1.0 47.1 35.3 27.5 60.6 35.2 40.7 50.6 55.3 50.8 30.3 92.0 38.6 0.3 3.2 2.0 2.9 6.0 0.4 0.6 0.6 0.0 1.8 13.5 7.5 2.5 22.8 2.0 9.2 0.0 0.2 0.1 1.4 9.8 16.0 0.0 5.7 0.7 1.1 6.0 0.0 6.1 18.8 0.3 0.2 2.6 7.8 0.0 3.4 1.4 2.5 0.3 30.3 3.6 1.5 2.0 0.0 0.7 0.0 1.2 0.1 3.6 2.8 0.2 10.4 0.0 1.5 0.7 15.0 2.9 0.4 0.5 4.3 0.2 10.8 2.7 1.8 0.0 1.4 1.2 0.1 2.0 8.1 1.0 0.0 1.4 0.3 0.8 1.3 DHRSX "DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6" ENSG00000169084 "Dehydrogenase/reductase X-linked" Q8N5I4 X 2219506-2502805 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003035, HPA075955" Approved Uncertain "Mitotic spindle,Cytosol" "Secreted to blood" Yes NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 1: Pancreatic cells - Digestion" Cytosol "Mitotic spindle" "HPA003035: AB_1080631, HPA075955: " "unprognostic (7.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.95e-2)" "unprognostic (4.65e-3)" "unprognostic (8.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (4.59e-3)" "unprognostic (1.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.08e-2)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (1.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.69e-2)" 13.1 16.2 7.0 4.8 8.2 5.2 12.2 6.7 7.7 13.3 11.9 12.7 6.5 13.0 8.0 6.0 11.0 8.8 19.9 6.1 6.8 14.7 30.6 10.3 5.6 11.5 10.1 12.6 21.9 11.5 10.6 8.2 8.4 13.2 8.3 2.2 14.7 7.0 12.4 9.0 10.8 6.9 8.5 10.1 16.5 6.4 10.9 6.1 13.3 7.0 3.9 11.2 9.3 8.2 8.1 35.7 23.9 11.0 28.8 18.0 18.5 17.8 29.9 13.3 17.9 26.9 16.8 12.6 22.6 21.5 31.4 3.9 16.4 14.3 9.4 24.1 26.1 12.2 17.9 21.2 33.8 6.6 9.5 22.3 17.7 11.6 11.4 22.7 10.9 13.9 14.0 6.1 21.7 9.2 28.5 9.7 6.9 10.6 9.9 10.4 12.4 3.5 14.5 19.3 24.3 22.9 17.0 20.3 14.2 14.8 8.7 10.8 15.6 14.5 3.6 8.4 10.6 7.1 0.1 33.2 9.7 8.7 6.7 14.9 38.3 34.6 15.1 30.6 16.0 25.0 13.5 12.7 35.1 20.1 12.3 10.6 56.4 17.7 19.5 28.3 18.2 21.0 7.0 8.2 6.7 7.7 6.1 6.8 11.5 10.1 8.4 8.5 10.9 8.2 8.7 19.2 9.3 64.3 19.2 10.6 22.9 58.0 20.5 9.5 19.3 16.9 23.4 25.8 24.4 25.8 10.4 42.9 17.0 32.9 13.7 52.3 0.6 16.1 15.9 14.8 19.2 13.7 41.2 81.2 43.5 26.9 21.4 14.4 17.8 27.1 15.0 50.6 38.4 3.3 42.7 21.4 32.6 20.8 30.7 3.0 24.2 26.3 12.4 61.8 35.9 9.4 14.4 46.3 31.9 71.0 28.8 25.2 29.1 65.3 49.2 43.7 14.8 6.2 19.7 12.0 18.3 12.0 21.2 11.3 6.5 107.3 14.0 14.6 24.1 29.2 DUOXA2 ENSG00000140274 "Dual oxidase maturation factor 2" Q1HG44 15 45114326-45118421 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Protein transport, Transport" "Congenital hypothyroidism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 63.9;urinary bladder: 41.9" "Cell type enhanced" "Detected in some" "Ductal cells: 856.3;Exocrine glandular cells: 178.0;Pancreatic endocrine cells: 696.7;Urothelial cells: 552.0" "Cancer enhanced" "Detected in many" "pancreatic cancer: 27.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA063548 Enhanced NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "HPA063548: AB_2685037" "unprognostic (1.87e-1)" "unprognostic (9.88e-2)" "unprognostic (7.37e-2)" "unprognostic (6.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.00e-3)" "unprognostic (6.73e-2)" "unprognostic (2.03e-1)" "unprognostic (2.10e-1)" "unprognostic (3.15e-2)" "unprognostic (1.26e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-4)" "unprognostic (9.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.37e-1)" "unprognostic (5.54e-2)" 0.1 0.3 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.1 0.4 0.0 0.0 5.6 0.0 63.9 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.9 0.1 0.0 1.5 0.0 0.0 0.0 2.1 0.2 0.0 0.0 15.9 0.0 0.0 0.0 11.4 0.0 0.6 41.9 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 1.1 0.0 2.2 0.0 28.1 46.4 0.0 0.0 0.0 0.0 0.9 12.8 32.7 0.0 0.0 0.0 0.0 85.2 0.0 856.3 0.0 0.3 0.1 1.0 0.0 0.0 0.0 178.0 0.0 0.5 57.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 4.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.9 0.0 0.0 0.0 0.1 696.7 61.8 0.0 0.0 14.2 0.9 0.1 106.7 0.0 0.0 0.0 7.1 0.3 0.2 0.0 0.0 0.0 0.6 0.2 23.8 552.0 DYNC1LI2 DNCLI2 ENSG00000135720 "Dynein cytoplasmic 1 light intermediate chain 2" O43237 16 66720893-66751609 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 311.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049538, HPA057201" Approved Approved Centrosome,Cytosol NA NA 21000 "Cluster 18: Basophils - Vesicular transport" "Cluster 70: Brain - Nervous system development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 1: Pancreatic cells - Digestion" Centrosome Cytosol "HPA049538: , HPA057201: AB_2683366" "unprognostic (6.03e-2)" "unprognostic (2.40e-2)" "unprognostic (8.28e-2)" "unprognostic (1.57e-2)" "unprognostic (5.35e-2)" "unprognostic (2.80e-1)" "unprognostic (7.58e-2)" "unprognostic (3.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (6.51e-3)" "unprognostic (4.77e-2)" "unprognostic (1.92e-1)" "unprognostic (7.70e-3)" "unprognostic (1.34e-1)" 60.9 44.9 225.7 39.2 240.6 42.4 44.1 207.1 311.6 46.2 131.4 70.5 43.3 50.7 40.6 50.6 37.7 48.7 59.4 184.1 202.3 43.0 29.1 45.9 27.0 228.5 228.0 45.5 44.7 65.7 35.6 46.8 226.2 52.7 61.1 37.3 48.6 49.9 42.3 51.3 44.6 64.9 244.5 36.3 50.2 34.1 221.3 24.6 61.6 49.9 28.8 45.7 40.8 265.1 52.5 54.0 79.1 71.0 100.1 98.3 71.6 84.5 67.1 67.5 87.0 73.4 50.6 21.9 64.6 83.3 49.1 74.1 61.2 60.4 98.2 14.9 43.9 27.0 68.1 70.6 55.5 29.0 38.5 64.8 80.6 77.8 53.4 94.3 96.2 22.4 44.4 28.0 88.8 37.5 18.1 37.5 47.5 58.4 93.0 39.4 166.3 26.5 67.2 73.3 78.8 54.9 152.1 32.6 100.6 56.5 39.7 28.8 123.2 86.9 43.3 43.0 58.2 35.3 27.4 43.0 74.6 27.7 55.8 13.6 16.6 16.6 12.3 9.9 14.2 4.8 10.4 10.2 12.2 9.4 8.7 8.4 15.7 9.3 14.5 7.6 11.4 8.7 225.7 240.6 207.1 311.6 184.1 202.3 228.5 228.0 226.2 244.5 221.3 265.1 117.9 102.5 120.4 44.1 29.5 66.2 63.1 66.1 52.3 82.5 54.8 51.2 48.3 54.3 93.8 27.6 33.3 61.3 47.2 114.0 7.9 85.7 112.6 77.6 68.5 97.6 106.1 28.4 50.9 58.1 62.0 66.7 52.5 87.4 36.7 87.5 62.4 33.3 30.6 107.7 45.4 78.6 65.1 39.9 53.7 66.8 63.3 36.8 69.4 34.7 37.8 116.0 35.0 51.3 106.9 101.7 56.7 80.5 37.3 83.6 60.0 49.4 105.0 61.4 118.3 93.4 87.0 103.0 51.1 53.6 69.9 84.8 32.2 61.2 66.7 95.8 EIF4EBP1 "4E-BP1, PHAS-I" ENSG00000187840 "Eukaryotic translation initiation factor 4E binding protein 1" Q13541 8 38030534-38060365 "Cancer-related genes, Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 188.9;salivary gland: 164.2" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 730.0;Pancreatic endocrine cells: 277.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005032, CAB005039, HPA023501" Supported Supported Nucleoplasm,Cytosol NA NA 44000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 50: Non-specific - Ribosome" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095" "unprognostic (1.55e-2)" "unprognostic (2.45e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.86e-4)" "unprognostic (6.94e-2)" "unprognostic (2.69e-1)" "unprognostic (1.94e-2)" "unprognostic (3.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.16e-2)" "unprognostic (3.18e-3)" "unprognostic (7.21e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (4.57e-2)" "unprognostic (5.72e-3)" 60.9 12.6 7.7 16.9 8.0 35.0 53.6 8.0 10.9 24.9 12.7 25.3 18.5 19.7 2.2 86.0 21.7 8.9 32.7 8.0 9.8 19.5 63.5 25.0 10.3 9.8 8.5 22.2 188.9 7.8 9.2 28.6 9.8 19.2 15.4 1.5 164.2 17.0 98.1 20.8 23.1 14.4 8.5 23.9 43.8 5.5 10.1 9.6 9.6 27.2 10.4 33.6 26.5 10.8 146.9 113.2 32.4 193.2 41.3 32.3 77.0 130.5 111.9 128.4 203.5 74.8 56.3 46.3 101.5 121.3 77.1 85.1 109.1 197.5 74.8 36.0 190.9 269.6 52.0 104.9 423.6 98.8 60.4 100.0 314.9 142.0 264.1 40.1 208.2 57.7 152.7 221.8 54.8 141.7 95.9 297.8 186.0 112.9 243.7 80.3 80.4 197.4 49.3 22.3 281.6 200.8 26.1 78.8 534.8 20.3 105.8 192.2 105.2 76.1 167.1 179.9 137.8 185.1 121.6 72.1 173.4 213.4 169.1 51.1 416.3 258.3 27.9 336.6 27.3 130.7 32.8 30.9 335.0 103.3 26.2 26.0 39.4 35.0 268.3 242.6 66.0 258.3 7.7 8.0 8.0 10.9 8.0 9.8 9.8 8.5 9.8 8.5 10.1 10.8 23.6 9.6 8.3 1.6 25.2 74.4 42.4 114.8 51.8 3.6 84.8 72.8 41.7 57.2 97.3 20.2 2.1 41.3 27.3 70.1 29.4 226.1 17.0 11.6 39.0 54.6 40.2 79.9 0.8 730.0 224.2 68.6 35.7 12.5 18.4 76.0 65.3 103.4 223.4 0.0 1.3 138.2 79.3 108.6 82.2 106.2 43.5 83.9 72.9 1.9 101.9 19.2 21.6 4.0 0.4 277.9 64.5 19.2 38.7 100.2 19.5 103.1 33.5 2.2 13.1 17.6 85.2 1.9 25.5 209.3 85.4 38.6 19.8 69.3 83.8 58.9 ERICH5 "C8orf47, FLJ39553" ENSG00000177459 "Glutamate rich 5" Q6P6B1 8 98064522-98093610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 34.2" "Cell type enhanced" "Detected in many" "Cholangiocytes: 100.1;Ductal cells: 57.6;Endometrial ciliated cells: 27.8;Proximal tubular cells: 24.5;Respiratory ciliated cells: 39.4" "Cancer enhanced" "Detected in many" "liver cancer: 23.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 9 "myeloid DC: 2.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 2.2" "Cell line enhanced" "Detected in some" "A549: 7.3;HAP1: 8.0;HEK 293: 11.5;JURKAT: 14.7;RPTEC TERT1: 7.5;RT4: 18.2" "Not detected" "Not detected" "HPA025070, HPA025293, HPA027233" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 15: RT4 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780" "unprognostic (2.88e-3)" "unprognostic (1.49e-1)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (6.86e-2)" "unprognostic (2.39e-1)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (4.66e-1)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (5.73e-1)" "prognostic favorable (3.76e-4)" "unprognostic (4.36e-2)" "unprognostic (9.22e-2)" "unprognostic (3.17e-2)" "prognostic favorable (9.38e-4)" 0.5 0.1 1.5 0.3 2.4 0.0 1.0 0.9 1.4 2.5 1.2 1.9 5.3 1.3 0.6 0.7 11.1 12.3 5.3 1.0 2.4 5.6 10.2 0.9 1.0 1.8 2.1 0.9 34.2 2.2 1.3 0.2 1.9 2.7 3.3 2.3 1.3 2.3 0.0 0.7 1.5 0.5 1.1 0.2 12.6 2.4 4.7 0.7 0.6 0.0 0.7 1.9 0.5 1.3 0.0 7.3 0.0 0.0 0.1 0.0 4.7 4.6 1.8 2.3 1.8 0.1 2.4 0.0 6.0 1.2 3.6 0.4 8.0 0.2 2.8 0.0 11.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.0 14.7 0.0 0.0 0.1 0.2 0.0 0.8 1.6 0.2 2.8 0.0 0.0 0.2 7.5 18.2 4.1 0.2 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 2.4 0.9 1.4 1.0 2.4 1.8 2.1 1.9 1.1 4.7 1.3 0.0 3.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.2 2.1 1.3 8.0 100.1 3.1 7.3 0.0 0.3 0.0 1.6 0.0 57.6 0.3 27.8 0.6 0.8 18.0 0.0 1.1 18.4 1.8 0.2 7.7 7.7 0.0 4.3 0.4 2.6 0.1 0.0 1.6 2.4 0.0 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.1 8.0 0.0 0.5 0.1 14.8 1.6 0.0 0.0 2.5 0.7 24.5 39.4 0.1 0.0 0.2 1.0 0.2 4.7 1.1 0.0 0.1 0.2 0.7 3.6 2.6 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630247-69633596 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.3" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 19.4;Collecting duct cells: 16.5;Distal tubular cells: 11.7;Ductal cells: 24.3;Exocrine glandular cells: 18.4;Pancreatic endocrine cells: 20.7;Proximal tubular cells: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 13 "gdT-cell: 4.3;MAIT T-cell: 10.9;memory CD4 T-cell: 10.5;memory CD8 T-cell: 7.0;naive CD4 T-cell: 17.2;naive CD8 T-cell: 5.7;T-reg: 7.8" "Lineage enriched" "Detected in single" 25 "T-cells: 17.2" "Cell line enhanced" "Detected in many" "PC-3: 57.5" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavorable (8.64e-4)" "prognostic unfavorable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favorable (9.72e-4)" 1.6 3.0 26.3 1.9 27.3 1.1 4.7 30.4 40.3 2.2 19.2 6.6 2.7 3.2 11.1 4.8 4.3 2.0 6.6 35.5 31.7 10.7 3.7 4.0 2.9 21.7 24.2 2.1 8.2 8.2 12.7 1.2 28.2 7.8 2.3 11.3 5.5 4.7 4.7 3.4 3.5 3.8 21.5 1.4 5.8 22.2 26.4 2.8 5.8 1.2 2.3 5.8 3.0 22.2 29.4 31.9 3.9 31.8 0.0 0.0 13.6 2.9 0.8 5.1 5.6 23.4 23.6 0.0 42.8 0.6 18.6 11.8 16.6 9.6 7.1 29.4 22.8 0.0 6.7 8.8 8.1 0.0 10.0 0.0 9.4 0.2 4.8 3.8 0.0 43.8 11.1 0.1 0.5 39.9 0.3 0.0 19.1 11.8 57.5 0.0 0.0 0.4 10.9 16.6 16.0 22.2 12.1 29.6 19.0 7.8 20.5 5.1 1.4 0.8 19.4 0.1 8.5 5.1 15.2 0.1 0.4 0.0 0.8 0.0 0.0 0.0 4.3 0.0 10.9 0.1 10.5 7.0 0.1 0.4 17.2 5.7 0.6 0.2 0.0 0.1 7.8 3.1 26.3 27.3 30.4 40.3 35.5 31.7 21.7 24.2 28.2 21.5 26.4 22.2 1.4 0.0 4.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 8.3 19.4 0.0 0.0 3.1 16.5 0.0 7.5 0.6 0.0 11.7 24.3 0.0 5.7 0.4 0.7 0.0 0.0 0.0 18.4 5.6 0.6 0.0 5.0 0.0 8.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.3 0.0 0.0 13.5 4.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.9 2.8 3.7 0.0 0.0 FBXO2 "Fbg1, Fbs1, FBX2, Nfb42, OCP1" ENSG00000116661 "F-box protein 2" Q9UK22 1 11637018-11655785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 238.9;choroid plexus: 125.3;pancreas: 86.9;pituitary gland: 118.3" "Cell type enriched" "Detected in many" 4 "Exocrine glandular cells: 685.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 113.4;HBEC3-KT: 96.9;Hep G2: 239.8;SiHa: 440.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005472 Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 39: CACO-2 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "HPA005472: AB_2667332" "unprognostic (2.02e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-1)" "unprognostic (8.13e-3)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.30e-2)" "unprognostic (1.18e-2)" "unprognostic (1.41e-1)" "unprognostic (5.44e-2)" "unprognostic (1.68e-2)" "prognostic favorable (3.45e-6)" "unprognostic (5.26e-2)" "unprognostic (5.21e-2)" "unprognostic (4.82e-2)" "unprognostic (1.64e-1)" 6.8 25.2 217.0 1.8 172.1 0.0 13.5 161.1 216.1 7.2 125.3 4.9 16.4 2.3 6.7 8.9 5.9 2.5 11.6 183.3 238.9 32.8 28.1 5.7 2.0 200.2 196.2 3.6 86.9 29.7 118.3 0.1 201.7 15.1 0.4 7.5 25.1 7.5 4.8 18.1 5.3 0.7 176.0 3.7 9.6 12.0 195.1 10.6 8.4 1.0 3.6 5.1 13.1 192.3 35.7 10.8 0.4 35.1 0.7 0.0 5.3 1.5 3.0 1.1 0.2 113.4 10.0 0.0 40.6 0.3 8.3 0.1 3.6 96.9 0.1 0.8 1.0 0.0 1.7 239.8 4.6 0.1 0.0 3.0 17.0 0.0 0.9 1.1 0.4 0.1 0.3 0.1 0.0 0.5 0.0 0.0 1.3 14.3 1.3 0.1 0.1 0.2 8.2 3.0 3.6 4.7 440.5 0.1 3.9 3.5 21.1 0.0 0.0 0.3 3.1 0.0 0.0 2.4 2.1 1.7 0.7 0.0 1.0 0.0 0.0 0.0 0.9 0.0 1.3 0.7 0.5 1.2 0.0 0.5 0.8 1.1 0.0 0.0 0.0 0.0 0.4 0.2 217.0 172.1 161.1 216.1 183.3 238.9 200.2 196.2 201.7 176.0 195.1 192.3 1.2 0.0 1.5 40.8 8.4 19.6 62.3 149.9 90.5 11.3 15.0 75.4 3.7 15.7 33.5 47.8 2.1 0.8 5.9 0.2 86.1 23.2 2.1 1.2 0.7 1.8 1.2 0.0 16.5 685.9 3.9 8.7 6.6 0.7 4.5 0.2 2.5 102.0 0.4 28.6 16.7 0.7 38.7 2.2 2.6 2.4 34.8 1.1 44.4 5.6 3.2 106.6 7.2 6.6 10.4 132.1 2.2 40.6 3.3 39.2 2.0 7.2 44.4 15.8 0.0 1.1 7.7 18.4 12.1 10.0 9.9 1.0 13.0 0.5 0.4 25.0 FGF19 ENSG00000162344 "Fibroblast growth factor 19" O95750 11 69698238-69704022 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "gallbladder: 237.1" "Group enriched" "Detected in some" 4 "Cholangiocytes: 24.3;Ductal cells: 15.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "CAPAN-2: 138.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA036082 Approved "Secreted to blood" NA NA 133000 "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "HPA036082: AB_10669665" "unprognostic (7.46e-3)" "unprognostic (2.43e-3)" "unprognostic (5.52e-3)" "unprognostic (1.22e-1)" "unprognostic (4.68e-3)" "unprognostic (6.45e-2)" "unprognostic (5.72e-3)" "unprognostic (2.26e-1)" "unprognostic (6.39e-3)" "unprognostic (1.66e-2)" "unprognostic (8.82e-3)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.4 0.1 0.0 237.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 138.2 0.0 0.1 0.0 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.9 0.2 0.0 0.0 0.7 1.4 0.6 24.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.1 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.5 4.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 1.3 0.0 0.0 0.0 0.3 1.8 FP565260.1 ENSG00000275464 "Periodic tryptophan protein 2 homolog" 21 5130871-5154658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 9.1;Ductal cells: 9.3;Exocrine glandular cells: 8.0;granulocytes: 5.1;Hofbauer cells: 6.3;Pancreatic endocrine cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 102.4" HPA024573 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 2: Immune cells - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 1: Pancreatic cells - Digestion" Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (4.43e-1)" "unprognostic (9.66e-3)" "unprognostic (2.58e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-3)" "unprognostic (8.40e-3)" "unprognostic (5.16e-2)" "unprognostic (1.07e-2)" "unprognostic (9.34e-3)" "unprognostic (1.74e-2)" "unprognostic (5.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" 9.2 9.2 6.4 9.9 8.8 12.1 7.4 7.2 8.0 5.9 4.9 8.5 9.1 6.8 1.7 8.3 7.8 7.3 7.5 7.1 6.8 9.0 6.8 7.1 13.4 7.6 7.2 6.7 7.7 6.5 6.0 7.9 9.1 6.5 8.4 3.5 6.7 4.7 10.1 8.6 8.2 7.3 6.8 11.5 7.6 7.1 7.2 6.7 6.6 3.2 5.3 11.4 7.1 13.7 32.0 24.0 15.4 24.2 6.6 5.0 9.1 0.2 0.0 0.1 0.1 0.4 20.1 0.3 14.1 10.5 20.8 21.0 42.9 19.0 0.0 7.4 15.1 102.4 12.4 11.9 10.4 47.6 29.1 17.8 22.5 25.5 20.1 5.0 20.1 16.5 56.8 11.6 6.6 28.4 34.4 33.1 60.4 36.5 29.3 54.0 14.2 28.8 13.5 25.3 16.6 27.3 25.5 38.4 14.9 4.2 31.5 24.9 10.2 12.0 29.7 0.3 32.9 13.9 16.0 63.5 20.4 62.3 16.7 3.3 7.3 6.9 18.5 12.6 21.2 11.0 11.3 13.5 8.7 11.2 11.1 15.2 4.1 9.9 18.2 5.5 8.5 11.6 6.4 8.8 7.2 8.0 7.1 6.8 7.6 7.2 9.1 6.8 7.2 13.7 0.9 0.0 9.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 1.9 0.0 0.0 2.5 0.0 0.0 2.7 1.1 0.8 0.0 9.3 0.0 0.8 1.1 0.9 0.0 0.0 0.0 8.0 1.4 0.9 0.0 0.9 5.1 0.6 0.0 0.0 6.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.3 1.2 0.4 0.9 0.0 FURIN "FUR, PACE, PCSK3, SPC1" ENSG00000140564 "Furin, paired basic amino acid cleaving enzyme" P09958 15 90868588-90883564 "Enzymes, Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 305.6;salivary gland: 220.5" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 117.5;Hepatocytes: 131.8;Pancreatic endocrine cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009499, HPA067869" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 130000 "Cluster 10: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" Nucleoplasm "CAB009499: AB_2105095, HPA067869: " "unprognostic (2.46e-1)" "unprognostic (2.73e-2)" "unprognostic (7.33e-2)" "unprognostic (2.30e-2)" "unprognostic (4.11e-3)" "unprognostic (4.37e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (9.92e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (4.52e-3)" "unprognostic (4.57e-2)" "unprognostic (4.46e-2)" "unprognostic (4.27e-3)" "unprognostic (8.20e-2)" 54.5 24.4 12.8 36.4 10.5 73.8 42.4 10.6 14.5 26.4 11.7 32.8 27.6 32.3 9.8 33.7 30.4 19.4 58.5 14.9 9.0 56.8 305.6 63.2 13.0 12.5 10.8 22.4 108.6 27.3 45.9 40.6 11.3 60.1 12.1 12.9 220.5 17.7 61.3 62.7 35.5 14.3 10.4 51.4 34.0 8.6 15.6 11.8 56.1 25.3 11.2 30.2 33.3 9.3 50.8 31.2 6.8 29.8 49.4 32.1 77.5 64.4 48.1 26.3 18.1 45.4 54.3 1.9 148.8 47.5 46.1 91.5 14.0 32.5 5.4 148.0 35.2 90.9 52.8 57.7 26.2 13.0 141.2 35.6 35.3 29.5 13.2 62.4 84.7 14.6 70.5 8.5 17.8 32.3 5.0 29.2 21.5 44.2 9.3 7.9 26.6 10.9 35.2 39.1 13.1 9.2 54.5 28.5 42.5 31.9 10.7 31.4 125.9 29.4 60.1 43.7 95.5 15.2 93.4 3.4 55.8 40.1 60.7 2.0 0.9 1.5 0.7 0.1 0.2 0.4 0.2 0.3 0.6 0.1 0.0 0.1 0.7 0.4 0.0 0.3 0.0 1.1 12.8 10.5 10.6 14.5 14.9 9.0 12.5 10.8 11.3 10.4 15.6 9.3 44.1 3.2 27.4 4.2 7.3 19.4 10.0 10.4 2.8 12.8 12.0 9.0 16.3 21.5 8.5 22.0 25.0 20.9 26.9 49.5 0.0 47.1 0.5 15.2 9.7 29.4 37.8 26.5 7.9 117.5 16.5 11.4 21.9 32.3 15.8 7.0 23.9 131.8 24.8 8.4 7.5 31.7 10.2 35.3 42.1 1.4 11.1 33.6 16.0 5.6 14.0 13.6 24.7 2.0 4.4 108.3 26.4 10.9 7.2 24.3 28.7 7.8 2.0 28.0 26.3 10.5 18.6 2.8 3.6 8.5 23.0 84.3 19.6 4.7 17.9 16.4 GDPGP1 C15orf58 ENSG00000183208 "GDP-D-glucose phosphorylase 1" Q6ZNW5 15 90233808-90245811 "Enzymes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor, Hydrolase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA048189, HPA059841" Approved Approved Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA048189: AB_2680307, HPA059841: AB_2684138" "prognostic favorable (6.32e-4)" "unprognostic (1.85e-1)" "unprognostic (2.17e-1)" "unprognostic (2.42e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-1)" "unprognostic (3.68e-2)" "unprognostic (4.46e-3)" "unprognostic (1.53e-1)" "unprognostic (3.00e-1)" "unprognostic (1.82e-2)" "unprognostic (2.93e-3)" "unprognostic (8.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.02e-3)" 1.8 3.2 3.9 3.0 3.0 2.0 2.3 4.3 4.2 2.0 3.1 5.7 5.3 2.2 3.0 2.4 4.6 3.0 5.8 3.2 2.9 4.3 4.9 2.9 3.5 3.7 2.9 2.9 3.5 4.9 3.7 1.0 4.6 3.7 7.7 2.7 3.8 3.1 7.9 2.1 3.9 2.8 1.8 3.2 3.5 4.6 2.9 3.1 3.8 1.5 4.1 3.4 1.5 5.0 3.0 11.8 1.4 4.3 4.3 0.9 3.9 2.7 1.7 3.5 3.3 3.5 11.5 7.5 5.2 2.1 2.6 5.0 4.5 3.2 1.4 6.7 7.8 6.7 7.0 5.1 4.6 3.6 4.2 1.1 2.1 2.4 1.3 3.9 4.2 4.4 2.5 2.6 2.1 6.5 2.7 1.6 1.8 9.2 4.8 4.7 1.0 3.8 4.1 5.9 4.5 2.0 4.3 6.6 4.5 2.6 7.6 3.7 4.2 1.8 1.9 2.7 2.7 5.8 7.3 3.4 4.1 3.0 3.3 3.8 2.2 1.0 3.1 2.6 2.7 2.3 2.9 3.7 2.0 4.2 3.0 2.8 3.1 3.4 2.2 2.1 3.9 1.4 3.9 3.0 4.3 4.2 3.2 2.9 3.7 2.9 4.6 1.8 2.9 5.0 1.4 0.0 3.2 0.3 2.1 0.0 2.8 0.9 1.8 3.8 3.4 2.2 6.4 8.6 1.5 7.3 6.2 2.4 2.5 6.5 3.9 3.8 3.0 3.8 1.6 1.7 5.4 1.7 2.6 6.0 1.2 1.5 4.1 2.3 3.8 2.3 1.4 4.5 4.1 1.7 2.8 3.6 0.0 2.2 0.0 2.4 2.8 3.5 0.0 1.0 2.3 3.5 2.1 1.0 2.1 4.9 5.5 2.2 2.4 2.2 3.8 5.8 3.4 4.4 0.0 3.8 1.0 2.9 2.8 1.8 0.3 0.4 3.2 1.5 4.2 3.1 GP2 ZAP75 ENSG00000169347 "Glycoprotein 2" P55259 16 20309574-20327808 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 966 "pancreas: 35381.6" "Cell type enriched" "Detected in some" 5 "Exocrine glandular cells: 504.1" "Cancer enriched" "Detected in many" 14 "pancreatic cancer: 320.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015739, HPA016668" Enhanced "Secreted to digestive system" NA NA 41000 "Cluster 11: Basophils - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 1: Pancreatic cells - Digestion" "HPA015739: AB_1849905, HPA016668: AB_1849907" "unprognostic (2.14e-2)" "unprognostic (1.97e-2)" "unprognostic (5.68e-2)" "unprognostic (4.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.84e-1)" "unprognostic (6.35e-2)" "unprognostic (8.17e-3)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" 7.1 1.9 0.2 0.9 0.2 0.7 3.8 0.6 0.4 2.5 0.4 3.9 36.6 2.1 0.2 3.9 1.4 18.7 6.5 0.3 0.2 33.4 5.0 1.5 2.1 0.2 0.6 15.4 35381.6 0.0 2.9 2.4 0.3 33.4 6.2 0.1 7.5 0.0 1.6 1.8 10.1 0.1 0.1 2.5 27.4 1.9 0.2 0.1 1.3 0.0 0.2 1.0 1.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.6 0.4 0.3 0.2 0.2 0.6 0.3 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.2 1.1 0.1 0.1 87.2 0.0 0.0 0.0 0.0 0.0 1.7 9.8 1.3 7.5 0.3 0.5 0.2 0.0 0.0 0.0 504.1 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.0 0.0 0.3 15.6 0.3 0.4 0.0 0.0 4.2 0.2 0.0 0.0 0.0 20.7 13.9 0.4 0.0 69.7 2.0 0.0 0.0 0.3 0.0 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.1 19.9 2.1 GPHA2 "A2, GPA2, MGC126572, ZSIG51" ENSG00000149735 "Glycoprotein hormone subunit alpha 2" Q96T91 11 64934471-64935893 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "pancreas: 360.5" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 2.5;Exocrine glandular cells: 17.4;Pancreatic endocrine cells: 2.4;Spermatocytes: 7.7;Spermatogonia: 3.2" "Cancer enriched" "Detected in some" 7 "testis cancer: 15.8" "Region enhanced" "Detected in single" "cerebellum: 3.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "Hep G2: 21.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA067068 Approved Vesicles "Secreted to blood" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 1: Pancreatic cells - Digestion" Vesicles "HPA067068: " "unprognostic (1.13e-1)" "unprognostic (8.31e-3)" "unprognostic (1.51e-2)" "unprognostic (9.22e-4)" "unprognostic (7.88e-3)" "unprognostic (2.62e-1)" "unprognostic (1.45e-1)" "unprognostic (3.20e-2)" "unprognostic (1.82e-1)" "unprognostic (1.75e-1)" "unprognostic (5.03e-2)" "unprognostic (9.86e-3)" "unprognostic (1.70e-1)" 0.0 0.1 0.3 0.2 0.6 0.1 0.1 3.6 0.6 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.4 16.9 0.0 0.3 0.3 0.8 0.7 0.3 0.6 0.4 0.3 2.7 360.5 0.0 28.0 0.0 0.6 0.7 0.0 0.1 0.3 0.5 0.0 0.5 0.5 0.0 0.2 0.6 1.1 10.8 0.4 0.1 0.3 0.0 0.5 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 21.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 3.6 0.6 0.3 0.3 0.4 0.3 0.6 0.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 17.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 0.0 0.5 0.2 0.0 0.0 0.0 0.0 7.7 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 HNRNPA1P48 ENSG00000224578 "Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48" 16 51553436-51647132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "Ductal cells: 88.9;Enteroendocrine cells: 67.5;Exocrine glandular cells: 138.9;granulocytes: 109.6;monocytes: 57.4;Pancreatic endocrine cells: 77.9;Undifferentiated cells: 66.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001666, HPA005812" Uncertain Uncertain Nucleoplasm NA NA "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA001666: AB_1850836, HPA005812: AB_2667441" "unprognostic (2.61e-2)" "unprognostic (2.08e-1)" "unprognostic (3.22e-2)" "unprognostic (2.07e-3)" "unprognostic (7.23e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.48e-1)" "unprognostic (2.86e-1)" "unprognostic (6.09e-2)" "unprognostic (1.55e-3)" "unprognostic (7.66e-2)" "unprognostic (5.84e-2)" "unprognostic (2.17e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-3)" "unprognostic (2.11e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 19.2 32.8 0.0 32.7 0.0 0.0 0.0 0.0 0.0 25.1 16.4 12.2 0.0 22.3 1.8 0.0 0.0 14.9 19.1 11.7 88.9 0.0 7.0 12.6 13.1 67.5 0.0 0.0 138.9 0.0 13.7 0.0 8.1 109.6 13.0 0.0 0.0 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 57.4 0.0 0.0 0.0 0.0 77.9 14.3 0.0 1.6 0.0 0.0 21.1 14.6 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 20.9 8.7 66.2 0.0 HTR3A "5-HT3A, 5-HT3R, HTR3" ENSG00000166736 "5-hydroxytryptamine receptor 3A" P46098 11 113974881-113990313 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 8.0;salivary gland: 5.0" "Group enriched" "Detected in some" 11 "Ductal cells: 23.9;Exocrine glandular cells: 53.3;Pancreatic endocrine cells: 34.7" "Cancer enriched" "Detected in many" 7 "ovarian cancer: 15.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 15 "memory B-cell: 3.9;naive B-cell: 13.8;plasmacytoid DC: 11.6" "Group enriched" "Detected in many" 127 "B-cells: 13.8;dendritic cells: 11.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;Daudi: 5.9;NTERA-2: 3.6;SCLC-21H: 18.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "amygdala: 1.7;cerebral cortex: 2.7;hippocampal formation: 2.5" HPA069442 Supported NA NA "Cluster 24: B-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 1: Pancreatic cells - Digestion" "HPA069442: AB_2732132" "unprognostic (6.46e-3)" "prognostic favorable (6.26e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (3.36e-3)" "unprognostic (8.36e-3)" "unprognostic (1.65e-5)" "unprognostic (1.46e-2)" "unprognostic (8.87e-2)" "unprognostic (6.21e-2)" "unprognostic (6.80e-3)" "unprognostic (3.00e-2)" "unprognostic (1.65e-2)" "unprognostic (8.72e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-1)" "unprognostic (3.40e-2)" 0.0 0.4 0.7 2.1 1.2 0.0 0.0 0.4 1.0 0.0 0.4 2.1 0.6 0.1 0.0 0.5 0.0 0.0 0.0 1.1 0.5 0.1 0.0 0.0 6.5 0.4 0.5 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 5.0 0.0 0.0 0.7 1.7 0.7 0.4 0.5 0.8 0.1 0.5 0.4 0.0 0.0 8.0 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 5.9 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.6 13.8 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.2 0.7 1.2 0.4 1.0 1.1 0.5 0.4 0.5 0.4 0.4 0.5 0.6 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.8 0.0 0.0 3.0 0.1 0.0 23.9 0.0 0.3 0.0 0.0 0.0 0.0 0.3 53.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.1 34.7 0.1 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IL32 "NK4, TAIF, TAIFb, TAIFd" ENSG00000008517 "Interleukin 32" P24001 16 3065297-3082192 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 829.3;pancreas: 674.4" "Cell type enhanced" "Detected in many" "Ductal cells: 1696.0;Exocrine glandular cells: 1490.0;Pancreatic endocrine cells: 2546.1;Proximal enterocytes: 4916.6;Proximal tubular cells: 4315.8;T-cells: 1711.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "T-reg: 4625.7" "Lineage enriched" "Detected in all" 8 "T-cells: 4625.7" "Cell line enhanced" "Detected in many" "CACO-2: 514.7;CAPAN-2: 328.6;HDLM-2: 707.9;Hep G2: 504.3;Karpas-707: 404.6;MOLT-4: 319.9;RH-30: 348.0;U-937: 314.5" "HPA029397, CAB030029" Uncertain "Secreted to blood" NA NA 46100 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 2: Karpas-707 - Immune response" "Cluster 1: Pancreatic cells - Digestion" "CAB030029: AB_1089175, HPA029397: AB_10612120" "unprognostic (2.00e-2)" "unprognostic (2.89e-2)" "unprognostic (2.86e-1)" "prognostic favorable (1.33e-4)" "unprognostic (2.95e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (2.58e-2)" "unprognostic (1.73e-3)" "unprognostic (2.19e-2)" "unprognostic (3.32e-3)" "unprognostic (3.51e-1)" "unprognostic (3.30e-2)" "unprognostic (8.08e-2)" "unprognostic (3.86e-2)" "unprognostic (3.16e-2)" "unprognostic (4.29e-3)" 91.1 36.7 21.3 206.7 21.0 49.1 58.7 20.3 27.6 19.2 19.0 206.5 339.8 30.4 13.5 45.5 20.6 117.4 180.6 19.1 20.0 418.8 829.3 271.5 402.7 24.0 20.4 22.3 674.4 10.2 17.7 62.8 23.0 54.2 142.7 1.0 87.1 42.2 543.7 26.9 558.9 88.4 21.2 440.7 87.4 19.2 24.8 198.0 84.3 328.6 200.2 118.8 23.1 21.3 254.1 10.7 1.2 0.3 0.5 28.4 19.5 12.4 31.3 14.9 24.8 514.7 328.6 0.6 59.8 7.0 92.1 10.7 1.0 29.6 18.0 707.9 2.7 1.2 49.8 504.3 55.7 1.4 20.5 34.2 3.4 12.9 54.9 12.1 60.0 7.9 0.7 404.6 19.5 1.7 319.9 8.2 7.2 3.2 7.6 0.7 348.0 34.4 239.3 16.7 0.7 3.9 109.9 7.4 1.9 50.9 7.2 4.0 161.6 56.9 67.2 3.1 36.5 4.7 10.7 1.6 1.1 314.5 29.7 30.8 10.9 12.7 2570.7 9.1 2584.2 9.3 2337.1 2483.4 9.2 7.8 884.8 1712.5 46.9 553.7 11.3 13.4 4625.7 2238.1 21.3 21.0 20.3 27.6 19.1 20.0 24.0 20.4 23.0 21.2 24.8 21.3 334.4 198.7 64.9 0.0 81.7 59.5 68.0 462.2 12.0 0.4 50.3 44.3 5.6 221.6 119.6 119.5 0.0 9.0 550.3 1038.3 252.4 1696.0 0.2 46.5 36.7 286.4 135.1 64.6 0.1 1490.0 14.1 136.7 118.3 53.7 52.6 1.5 68.6 124.1 4.2 0.0 0.1 273.1 244.1 40.5 116.1 1.9 35.1 60.7 65.8 5.6 225.8 0.0 518.0 0.0 0.1 2546.1 1004.5 45.9 81.7 101.2 4916.6 4315.8 55.1 0.6 19.7 278.5 117.4 5.8 1.3 7.1 51.6 6.6 1711.8 27.8 182.2 105.7 INAVA "C1orf106, FLJ10901" ENSG00000163362 "Innate immunity activator" Q3KP66 1 200891048-200915742 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.2;intestine: 55.4;skin 1: 47.0" "Cell type enhanced" "Detected in some" "Ductal cells: 33.3;Endometrial ciliated cells: 26.8;Exocrine glandular cells: 45.5;Glandular and luminal cells: 25.1;Pancreatic endocrine cells: 118.6;Proximal tubular cells: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 60.3;CAPAN-2: 49.6;HaCaT: 66.0;OE19: 57.8;RPMI-8226: 54.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027499, HPA027511, HPA079622" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "Nuclear bodies" "HPA027499: AB_10599708, HPA027511: AB_10600334, HPA079622: " "unprognostic (3.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.78e-5)" "unprognostic (4.56e-2)" "unprognostic (2.18e-1)" "unprognostic (2.74e-2)" "unprognostic (6.62e-3)" "unprognostic (2.84e-2)" "unprognostic (9.38e-2)" "unprognostic (2.52e-2)" "unprognostic (2.81e-1)" "unprognostic (3.23e-3)" "unprognostic (1.67e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-1)" "unprognostic (7.73e-2)" 0.1 0.0 1.4 4.0 1.4 4.5 1.7 0.8 1.3 8.8 1.8 33.8 47.3 1.1 0.5 44.2 4.2 16.3 0.2 1.4 1.4 15.3 0.4 3.5 0.4 1.1 1.4 0.1 13.2 0.1 0.3 1.9 1.0 7.0 30.1 0.4 12.3 2.6 0.2 47.0 55.4 1.1 1.0 0.3 27.3 1.1 1.5 0.9 0.1 0.0 5.7 17.1 20.3 1.0 27.5 40.8 23.3 0.0 0.0 0.0 60.3 0.0 0.0 0.7 0.5 43.4 49.6 0.0 13.3 0.0 1.1 66.0 0.0 17.4 0.5 0.0 5.0 3.8 1.8 17.2 0.1 8.5 0.8 0.0 26.1 0.4 1.1 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.1 1.4 45.2 57.8 9.2 0.2 9.7 54.0 24.4 34.9 0.1 2.8 2.6 41.5 0.0 27.3 17.1 7.9 0.0 0.1 10.1 0.1 2.9 46.2 20.6 0.0 0.1 8.6 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.4 1.4 0.8 1.3 1.4 1.4 1.1 1.4 1.0 1.0 1.5 1.0 0.6 12.8 7.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.5 3.3 0.0 0.0 5.0 14.7 0.0 7.6 0.1 0.0 5.9 33.3 0.0 26.8 2.2 0.7 0.0 0.0 0.0 45.5 13.2 0.4 0.0 25.1 1.3 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.6 0.0 0.0 0.0 0.0 0.0 26.0 4.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.5 0.3 0.0 0.0 INO80B "hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4" ENSG00000115274 "INO80 complex subunit B" Q9C086 2 74455087-74457944 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 28.0;Suprabasal keratinocytes: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA070644, HPA078274" Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "Nucleoli, Nuclear bodies" "HPA070644: AB_2732159, HPA078274: " "prognostic favorable (2.89e-4)" "unprognostic (2.24e-2)" "unprognostic (5.62e-2)" "unprognostic (6.59e-3)" "unprognostic (9.45e-2)" "unprognostic (3.82e-2)" "unprognostic (2.20e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-2)" "unprognostic (7.52e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (1.56e-5)" "prognostic favorable (8.44e-4)" "unprognostic (1.51e-1)" "unprognostic (3.21e-1)" "unprognostic (1.18e-3)" 26.3 30.5 18.9 18.0 20.7 20.6 29.1 17.2 27.6 38.1 15.7 24.1 19.4 30.4 17.1 31.1 31.5 15.1 20.1 19.6 17.5 27.4 32.1 25.9 18.9 18.4 17.1 48.1 41.9 19.6 42.0 11.6 19.2 34.7 12.3 18.7 29.9 17.9 30.1 40.8 23.9 14.8 14.2 24.5 32.7 31.0 16.7 12.8 39.3 9.1 20.1 27.1 32.2 20.9 27.8 29.0 11.0 14.2 21.0 29.6 28.2 25.7 23.0 19.4 16.3 19.9 34.4 46.7 32.2 18.8 18.2 29.1 9.1 20.4 15.8 42.5 28.8 35.9 14.5 20.5 22.4 33.9 17.2 29.5 35.0 27.8 31.2 48.4 26.2 27.4 20.7 18.5 16.5 32.7 44.3 47.7 7.7 20.2 39.7 26.3 34.9 47.4 23.5 18.9 16.7 31.8 13.5 37.3 15.4 12.1 16.1 11.6 22.1 17.7 27.9 29.7 20.0 65.8 48.4 16.9 33.3 21.3 18.9 3.2 2.5 1.0 1.2 1.9 1.6 2.6 1.4 0.7 1.6 2.1 1.2 1.1 3.2 2.1 1.7 3.2 2.2 0.9 18.9 20.7 17.2 27.6 19.6 17.5 18.4 17.1 19.2 14.2 16.7 20.9 4.4 0.0 2.2 0.0 5.4 28.0 2.8 8.5 2.2 14.0 11.3 6.0 0.9 4.3 6.8 3.7 12.5 4.3 7.1 5.8 0.0 15.9 3.0 6.5 5.7 5.4 4.8 9.3 0.0 27.0 4.7 3.4 2.6 3.8 5.7 2.4 6.8 10.8 5.6 13.5 0.0 7.9 12.2 9.7 21.0 6.5 3.1 4.3 5.4 0.0 12.5 4.7 9.2 0.0 0.0 17.4 3.3 3.0 5.1 2.2 11.6 6.5 12.3 15.0 0.0 2.1 4.9 5.6 1.9 3.3 31.7 5.3 7.5 2.2 6.7 2.0 INS "IDDM1, IDDM2" ENSG00000254647 Insulin P01308 11 2159779-2161221 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism" Hormone "Cancer-related genes, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 135 "pancreas: 12983.6" "Cell type enriched" "Detected in some" 21 "Pancreatic endocrine cells: 1475.2" "Cancer enriched" "Detected in single" 7165 "pancreatic cancer: 1751.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "EFO-21: 268.3;U-2 OS: 376.2;U-698: 132.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 13 "midbrain: 1.3" "CAB000048, HPA004932, CAB012098, CAB053843" Enhanced "Secreted to blood" NA NA 437000 "Cluster 25: Pancreas - Digestion" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816" "unprognostic (7.61e-2)" 19.2 4.0 0.1 0.2 0.1 49.8 0.6 0.0 0.0 0.7 0.0 12.8 1.5 1.4 0.0 1.8 0.3 3.7 5.6 0.1 0.1 40.7 1.4 1.7 5.4 0.2 0.4 2.6 12983.6 0.0 0.3 1.4 0.8 0.5 0.0 0.0 3.1 0.0 0.3 96.4 0.7 0.0 0.0 1.4 42.2 0.3 0.0 0.0 1.3 0.0 0.0 5.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 268.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 376.2 0.0 31.8 0.0 15.9 132.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 67.2 0.0 0.0 0.0 0.0 1475.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IRAK1 "IRAK, pelle" ENSG00000184216 "Interleukin 1 receptor associated kinase 1" P51617 X 154010506-154019902 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004461, HPA054476" Supported Supported Nucleoplasm,Cytosol No No "Cluster 15: NK-cells - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" Cytosol Nucleoplasm "CAB004461: AB_2249106, HPA054476: AB_2682501" "unprognostic (4.46e-3)" "unprognostic (9.32e-2)" "unprognostic (1.71e-2)" "unprognostic (5.04e-3)" "unprognostic (7.09e-3)" "unprognostic (4.43e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (7.89e-3)" "unprognostic (3.36e-2)" "unprognostic (3.69e-2)" "unprognostic (1.95e-1)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.06e-4)" "unprognostic (2.76e-3)" "unprognostic (2.36e-1)" "unprognostic (2.21e-3)" "unprognostic (3.04e-1)" 48.6 61.2 24.4 37.6 25.3 82.4 40.7 23.6 34.9 29.0 20.0 41.4 43.3 31.8 7.7 69.1 28.8 20.2 34.4 22.3 26.5 44.2 64.7 48.9 33.7 38.1 30.0 28.9 84.9 12.4 37.5 17.8 30.8 46.1 15.0 4.5 41.6 21.0 92.5 44.3 51.1 16.4 29.6 69.9 41.9 20.8 34.3 19.4 24.5 16.8 24.0 47.7 36.5 29.4 467.2 178.9 24.5 201.2 48.4 38.5 108.3 68.8 64.5 104.0 96.0 142.3 199.4 200.8 371.4 73.6 157.6 124.3 57.6 112.4 39.8 156.7 173.4 73.3 158.6 85.7 110.8 174.2 118.7 53.2 96.1 99.0 107.8 53.2 62.8 39.6 130.9 220.3 73.3 171.4 70.8 152.1 60.9 148.4 353.5 181.6 126.4 334.7 68.5 86.3 137.4 98.7 82.2 88.6 135.2 9.5 34.3 179.2 86.4 123.8 194.6 284.6 424.2 274.8 190.6 358.2 179.6 205.1 130.8 1.3 7.2 6.2 5.3 9.2 4.7 6.5 4.3 4.4 4.8 7.9 2.5 4.7 5.2 5.4 7.5 10.9 2.3 3.3 24.4 25.3 23.6 34.9 22.3 26.5 38.1 30.0 30.8 29.6 34.3 29.4 20.2 0.0 13.3 5.9 29.7 13.4 14.5 10.9 5.2 9.1 23.9 19.0 9.3 18.6 16.0 11.0 6.2 11.4 33.0 41.4 7.9 40.5 0.9 9.8 13.5 18.1 20.4 18.1 9.7 113.6 20.9 15.2 18.3 17.3 12.7 25.5 13.2 35.9 57.2 16.8 8.9 27.2 0.0 51.4 24.7 3.8 18.0 43.0 14.2 11.2 24.2 21.8 13.4 4.5 6.6 75.0 28.6 21.4 33.5 30.0 39.4 19.6 10.0 5.3 0.0 14.5 14.9 1.6 8.1 15.1 13.1 12.3 19.6 18.4 39.4 25.3 ITGA3 "CD49c, GAP-B3, MSK18, VCA-2, VLA3a" ENSG00000005884 "Integrin subunit alpha 3" P26006 17 50055968-50090481 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 111.9;Exocrine glandular cells: 105.1;Pancreatic endocrine cells: 245.6;Urothelial cells: 104.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 647.2;hTERT-RPE1: 572.8;RPTEC TERT1: 562.0;U-87 MG: 920.8;WM-115: 570.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008572, CAB018594" Enhanced Supported "Plasma membrane" NA NA 170000 "Cluster 7: Kidney - Transmembrane transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane" "CAB018594: AB_668044, HPA008572: AB_2668094" "unprognostic (3.24e-3)" "prognostic unfavorable (6.75e-4)" "unprognostic (9.51e-2)" "unprognostic (3.46e-3)" "unprognostic (3.45e-3)" "prognostic unfavorable (1.36e-4)" "unprognostic (8.28e-3)" "unprognostic (2.76e-3)" "unprognostic (1.26e-3)" "unprognostic (1.82e-2)" "prognostic unfavorable (5.95e-5)" "unprognostic (7.05e-2)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (2.35e-2)" 17.5 29.8 5.3 9.9 5.4 0.4 17.3 6.0 6.1 14.8 5.2 25.4 30.4 21.3 11.7 24.1 24.5 17.9 13.2 5.0 10.9 68.9 2.2 65.8 3.0 7.5 6.6 12.8 15.9 17.7 21.1 26.7 11.9 19.5 15.5 4.4 19.4 15.7 9.0 30.8 26.7 15.6 4.2 11.1 24.5 2.1 7.8 5.9 43.5 4.1 6.2 46.7 17.1 4.0 181.8 234.9 1.4 7.5 4.3 17.5 37.3 83.4 177.9 123.1 93.2 5.3 276.2 0.4 507.9 59.5 400.4 126.8 2.2 647.2 73.9 22.9 3.5 0.1 56.8 1.6 105.1 0.3 5.0 21.6 313.5 123.2 540.7 572.8 91.6 9.1 0.1 2.6 236.0 52.9 0.7 0.5 5.5 81.2 141.0 0.4 12.1 13.7 562.0 311.1 9.7 3.9 89.8 12.2 205.0 56.2 21.1 2.4 200.8 541.8 169.4 5.6 329.5 8.1 14.2 5.9 920.8 1.9 570.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.3 5.4 6.0 6.1 5.0 10.9 7.5 6.6 11.9 4.2 7.8 4.0 8.5 54.5 30.1 3.6 3.4 57.4 63.5 63.5 48.3 18.0 17.1 32.0 5.3 27.1 26.2 77.3 25.0 2.8 1.3 91.2 0.0 111.9 0.5 26.4 3.1 14.7 14.5 0.0 24.3 105.1 3.2 5.3 47.4 20.7 3.8 3.4 8.9 0.3 1.1 3.3 20.0 25.1 16.2 1.2 8.2 0.6 1.8 2.0 17.8 8.4 4.3 3.1 2.1 3.0 0.8 245.6 26.7 4.1 4.5 72.6 69.6 4.4 21.7 16.2 13.1 5.6 23.4 0.5 1.6 17.0 23.2 1.8 3.8 0.9 44.7 104.2 KCNK16 "K2p16.1, TALK-1, TALK1" ENSG00000095981 "Potassium two pore domain channel subfamily K member 16" Q96T55 6 39314698-39322968 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "pancreas: 23.7;stomach 1: 10.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 17 "pancreatic cancer: 13.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "basophil: 2.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.1" "Cell line enriched" "Detected in single" 390 "SCLC-21H: 127.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 25: Pancreas - Digestion" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (3.29e-2)" "unprognostic (3.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 10.3 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK3 "K2p3.1, TASK, TASK-1, TASK1" ENSG00000171303 "Potassium two pore domain channel subfamily K member 3" O14649 2 26692690-26733420 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "adrenal gland: 181.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 82.1;Collecting duct cells: 103.0;Enteroendocrine cells: 23.4;Exocrine glandular cells: 95.2" "Cancer enhanced" "Detected in many" "renal cancer: 9.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 5.1;EFO-21: 11.0;HeLa: 3.6;SCLC-21H: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (4.16e-3)" "unprognostic (7.13e-2)" "unprognostic (1.04e-1)" "unprognostic (1.67e-4)" "unprognostic (2.08e-1)" "unprognostic (2.91e-1)" "unprognostic (5.01e-2)" "unprognostic (2.16e-1)" "unprognostic (3.31e-1)" "unprognostic (5.48e-2)" "unprognostic (3.77e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.37e-7)" "unprognostic (3.09e-2)" "unprognostic (7.45e-2)" "unprognostic (1.44e-2)" "unprognostic (9.24e-3)" 3.8 181.6 5.1 1.3 4.4 0.1 2.9 4.9 6.0 8.4 0.0 5.5 1.2 6.3 1.5 2.1 4.0 1.2 13.1 3.0 14.3 2.7 0.5 25.7 0.1 27.0 19.3 2.1 35.5 12.1 8.4 24.8 26.8 6.3 0.9 3.3 0.4 3.3 0.8 0.7 2.4 2.7 5.4 1.1 4.2 0.6 10.4 0.1 3.6 0.0 0.0 4.2 2.8 3.9 0.0 0.7 0.2 0.0 5.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 11.0 0.0 1.7 0.0 0.0 0.0 0.0 2.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.4 0.0 25.9 2.3 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 5.1 4.4 4.9 6.0 3.0 14.3 27.0 19.3 26.8 5.4 10.4 3.9 0.3 0.0 2.8 0.3 0.1 0.0 0.2 0.3 0.0 82.1 0.2 3.6 12.7 0.0 0.0 103.0 0.0 0.2 0.1 0.0 0.0 1.0 0.4 0.3 7.7 1.2 23.4 0.0 2.1 95.2 0.2 2.7 0.0 0.2 0.0 1.2 0.4 0.0 0.4 1.7 14.5 1.8 0.0 0.0 0.9 1.9 0.9 0.3 0.0 0.0 0.6 1.4 0.0 1.5 0.3 19.2 0.0 0.0 0.3 1.6 0.1 0.1 0.0 4.1 6.6 0.6 4.9 0.0 1.5 0.0 0.1 0.5 0.4 11.5 0.1 0.4 KDF1 "C1orf172, FLJ34633, RP11-344H11.3" ENSG00000175707 "Keratinocyte differentiation factor 1" Q8NAX2 1 26949562-26960468 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 32.6;Ductal cells: 29.4;Syncytiotrophoblasts: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 36 "B-cells: 3.4;T-cells: 6.2" "Cell line enhanced" "Detected in some" "A-431: 24.9;BEWO: 20.8;CAPAN-2: 22.7;HaCaT: 21.4;HBEC3-KT: 30.3;hTCEpi: 38.5;OE19: 39.3;SK-BR-3: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA028634, HPA028639" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 30: Non-specific - Translation" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 30: Epithelial cell lines - Translation" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane" Cytosol "HPA028634: , HPA028639: AB_10599191" "unprognostic (2.58e-1)" "unprognostic (1.23e-1)" "unprognostic (6.46e-2)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (8.45e-2)" "unprognostic (9.09e-2)" "unprognostic (9.01e-2)" "unprognostic (2.73e-1)" "unprognostic (3.91e-1)" "prognostic favorable (3.04e-13)" "unprognostic (1.38e-3)" "unprognostic (7.83e-2)" "unprognostic (8.03e-2)" "prognostic favorable (4.40e-4)" 0.1 1.1 0.4 1.3 0.3 0.1 10.3 1.6 1.3 4.0 0.3 8.9 12.4 0.9 19.7 20.2 7.4 2.9 0.4 0.4 0.2 11.0 4.7 4.4 0.8 0.3 0.3 0.1 16.2 12.5 10.4 3.9 0.4 7.2 7.1 1.3 12.8 4.6 0.0 17.7 10.5 0.3 0.2 0.6 10.6 2.6 0.3 2.3 10.0 0.0 3.4 4.8 8.3 0.7 24.9 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 12.1 22.7 0.0 0.9 0.0 0.0 21.4 0.0 30.3 0.0 0.1 0.4 0.0 0.0 4.4 0.3 0.0 0.0 0.1 38.5 0.0 3.1 0.0 0.0 0.0 1.4 0.0 0.0 14.7 0.0 0.1 1.7 39.3 0.1 0.0 0.0 3.7 5.5 11.7 14.9 0.0 0.2 25.2 0.1 2.7 16.1 0.4 0.2 0.0 0.0 0.0 0.0 2.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.2 2.5 4.3 3.0 0.1 3.4 6.2 3.8 0.0 0.0 0.0 0.0 0.2 1.7 0.4 0.3 1.6 1.3 0.4 0.2 0.3 0.3 0.4 0.2 0.3 0.7 0.2 12.8 8.8 0.0 0.8 0.0 14.3 0.0 10.8 0.6 15.1 16.3 0.3 12.8 2.5 14.7 0.0 32.6 1.5 17.2 25.4 29.4 0.4 7.3 0.8 0.7 7.8 0.0 0.2 23.2 26.5 0.6 13.7 8.0 0.0 0.1 0.0 4.4 2.7 0.0 0.1 13.1 0.0 0.3 0.0 0.1 0.3 0.1 0.0 0.0 0.2 1.1 0.0 0.0 0.1 21.8 25.2 0.0 0.4 16.8 26.2 10.1 5.1 2.5 0.0 0.0 0.3 6.3 7.5 14.4 0.0 29.7 1.2 0.0 16.9 19.0 KRT18 ENSG00000111057 "Keratin 18" P05783 12 52948871-52952906 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 3698.8;Ductal cells: 6583.8;Exocrine glandular cells: 4826.1;Extravillous trophoblasts: 5496.7;Pancreatic endocrine cells: 6071.5;Syncytiotrophoblasts: 7643.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "basophil: 76.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 76.7" "Cell line enhanced" "Detected in many" "A549: 5639.4;BEWO: 3818.0;CACO-2: 6249.4;CAPAN-2: 4576.4;MCF7: 8470.0;SK-BR-3: 4583.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 12.1" "CAB000008, CAB000030, HPA001605" Enhanced Supported Cytosol NA NA 140000000 "Cluster 38: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" Cytosol "CAB000008: , CAB000030: , HPA001605: AB_2666381" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-1)" "unprognostic (1.63e-2)" "unprognostic (1.25e-1)" "unprognostic (7.26e-3)" "unprognostic (4.09e-3)" "prognostic unfavorable (5.06e-4)" "unprognostic (8.81e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (3.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.27e-1)" "unprognostic (2.19e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" 170.3 29.0 2.6 77.5 1.4 1.5 209.8 5.3 1.6 243.5 34.8 424.1 324.3 27.8 226.0 118.4 193.5 180.6 38.3 2.2 6.9 247.2 519.5 177.8 8.6 26.1 4.3 16.4 570.2 79.5 251.9 474.5 30.3 183.3 492.3 0.6 323.4 129.5 2.1 44.5 370.7 23.4 2.5 28.5 289.9 8.3 13.9 10.3 244.1 1.4 27.8 199.7 62.2 2.5 2065.1 5639.4 1.1 7.9 0.7 1.1 3818.0 313.3 349.5 368.4 104.6 6249.4 4576.4 1.4 839.8 318.4 196.5 487.2 79.1 2228.5 217.9 2.6 138.2 19.4 865.7 1743.9 942.1 0.6 1.3 13.6 202.9 323.8 437.1 1046.9 399.0 3.4 511.4 0.2 0.3 8470.0 3.8 37.3 471.0 2740.1 457.9 3.0 0.3 236.1 1803.3 1144.9 65.6 3.7 512.7 4583.8 18.8 2696.0 2446.8 6.6 137.9 5.0 441.8 6.9 68.3 1.1 7.3 4.3 0.9 1.2 36.4 76.7 0.3 2.4 0.6 0.2 2.2 4.6 4.5 1.2 2.2 7.4 11.1 4.1 3.2 2.5 0.0 0.1 0.4 2.9 2.6 1.4 5.3 1.6 2.2 6.9 26.1 4.3 30.3 2.5 13.9 2.5 14.4 862.2 286.4 0.3 29.8 14.8 1605.7 912.1 447.3 0.1 814.6 615.6 5.3 1252.5 877.3 623.5 0.0 3698.8 14.2 1942.9 275.9 6583.8 1.0 462.3 60.3 77.8 642.3 15.4 0.0 4826.1 5496.7 203.5 971.5 742.4 48.9 51.2 57.1 610.9 308.3 1.7 0.0 2492.6 1969.3 9.8 13.8 3.8 10.5 28.3 208.1 1.0 41.5 6.2 0.0 0.0 0.0 6071.5 2164.1 0.0 13.7 1205.1 1912.3 718.5 500.8 0.6 0.0 0.6 298.6 2.7 26.0 395.7 6.7 7643.5 38.1 45.0 1635.0 1512.1 KRT75 K6HF ENSG00000170454 "Keratin 75" O95678 12 52424070-52434371 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 27.5" "Cell type enriched" "Detected in some" 7 "Ductal cells: 20.4" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 36.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "PC-3: 38.5;U-2 OS: 50.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019367, HPA076201" Enhanced Approved "Plasma membrane,Cytosol" NA NA 1500000000 "Cluster 61: Skin - Cornification" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Cytosol "Plasma membrane" "HPA019367: AB_1852239, HPA076201: AB_2686786" "unprognostic (2.83e-2)" "unprognostic (2.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.79e-2)" "unprognostic (8.85e-3)" "unprognostic (2.67e-1)" "unprognostic (2.17e-2)" "unprognostic (1.72e-1)" "unprognostic (6.60e-2)" "unprognostic (9.20e-2)" "unprognostic (5.19e-2)" "unprognostic (2.45e-1)" "unprognostic (8.98e-2)" "unprognostic (1.94e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 50.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.6 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 KRT80 KB20 ENSG00000167767 "Keratin 80" Q6KB66 12 52168996-52192014 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skin 1: 219.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 25.9;Ductal cells: 63.0;Endometrial ciliated cells: 33.0;Glandular and luminal cells: 33.5;Pancreatic endocrine cells: 48.4;Suprabasal keratinocytes: 37.4;Syncytiotrophoblasts: 58.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 202.5;MCF7: 287.3;SK-BR-3: 127.7;U-2 OS: 174.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA077836, HPA077918" Enhanced "Intermediate filaments" No No 230000000 "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "Intermediate filaments" "HPA077836: AB_2686857, HPA077918: AB_2686871" "prognostic unfavorable (1.05e-4)" "unprognostic (5.45e-3)" "unprognostic (5.35e-2)" "unprognostic (9.19e-3)" "unprognostic (2.85e-4)" "unprognostic (6.68e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-3)" "unprognostic (5.60e-2)" "unprognostic (4.06e-2)" "unprognostic (7.06e-3)" "unprognostic (1.02e-1)" "unprognostic (8.79e-3)" "unprognostic (8.85e-2)" "unprognostic (2.03e-1)" "unprognostic (1.51e-1)" "unprognostic (2.98e-2)" 0.4 5.3 0.0 0.3 0.0 0.1 8.7 0.3 0.6 18.5 0.0 0.1 0.5 1.2 0.9 51.0 3.4 2.7 0.3 0.1 0.0 2.7 0.7 3.4 0.0 0.0 0.0 0.2 11.6 7.0 0.4 7.3 0.0 1.5 0.1 0.5 24.8 3.4 1.3 219.1 0.3 0.1 0.0 0.1 0.5 0.3 0.0 0.8 0.8 0.0 41.1 9.9 36.5 0.0 202.5 66.7 0.0 0.0 0.0 0.0 54.2 2.9 1.8 15.3 4.6 4.5 85.9 0.0 94.4 2.3 99.4 98.5 0.0 1.3 5.3 0.4 0.0 0.0 99.4 2.4 10.1 0.1 0.1 1.1 11.9 3.5 23.0 70.2 23.2 0.0 0.0 0.1 5.4 287.3 0.2 0.1 0.4 58.5 10.1 0.2 79.4 3.0 87.1 35.7 24.5 1.3 50.1 127.7 1.2 5.6 24.1 1.0 13.5 0.3 174.4 0.2 71.6 0.1 0.3 0.5 18.0 7.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.2 3.9 4.4 0.0 0.0 14.7 4.6 0.4 10.0 9.4 11.0 0.0 25.9 0.1 0.3 0.0 63.0 0.9 33.0 3.7 0.5 0.0 0.0 0.1 20.4 3.4 0.4 0.0 33.5 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.1 12.2 0.0 1.6 0.5 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 48.4 0.0 0.0 0.0 4.8 0.1 1.8 21.7 0.0 0.0 0.4 2.2 0.1 0.0 2.9 37.4 58.3 0.3 0.3 0.3 8.5 KRT81 "Hb-1, KRTHB1" ENSG00000205426 "Keratin 81" Q14533 12 52285913-52291534 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "skin 1: 144.7" "Cell type enhanced" "Detected in some" "Breast glandular cells: 41.0;Club cells: 20.4;Ductal cells: 67.3;Pancreatic endocrine cells: 27.2" "Cancer enhanced" "Detected in many" "breast cancer: 46.1;cervical cancer: 49.2" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 49 "basophil: 170.8" "Lineage enriched" "Detected in many" 49 "granulocytes: 170.8" "Cell line enhanced" "Detected in many" "A-431: 3086.0;A549: 2296.0;MCF7: 700.1;PC-3: 1088.7;U-251 MG: 2151.1" HPA049778 Supported NA NA 130000000 "Cluster 38: Basophils - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 1: Pancreatic cells - Digestion" "HPA049778: AB_2680877" "unprognostic (1.69e-2)" "unprognostic (5.61e-2)" "unprognostic (6.57e-2)" "unprognostic (2.90e-1)" "unprognostic (5.64e-2)" "unprognostic (1.77e-1)" "unprognostic (2.00e-1)" "unprognostic (3.64e-3)" "unprognostic (1.87e-1)" "unprognostic (5.10e-2)" "unprognostic (4.89e-2)" "unprognostic (2.21e-1)" "unprognostic (2.64e-4)" "unprognostic (5.98e-2)" "unprognostic (1.86e-1)" "unprognostic (2.25e-1)" "unprognostic (7.31e-2)" 1.4 0.0 0.3 0.2 0.4 0.3 3.1 0.3 0.6 0.1 0.1 0.3 0.3 0.3 0.2 0.1 0.1 0.0 0.0 0.4 0.4 0.0 0.1 0.2 0.0 0.4 0.3 0.0 0.2 0.0 0.1 1.0 0.3 0.3 0.0 0.0 2.1 0.2 0.2 144.7 0.2 0.0 0.3 0.2 0.1 0.4 0.4 0.2 0.9 0.0 0.0 0.1 0.1 0.4 3086.0 2296.0 0.0 0.0 0.0 0.0 0.3 18.6 3.2 23.9 2.2 6.7 0.7 0.0 3.0 0.3 1.6 43.2 0.0 0.0 4.2 4.6 0.0 0.0 1.3 0.2 1.4 0.0 0.2 0.0 0.0 0.4 1.1 32.9 0.0 0.0 0.0 1.6 0.2 700.1 0.3 6.4 0.2 0.1 1088.7 0.5 0.0 10.4 0.6 0.2 0.7 0.0 1.0 179.1 11.1 0.1 0.5 12.9 0.2 0.4 564.4 0.2 2151.1 0.3 4.4 3.1 0.4 7.2 0.2 170.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.3 0.3 0.4 0.3 0.6 0.4 0.4 0.4 0.3 0.3 0.3 0.4 0.4 0.1 0.0 0.0 0.3 0.0 0.0 3.3 4.4 0.0 0.0 41.0 4.6 0.3 0.0 20.4 0.0 0.0 0.1 12.8 0.1 0.0 67.3 0.9 1.9 0.3 0.4 0.0 0.0 3.9 1.3 2.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 4.1 0.0 0.4 2.5 0.0 0.1 0.0 1.0 0.0 0.0 6.2 0.0 3.3 27.2 0.0 0.0 0.1 2.6 0.0 0.0 2.0 0.0 0.0 1.2 6.8 0.0 0.1 0.0 0.3 2.9 10.5 0.0 0.0 6.0 KRTAP2-3 KAP2.3 ENSG00000212724 "Keratin associated protein 2-3" P0C7H8 17 41059240-41060114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 104 "skin 1: 20.6" "Cell type enhanced" "Detected in some" "Ductal cells: 104.8;Endometrial ciliated cells: 22.0;Glandular and luminal cells: 35.5;Pancreatic endocrine cells: 10.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 36.8;fHDF/TERT166: 22.2;HBF TERT88: 31.9;LHCN-M2: 41.0;U-2 OS: 15.9" HPA059203 Supported NA NA "Cluster 61: Skin - Cornification" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "HPA059203: AB_2683947" "unprognostic (2.22e-1)" "unprognostic (2.58e-2)" "unprognostic (3.79e-3)" "unprognostic (3.25e-3)" "unprognostic (2.78e-2)" "unprognostic (6.91e-2)" "unprognostic (1.38e-1)" "unprognostic (6.41e-4)" "unprognostic (7.83e-6)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.1 0.0 36.8 1.2 9.0 7.6 0.4 0.3 0.0 0.0 22.2 2.2 0.1 0.0 0.6 31.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.6 0.0 0.0 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 5.4 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 15.9 1.0 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 1.5 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 104.8 0.0 22.0 1.6 0.4 0.0 0.0 0.0 0.6 0.4 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 LYPD1 "LYPDC1, MGC29643" ENSG00000150551 "LY6/PLAUR domain containing 1" Q8N2G4 2 132643286-132671579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 31.2;choroid plexus: 15.4;fallopian tube: 53.5;pituitary gland: 33.7" "Cell type enhanced" "Detected in some" "Ductal cells: 73.8;Exocrine glandular cells: 74.5;monocytes: 62.0;Oligodendrocyte precursor cells: 28.1;Pancreatic endocrine cells: 43.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 57.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "eosinophil: 3.6" "Lineage enriched" "Detected in single" 22 "granulocytes: 3.6" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 41.6;HUVEC TERT2: 32.7;SK-MEL-30: 36.5;U-251 MG: 65.9;WM-115: 140.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068333 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "Vesicles, Plasma membrane" "HPA068333: " "unprognostic (9.25e-2)" "unprognostic (7.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.07e-2)" "unprognostic (6.40e-3)" "unprognostic (5.60e-2)" "unprognostic (8.36e-3)" "unprognostic (1.05e-2)" "unprognostic (6.70e-2)" "unprognostic (2.86e-2)" "unprognostic (1.51e-2)" "unprognostic (1.43e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" 0.6 0.8 24.8 0.3 27.1 0.4 0.8 19.5 25.5 0.3 15.4 8.1 0.1 0.9 0.1 1.5 53.5 1.2 0.8 24.2 29.2 5.9 1.0 1.0 0.6 29.9 30.0 1.3 5.1 0.3 33.7 0.0 27.7 0.7 0.2 1.6 5.5 0.1 0.3 0.3 1.6 0.6 27.3 0.3 0.9 0.7 31.2 2.2 0.9 0.1 1.0 0.8 0.6 21.5 0.4 8.6 11.6 0.2 0.0 0.0 0.0 1.9 1.5 6.3 1.4 0.6 1.1 0.0 18.3 5.1 3.0 7.2 0.0 0.0 2.9 0.1 1.8 0.0 4.0 0.0 0.0 0.0 0.2 0.0 0.1 41.6 0.0 1.7 32.7 0.0 0.0 0.1 0.0 0.8 0.0 0.0 11.1 0.2 3.3 0.0 0.0 0.0 15.1 0.2 1.1 2.3 1.8 0.2 36.5 26.8 0.1 0.3 1.5 0.7 17.4 5.9 65.9 0.1 0.0 0.1 10.0 0.0 140.5 0.6 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 27.1 19.5 25.5 24.2 29.2 29.9 30.0 27.7 27.3 31.2 21.5 0.7 0.0 0.0 8.1 0.2 0.1 0.1 0.4 0.0 1.6 2.0 0.9 0.2 2.8 0.2 5.5 0.0 0.0 0.0 0.5 1.9 73.8 5.6 1.4 0.1 0.2 1.8 0.0 0.8 74.5 0.0 2.2 0.0 0.9 0.0 0.1 0.4 0.0 0.1 15.2 4.7 0.0 0.0 0.8 0.7 9.3 4.1 0.1 0.0 0.0 62.0 1.4 0.0 28.1 4.4 43.4 0.0 0.0 0.0 0.1 0.1 4.8 0.3 0.8 0.0 0.2 3.9 2.6 2.1 0.3 0.0 0.0 0.1 0.0 0.1 0.1 MMP7 "MPSL1, PUMP-1" ENSG00000137673 "Matrix metallopeptidase 7" P09237 11 102520508-102530750 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 509.9;salivary gland: 267.9;urinary bladder: 211.2" "Cell type enriched" "Detected in many" 8 "Ductal cells: 8176.2" "Cancer enhanced" "Detected in all" "pancreatic cancer: 352.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 145.9;CAPAN-2: 815.9;EFO-21: 189.8;RPTEC TERT1: 350.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025869, HPA051358" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA 2810000 35000 "Cluster 5: Breast - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Vesicles" "CAB025869: , HPA051358: AB_2681452" "unprognostic (1.06e-3)" "unprognostic (9.51e-2)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (7.70e-3)" "unprognostic (7.28e-2)" "prognostic unfavorable (2.53e-4)" "prognostic unfavorable (3.38e-4)" "unprognostic (3.96e-2)" "unprognostic (5.63e-2)" "unprognostic (6.59e-3)" "unprognostic (1.51e-1)" "unprognostic (6.36e-3)" "unprognostic (1.42e-2)" "unprognostic (5.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" 3.8 0.1 0.0 2.0 0.0 0.3 168.7 0.0 0.3 13.3 0.0 1.6 0.6 97.4 27.9 21.3 91.2 509.9 0.2 0.0 0.0 140.2 3.4 31.6 1.9 0.0 0.0 0.7 85.2 0.0 0.3 0.8 0.0 54.0 1.0 0.0 267.9 34.9 0.1 32.4 0.6 4.8 0.0 0.2 7.3 0.6 0.4 3.3 0.4 0.0 29.3 211.2 1.7 0.0 0.2 145.9 0.0 0.4 0.0 0.0 0.2 0.0 2.1 0.1 0.1 1.9 815.9 0.0 189.8 0.0 0.0 1.1 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.6 1.0 0.1 0.2 0.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.5 11.8 0.0 0.0 0.0 0.0 350.1 1.0 0.0 0.0 0.0 0.0 0.0 3.9 0.3 0.1 0.0 0.7 3.0 0.0 1.6 0.1 0.6 0.4 1.0 5.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 86.6 43.3 0.0 1.5 1.0 382.2 135.4 1.2 0.0 124.2 93.7 0.7 100.1 401.2 1017.0 0.0 0.7 2.9 1.2 0.0 8176.2 6.1 62.1 3.3 8.8 0.0 0.0 0.0 209.4 0.3 3.4 0.0 124.6 2.5 0.0 0.0 0.0 98.0 0.0 0.0 0.0 38.7 0.6 0.3 10.3 11.8 12.6 0.0 0.0 65.2 0.0 0.0 0.0 0.0 850.9 0.0 0.0 0.1 603.3 0.0 33.9 72.6 0.0 0.0 0.0 31.4 0.1 0.2 17.0 2.4 0.8 3.6 0.0 2.3 840.8 MRPS17 "HSPC011, MRP-S17, RPMS17" ENSG00000239789 "Mitochondrial ribosomal protein S17" Q9Y2R5 7 55951877-55956500 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 195.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047159 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "HPA047159: AB_2679961" "unprognostic (3.38e-1)" "unprognostic (2.71e-2)" "unprognostic (1.24e-1)" "unprognostic (8.61e-3)" "unprognostic (2.16e-2)" "unprognostic (1.94e-2)" "unprognostic (7.07e-3)" "unprognostic (1.80e-1)" "unprognostic (3.92e-1)" "unprognostic (2.86e-2)" "unprognostic (1.79e-2)" "unprognostic (1.47e-1)" "unprognostic (4.20e-3)" "unprognostic (7.17e-2)" "unprognostic (2.36e-2)" "unprognostic (2.24e-1)" "unprognostic (2.63e-1)" 9.6 13.6 14.8 7.8 15.0 10.2 11.2 14.8 18.3 7.4 11.6 13.0 8.9 9.9 9.2 13.5 10.1 5.1 20.0 15.6 15.1 16.8 22.1 6.9 9.1 14.3 13.9 9.5 13.6 9.7 8.3 6.5 14.8 10.4 9.8 5.6 9.0 10.5 32.9 8.2 9.1 9.3 13.0 10.2 11.6 11.9 15.9 9.1 8.2 32.7 9.3 11.0 7.8 14.6 195.1 25.3 17.4 36.6 17.3 16.9 22.0 20.6 20.3 25.0 28.4 31.0 26.0 49.3 29.6 16.9 57.9 43.3 38.6 39.3 30.1 20.7 30.0 14.7 35.8 32.2 24.9 37.4 14.5 19.4 31.6 25.0 41.2 18.3 26.5 27.8 57.9 19.2 22.6 21.8 29.9 51.4 37.4 47.7 43.2 23.9 16.8 38.9 40.4 23.4 25.7 22.6 23.4 76.1 28.5 29.6 49.9 29.3 17.9 8.3 40.8 60.2 47.8 16.7 34.2 83.2 8.4 18.9 38.2 3.6 8.7 2.7 10.5 10.7 12.7 17.1 14.4 15.2 13.3 14.2 16.1 14.3 2.3 12.5 11.0 13.2 15.5 7.9 14.8 15.0 14.8 18.3 15.6 15.1 14.3 13.9 14.8 13.0 15.9 14.6 9.6 22.4 11.7 2.6 12.3 0.0 21.3 0.0 26.7 6.7 14.3 14.4 0.0 22.8 14.2 5.5 0.0 30.4 8.7 8.2 29.4 48.1 22.6 18.5 9.5 11.3 4.9 30.9 3.5 54.5 26.2 9.9 23.0 10.0 5.1 10.3 18.9 33.7 19.2 18.5 3.9 15.5 0.0 11.6 0.0 5.5 9.3 9.1 0.0 1.0 20.6 10.6 21.6 3.0 4.6 46.0 14.8 10.9 21.3 19.9 24.2 28.9 13.8 7.0 6.6 10.0 11.2 29.2 12.0 31.2 0.0 21.3 10.7 10.8 21.8 11.9 MYH9 "DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA" ENSG00000100345 "Myosin heavy chain 9" P35579 22 36281280-36387967 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 1343.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001644, CAB015386, HPA064783" Enhanced Supported "Nuclear bodies,Plasma membrane,Actin filaments,Cytosol" No No 410000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 82: Adipose tissue - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane, Actin filaments" "Nuclear bodies, Cytosol" "CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721" "unprognostic (1.38e-1)" "unprognostic (9.12e-2)" "unprognostic (4.21e-2)" "unprognostic (6.34e-2)" "unprognostic (1.49e-1)" "unprognostic (3.90e-2)" "unprognostic (9.56e-2)" "unprognostic (8.28e-2)" "unprognostic (5.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-1)" "unprognostic (7.98e-2)" "unprognostic (9.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.62e-1)" "unprognostic (2.59e-2)" 295.9 95.5 42.3 181.1 42.1 245.9 231.5 40.6 54.7 181.2 65.5 192.6 107.0 356.4 39.3 153.8 182.2 134.5 161.1 50.8 39.4 140.7 101.6 286.2 161.7 52.7 51.7 121.1 160.3 55.0 52.6 166.5 48.1 131.8 89.8 9.7 177.2 98.4 84.0 160.6 163.5 174.1 48.8 232.5 135.8 38.2 52.1 125.1 141.2 46.3 104.1 168.8 166.8 48.2 612.2 277.0 86.2 74.2 156.8 195.1 437.3 398.4 507.5 554.6 413.2 302.1 170.3 156.9 230.1 666.1 265.0 412.7 125.2 779.4 559.6 356.1 120.9 302.6 294.3 259.9 481.1 346.9 463.8 233.0 234.7 751.9 626.4 540.3 461.8 113.2 67.3 205.8 448.9 161.9 124.4 204.0 51.7 171.1 169.2 233.3 267.3 146.7 314.5 581.5 129.6 53.0 559.7 217.0 251.6 218.5 162.4 177.1 1343.7 1222.6 370.3 237.5 731.5 135.2 114.7 129.0 463.2 172.3 363.1 72.6 25.2 64.7 32.4 19.8 28.4 13.4 23.5 26.4 17.2 11.9 18.3 20.4 41.2 9.0 26.5 8.0 26.3 54.5 42.3 42.1 40.6 54.7 50.8 39.4 52.7 51.7 48.1 48.8 52.1 48.2 303.9 118.6 87.1 12.7 108.4 144.0 182.4 123.1 72.8 2.6 90.5 89.4 62.6 80.1 89.7 92.0 2.1 87.0 151.7 359.8 7.9 309.4 35.8 89.7 121.6 258.7 73.8 51.9 42.5 245.8 193.1 82.9 123.8 194.7 93.1 117.1 132.8 102.8 100.4 82.4 6.7 131.0 59.0 119.6 124.2 37.4 68.0 168.8 85.4 61.8 196.6 11.9 137.0 7.5 33.3 344.6 186.8 211.4 125.9 184.4 159.8 27.5 51.5 5.3 203.8 39.9 275.2 6.9 10.4 133.6 135.1 46.4 213.2 141.3 139.5 134.3 NCMAP "C1orf130, FLJ42528, MP11" ENSG00000184454 "Non-compact myelin associated protein" Q5T1S8 1 24556087-24609328 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "gallbladder: 7.3;pancreas: 8.5;salivary gland: 7.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 17.7;Ductal cells: 19.3;Exocrine glandular cells: 48.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.0;RPTEC TERT1: 1.6;T-47d: 4.0;U-266/70: 3.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "spinal cord: 147.1" HPA013656 Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 6: T47d - Mammary gland" "Cluster 1: Pancreatic cells - Digestion" "HPA013656: AB_2275006" "unprognostic (3.38e-2)" "unprognostic (3.52e-2)" "unprognostic (2.79e-1)" "prognostic favorable (2.83e-6)" "unprognostic (3.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (4.14e-1)" "unprognostic (1.73e-1)" "unprognostic (2.41e-2)" "unprognostic (1.04e-1)" "unprognostic (3.28e-3)" "unprognostic (9.88e-2)" "unprognostic (9.53e-2)" "unprognostic (1.63e-2)" "unprognostic (7.27e-3)" 0.3 0.2 0.4 0.2 0.5 0.5 1.5 1.2 0.7 1.1 0.3 0.6 5.0 0.4 0.2 0.2 1.0 7.3 0.1 0.4 0.5 1.2 4.7 3.9 0.3 0.5 0.3 0.1 8.5 0.0 3.4 0.8 0.8 1.4 0.3 1.3 7.8 0.1 0.3 0.4 2.2 0.0 0.2 0.1 4.9 0.1 0.5 0.0 4.2 0.4 0.4 0.6 0.1 1.7 0.1 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.5 1.6 0.5 0.1 0.1 0.0 0.1 0.0 0.5 4.0 0.1 0.3 0.1 0.1 0.1 0.1 3.0 0.4 0.0 0.0 0.1 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.4 0.5 1.2 0.7 0.4 0.5 0.5 0.3 0.8 0.2 0.5 1.7 0.0 3.2 17.7 0.3 0.1 0.0 1.6 0.7 0.0 0.4 3.6 1.9 1.1 8.6 3.2 3.7 4.2 1.4 0.2 0.8 0.0 19.3 0.0 1.8 1.0 0.3 1.8 0.0 0.6 48.3 0.2 0.4 0.5 5.7 1.3 0.0 0.0 2.0 0.1 0.0 0.6 0.7 4.1 0.0 0.4 0.0 0.0 0.2 3.6 7.5 1.1 3.6 0.0 0.5 1.2 10.4 1.7 0.0 2.8 2.3 4.2 1.1 1.0 0.5 0.0 1.4 0.3 0.1 0.1 0.0 0.1 9.3 0.6 0.0 0.9 2.2 NEURL3 "Lincr, LOC93082, RNF132" ENSG00000163121 "Neuralized E3 ubiquitin protein ligase 3" Q96EH8 2 96497646-96508109 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 16.2;pancreas: 25.1;salivary gland: 30.3" "Group enriched" "Detected in many" 4 "Ductal cells: 114.6;Exocrine glandular cells: 36.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.8;CAPAN-2: 15.6;GAMG: 5.5;RPMI-8226: 10.1;RT4: 4.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (4.97e-2)" "unprognostic (6.07e-2)" "unprognostic (7.22e-2)" "unprognostic (1.42e-2)" "unprognostic (2.49e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.29e-1)" "unprognostic (9.55e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-1)" "unprognostic (8.14e-3)" "unprognostic (1.23e-2)" "unprognostic (5.83e-2)" "unprognostic (6.57e-2)" "unprognostic (2.44e-1)" "unprognostic (6.57e-4)" 0.1 0.0 0.8 0.4 0.8 0.3 1.9 0.6 0.9 0.1 0.5 0.7 1.6 0.1 0.1 0.1 0.2 2.1 0.2 0.8 0.7 16.2 2.5 2.5 0.2 0.8 0.7 0.0 25.1 0.0 0.3 0.0 0.8 3.9 0.5 0.1 30.3 2.5 0.1 0.6 2.1 0.0 0.7 0.6 0.5 0.4 0.7 4.8 0.0 0.0 0.3 0.4 0.0 0.9 1.0 0.5 0.0 0.3 0.0 0.0 3.8 0.0 0.4 0.3 0.2 2.3 15.6 0.0 1.2 0.0 5.5 2.3 0.2 0.0 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 10.1 2.1 4.7 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.8 0.8 0.6 0.9 0.8 0.7 0.8 0.7 0.8 0.7 0.7 0.9 0.4 0.0 1.5 0.7 0.9 0.0 10.2 0.0 0.0 0.0 7.6 8.3 0.4 11.5 0.6 9.2 0.0 0.3 0.3 6.9 3.9 114.6 0.0 4.9 0.2 1.0 2.4 3.2 0.4 36.5 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.2 1.1 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 12.2 0.8 0.0 0.0 0.1 17.8 5.2 0.0 0.0 13.2 10.6 5.8 0.0 0.0 0.0 0.0 0.4 0.7 1.9 0.0 0.0 0.0 0.2 1.4 1.2 5.9 NPPB ENSG00000120937 "Natriuretic peptide B" P16860 1 11857464-11858945 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Hormone, Vasoactive, Vasodilator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 767 "heart muscle: 5154.6" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 351.7;Ductal cells: 266.6;Pancreatic endocrine cells: 86.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Group enriched" "Detected in some" 4 "basal ganglia: 3.4;cerebral cortex: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 135.5;CACO-2: 362.2;SuSa: 67.7" "Region enhanced" "Detected in single" "pons and medulla: 1.4" HPA077324 Approved Vesicles,Cytosol "Secreted to blood" NA NA 9680 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Vesicles Cytosol "HPA077324: " "unprognostic (3.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.49e-1)" "unprognostic (4.23e-1)" "unprognostic (3.28e-2)" 1.0 0.3 0.3 0.1 3.4 0.0 0.7 0.4 1.8 0.3 0.1 0.3 0.0 0.3 0.3 0.2 0.0 0.6 5154.6 0.3 0.3 0.3 0.5 6.7 0.9 0.3 0.4 0.8 4.0 0.1 0.5 0.8 0.3 0.5 0.0 0.1 1.2 0.0 0.8 0.5 0.4 0.0 0.6 0.1 0.7 0.8 0.5 0.1 0.5 0.0 0.0 0.2 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 135.5 0.3 0.0 2.1 1.1 362.2 0.0 0.0 0.1 0.1 0.3 3.8 0.1 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 67.7 0.0 0.0 0.0 0.0 32.0 0.2 0.2 0.0 0.1 0.0 0.1 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 0.4 1.8 0.3 0.3 0.3 0.4 0.3 0.6 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 351.7 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 266.6 0.1 0.8 0.1 4.9 0.0 0.0 0.2 8.3 2.2 11.7 0.0 1.4 0.0 0.2 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.2 0.0 0.0 0.0 86.2 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 17.6 5.8 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.1 PDIA2 "PDA2, PDI, PDIP, PDIR" ENSG00000185615 "Protein disulfide isomerase family A member 2" Q13087 16 283164-287215 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "pancreas: 2509.7" "Cell type enriched" "Detected in some" 4 "Exocrine glandular cells: 294.9" "Cancer enriched" "Detected in many" 5 "pancreatic cancer: 28.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.9;HEK 293: 7.9;Hep G2: 6.7;Karpas-707: 2.9;MCF7: 4.6;SH-SY5Y: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA051692, HPA053492" Enhanced "Intracellular and membrane" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 1: Pancreatic cells - Digestion" "HPA051692: AB_2681575, HPA053492: AB_2682169" "unprognostic (3.46e-2)" "unprognostic (7.98e-3)" "unprognostic (3.01e-2)" "unprognostic (1.30e-1)" "unprognostic (2.21e-1)" "unprognostic (2.17e-2)" "unprognostic (6.27e-3)" "unprognostic (1.11e-2)" "unprognostic (3.98e-1)" "unprognostic (1.76e-1)" "unprognostic (4.42e-2)" "unprognostic (2.90e-2)" "unprognostic (1.58e-14)" "unprognostic (3.06e-2)" "unprognostic (1.66e-1)" "unprognostic (8.75e-2)" "unprognostic (2.87e-2)" 2.8 0.6 64.4 0.4 70.1 0.6 0.8 80.5 96.0 0.6 61.2 2.7 23.9 0.3 0.9 0.9 0.7 0.1 4.4 64.2 66.7 0.6 0.6 0.7 0.2 76.6 67.1 1.5 2509.7 0.0 7.6 2.5 73.2 1.0 0.3 2.4 1.0 0.1 0.6 0.4 7.1 0.0 69.9 0.3 191.7 1.0 68.7 0.0 0.4 0.0 0.5 0.5 0.6 88.5 0.0 1.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.1 3.9 0.1 0.5 0.0 7.9 0.0 0.3 6.7 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.3 2.9 0.1 4.6 0.1 0.4 0.2 1.6 0.0 0.1 0.0 0.9 0.0 0.0 1.6 3.7 0.0 0.1 0.0 0.5 1.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.4 70.1 80.5 96.0 64.2 66.7 76.6 67.1 73.2 69.9 68.7 88.5 0.0 0.0 0.5 1.6 1.9 0.5 0.0 0.0 0.0 4.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.1 0.3 0.1 0.0 0.0 12.4 294.9 1.3 5.5 65.7 0.1 0.0 0.1 0.0 0.0 0.4 0.0 14.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 1.6 0.6 0.0 2.0 22.2 25.5 1.4 0.4 0.2 0.0 3.9 1.1 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 1.4 0.0 PDLIM7 ENIGMA ENSG00000196923 "PDZ and LIM domain 7" Q9NR12 5 177483394-177497606 "Predicted intracellular proteins" "Differentiation, Osteogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 570.3;skeletal muscle: 661.5" "Cell type enhanced" "Detected in many" "Ductal cells: 164.8;Exocrine glandular cells: 242.1;Pancreatic endocrine cells: 320.1;Peritubular cells: 223.0;Sertoli cells: 164.3;Smooth muscle cells: 157.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 177.1;eosinophil: 121.2;neutrophil: 438.7" "Lineage enriched" "Detected in all" 9 "granulocytes: 438.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018794, HPA048815" Approved Enhanced "Actin filaments,Focal adhesion sites" NA NA 1700000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Actin filaments, Focal adhesion sites" "HPA018794: AB_1855155, HPA048815: AB_2680530" "unprognostic (7.70e-3)" "unprognostic (3.75e-2)" "unprognostic (9.27e-3)" "prognostic unfavorable (5.45e-4)" "unprognostic (1.40e-1)" "unprognostic (3.48e-2)" "unprognostic (9.18e-3)" "prognostic unfavorable (4.07e-4)" "unprognostic (5.01e-2)" "unprognostic (3.10e-1)" "unprognostic (7.24e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (6.19e-10)" "unprognostic (6.72e-3)" "unprognostic (3.02e-1)" "unprognostic (1.93e-1)" "unprognostic (3.68e-2)" 74.3 26.7 23.0 74.5 27.2 50.3 58.2 18.8 39.8 183.7 30.2 570.3 31.5 489.5 28.8 64.5 236.0 45.0 79.9 22.3 27.6 52.8 16.0 84.7 15.1 23.9 23.4 94.2 15.1 9.6 66.3 33.2 24.9 245.3 24.9 5.7 42.3 200.7 661.5 38.0 111.7 177.6 20.8 84.5 156.1 37.6 28.5 11.5 37.1 70.5 7.6 315.4 125.0 20.5 115.8 25.8 120.7 89.4 32.5 59.9 118.9 232.4 132.8 128.9 89.0 50.9 109.6 20.4 220.4 156.4 69.5 59.5 19.7 160.6 30.3 27.5 27.6 73.6 92.2 52.6 83.6 38.8 237.3 132.0 29.1 115.6 51.5 191.9 85.4 18.3 52.4 15.3 102.5 103.9 7.0 88.6 75.7 23.2 108.8 144.4 101.3 14.0 89.1 29.6 17.5 35.8 91.5 16.9 44.6 39.9 24.3 31.3 292.9 153.8 168.1 60.5 211.7 4.0 4.7 24.1 73.3 44.2 35.7 177.1 46.7 121.2 5.3 22.9 6.3 9.6 3.1 7.2 26.7 5.3 3.0 4.0 438.7 2.3 29.3 1.9 7.0 23.9 23.0 27.2 18.8 39.8 22.3 27.6 23.9 23.4 24.9 20.8 28.5 20.5 36.6 0.0 0.6 11.1 7.5 14.5 47.1 106.8 6.2 6.3 7.6 65.3 21.0 4.3 20.9 25.8 14.6 12.5 4.4 5.5 25.4 164.8 27.0 7.5 44.8 51.0 3.5 9.4 13.9 242.1 53.3 65.0 9.7 7.3 17.2 18.6 51.0 1.6 64.0 8.4 7.4 2.1 36.7 16.6 18.3 49.3 44.7 44.9 10.6 5.6 31.0 16.2 1.0 2.0 1.7 320.1 33.6 223.0 3.2 30.4 1.0 15.7 13.2 22.6 164.3 24.6 157.7 11.6 38.7 12.2 15.8 14.1 10.8 18.2 3.1 25.3 PDX1 "IDX-1, IPF1, MODY4, PDX-1, STF-1" ENSG00000139515 "Pancreatic and duodenal homeobox 1" P52945 13 27920000-27926313 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 41.8;pancreas: 13.3" "Cell type enhanced" "Detected in some" "Cholangiocytes: 15.7;Ductal cells: 13.3;Enteroendocrine cells: 13.8;Exocrine glandular cells: 9.8;Gastric mucus-secreting cells: 4.6" "Group enriched" "Detected in many" 4 "colorectal cancer: 8.4;pancreatic cancer: 8.6;stomach cancer: 7.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.0;HEK 293: 2.3;HeLa: 5.9;OE19: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025873, HPA059146" Enhanced Supported Nucleoplasm NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "CAB025873: , HPA059146: AB_2683927" "unprognostic (2.79e-2)" "unprognostic (2.22e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (6.84e-2)" "unprognostic (3.89e-2)" "unprognostic (6.75e-3)" "unprognostic (7.10e-3)" "unprognostic (3.83e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 41.8 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 13.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 4.0 2.3 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 15.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 13.3 0.0 0.0 0.0 0.0 13.8 0.0 0.0 9.8 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 PEX16 ENSG00000121680 "Peroxisomal biogenesis factor 16" Q9Y5Y5 11 45909663-45918812 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043286 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 22: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 1: Pancreatic cells - Digestion" "HPA043286: AB_10794179" "unprognostic (2.48e-1)" "unprognostic (1.95e-2)" "unprognostic (8.14e-2)" "unprognostic (3.15e-2)" "unprognostic (1.76e-1)" "unprognostic (1.53e-1)" "unprognostic (9.06e-3)" "unprognostic (9.06e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (3.48e-3)" "unprognostic (1.51e-1)" "unprognostic (6.75e-3)" "unprognostic (5.72e-3)" "unprognostic (2.71e-1)" "unprognostic (1.00e-1)" "prognostic favorable (9.06e-4)" 23.4 27.1 22.3 10.9 23.8 20.3 22.2 23.4 24.4 18.2 16.6 20.6 21.3 18.7 6.3 21.3 18.9 10.1 17.0 23.0 22.7 26.7 50.2 16.2 16.6 26.2 23.6 18.3 40.0 10.1 32.0 6.7 23.2 21.7 5.1 4.4 21.6 9.7 18.1 27.2 25.3 6.0 21.9 24.5 27.6 25.8 23.6 11.8 21.8 7.5 8.6 20.1 18.0 26.0 15.0 19.9 6.7 16.8 11.0 13.2 19.4 11.6 15.2 15.5 12.0 22.6 10.7 25.6 15.0 10.9 14.7 27.2 6.9 23.0 3.7 22.4 23.6 16.7 28.8 20.1 34.8 24.9 33.8 21.3 20.1 9.4 15.1 9.1 17.0 21.9 13.4 29.6 10.7 42.0 21.3 32.5 15.1 28.7 20.0 18.4 16.8 29.4 10.0 26.5 17.0 22.7 13.3 27.1 24.5 4.2 40.4 21.1 13.6 14.8 19.0 36.9 21.5 47.1 33.1 16.2 16.2 14.7 16.2 35.3 44.1 36.8 47.9 51.0 44.9 57.0 48.9 49.6 47.8 50.5 44.4 46.7 32.2 44.9 38.6 44.7 61.1 46.1 22.3 23.8 23.4 24.4 23.0 22.7 26.2 23.6 23.2 21.9 23.6 26.0 25.1 3.2 5.4 3.9 35.7 16.6 24.4 47.6 19.4 15.7 25.9 22.4 3.8 22.8 25.1 14.7 10.4 39.9 31.9 45.8 50.9 37.3 25.9 19.7 13.8 21.5 28.1 25.9 4.8 88.7 22.2 15.7 17.9 20.3 21.0 16.2 21.8 68.6 34.2 15.2 5.1 26.5 30.5 37.7 19.7 32.6 19.3 20.0 21.4 3.7 46.6 28.8 26.8 5.0 10.6 55.9 49.2 14.3 27.1 26.1 90.5 68.1 26.4 18.0 32.9 16.8 24.4 27.2 15.4 21.6 21.0 64.0 33.0 19.9 29.6 28.2 PGA4 ENSG00000229183 "Pepsinogen A4" P0DJD7 11 61222349-61231694 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1281 "stomach 1: 66596.4" "Cell type enriched" "Detected in some" 8 "Exocrine glandular cells: 109.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "classical monocyte: 9.9;intermediate monocyte: 10.9;non-classical monocyte: 3.4" "Lineage enriched" "Detected in single" 26 "monocytes: 10.9" "Group enriched" "Detected in some" 6 "BJ hTERT+: 26.1;HMC-1: 9.5;THP-1: 15.7" HPA046875 Supported "Secreted to digestive system" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 4: Stomach - Digestion" "Cluster 3: HMC-1 - Innate immune response" "Cluster 1: Pancreatic cells - Digestion" "HPA046875: AB_2679851" "unprognostic (2.22e-1)" 9.6 8.3 0.1 2.1 0.1 0.0 9.0 0.1 0.2 7.5 0.1 52.0 2.5 4.6 0.0 9.1 19.1 0.3 6.2 0.1 0.1 30.3 11.7 37.9 0.0 0.1 0.1 4.1 18.8 0.0 3.5 3.8 0.1 16.2 0.4 0.3 4.5 0.7 2.5 4.1 2.9 0.8 0.1 5.2 66596.4 4.3 0.1 0.1 3.1 0.0 0.2 5.0 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.0 1.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 1.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.0 3.4 0.0 0.0 1.8 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 109.1 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PGA5 ENSG00000256713 "Pepsinogen A5" P0DJD9 11 61241175-61251444 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2014 "stomach 1: 39870.8" "Cell type enriched" "Detected in some" 77 "Exocrine glandular cells: 4383.1" "Cancer enriched" "Detected in some" 12 "stomach cancer: 15.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 29 "classical monocyte: 1.8;intermediate monocyte: 4.3;non-classical monocyte: 2.4" "Lineage enriched" "Detected in single" 44 "monocytes: 4.3" "Cell line enriched" "Detected in some" 19 "BJ hTERT+: 28.8" HPA046875 Supported "Secreted to digestive system" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 4: Stomach - Digestion" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "HPA046875: AB_2679851" "unprognostic (1.36e-3)" "unprognostic (2.98e-2)" "unprognostic (5.83e-3)" "unprognostic (2.11e-1)" "unprognostic (4.22e-1)" "unprognostic (4.36e-2)" "unprognostic (2.16e-2)" "unprognostic (1.05e-1)" "unprognostic (7.10e-2)" 19.7 4.4 0.3 1.1 0.3 0.0 4.5 0.1 0.6 4.0 0.0 6.2 0.6 1.9 0.0 7.0 5.1 0.1 3.5 0.7 0.0 2.4 7.0 5.4 0.0 0.1 0.0 2.6 8.2 0.0 3.8 0.5 0.1 1.8 0.1 1.5 2.5 0.5 1.9 2.1 2.1 0.9 0.0 3.9 39870.8 2.3 0.0 0.2 3.1 0.2 0.1 2.3 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 28.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.3 0.3 0.3 0.1 0.6 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 4383.1 0.0 0.1 56.6 0.0 0.0 0.2 0.0 0.0 6.7 0.0 0.0 0.0 0.0 5.1 0.0 1.6 0.9 1.3 0.0 0.0 1.0 25.1 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PGM2L1 "BM32A, FLJ32029" ENSG00000165434 "Phosphoglucomutase 2 like 1" Q6PCE3 11 74330316-74398433 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 90.1;Exocrine glandular cells: 124.5;Pancreatic endocrine cells: 140.1;Respiratory ciliated cells: 95.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 16.6;LHCN-M2: 19.9;RH-30: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056995, HPA060948" Enhanced Approved Mitochondria No No 140000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 10: Brain - Neuronal signaling" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 1: Pancreatic cells - Digestion" Mitochondria "HPA056995: AB_2683305, HPA060948: AB_2684394" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" "unprognostic (7.28e-3)" "unprognostic (8.91e-2)" "unprognostic (6.16e-2)" "unprognostic (1.55e-1)" "unprognostic (7.16e-6)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (5.97e-3)" "unprognostic (1.70e-2)" "unprognostic (2.98e-1)" "unprognostic (9.33e-3)" "unprognostic (3.71e-1)" "unprognostic (1.97e-1)" "unprognostic (3.04e-1)" "unprognostic (1.03e-2)" 1.9 2.6 17.6 3.7 22.1 3.2 1.9 0.0 21.5 4.9 0.0 3.2 1.3 4.4 0.8 1.0 3.2 3.3 1.1 23.1 16.2 1.6 1.0 1.8 3.0 1.9 4.5 0.9 3.1 0.7 3.9 1.1 2.2 2.9 3.5 2.6 2.6 1.3 5.9 0.7 1.5 4.0 0.3 1.5 2.1 1.3 5.7 8.1 2.7 11.1 2.7 6.4 1.9 7.8 2.7 3.8 14.5 2.7 4.3 1.9 0.4 3.5 2.6 3.0 3.3 1.4 6.8 0.3 8.5 2.3 5.3 1.3 2.9 0.7 2.8 1.1 1.5 2.1 2.0 1.1 0.5 2.4 3.2 1.0 0.7 6.8 1.2 3.2 16.6 5.0 2.8 1.8 19.9 0.3 9.9 2.1 2.9 2.0 3.3 3.1 18.9 0.1 7.8 0.5 0.7 2.9 5.7 1.3 2.6 3.9 0.2 0.4 14.0 6.6 6.0 2.7 3.7 2.4 3.8 0.3 0.6 3.4 1.6 1.2 0.3 0.5 0.9 0.3 1.3 1.1 1.6 1.1 0.2 0.8 1.5 0.8 0.3 1.4 0.2 0.8 3.9 0.5 17.6 22.1 0.0 21.5 23.1 16.2 1.9 4.5 2.2 0.3 5.7 7.8 19.6 6.4 6.4 8.5 20.9 7.6 41.2 14.3 10.8 23.9 26.5 19.4 7.3 17.2 30.2 9.2 16.7 0.6 17.6 13.8 5.9 37.4 14.1 28.1 23.5 32.1 11.9 47.5 90.1 124.5 5.3 21.0 7.1 25.5 8.2 16.1 29.3 1.0 5.4 8.4 64.8 16.2 18.3 23.0 21.6 3.6 2.5 9.9 16.0 20.6 4.6 4.4 12.3 14.6 7.1 140.1 9.3 3.8 13.4 50.4 4.2 5.3 95.4 11.0 26.3 21.3 16.7 34.2 21.2 9.0 5.3 0.1 25.0 8.8 20.9 55.6 PHETA1 "FAM109A, FLJ32356, IPIP27A, SES1" ENSG00000198324 "PH domain containing endocytic trafficking adaptor 1" Q8N4B1 12 111360651-111369121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 32.6;Granulosa cells: 9.6;Hofbauer cells: 10.6;Pancreatic endocrine cells: 33.8;Theca cells: 8.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 3.1" "Group enriched" "Detected in many" 4 "B-cells: 1.0;dendritic cells: 3.1;monocytes: 1.9" "Cell line enhanced" "Detected in many" "Hep G2: 43.5;OE19: 34.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (2.26e-1)" "unprognostic (6.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.05e-1)" "unprognostic (6.02e-2)" "unprognostic (1.15e-3)" "unprognostic (6.18e-3)" "unprognostic (1.11e-1)" "unprognostic (4.00e-2)" "unprognostic (5.51e-2)" "unprognostic (9.42e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.95e-1)" "unprognostic (1.31e-1)" "unprognostic (4.90e-2)" "unprognostic (2.80e-3)" 7.3 17.1 6.3 3.6 5.5 1.6 6.8 4.9 5.8 11.2 4.5 14.9 28.6 9.8 2.2 12.6 7.8 5.2 19.3 5.0 6.5 9.8 19.5 10.9 2.2 7.1 6.2 14.0 29.0 2.9 5.1 2.5 5.9 9.4 5.4 1.1 9.5 3.6 10.2 20.0 27.9 3.5 5.4 23.2 22.7 10.9 7.0 1.2 6.5 4.6 2.0 7.1 8.6 5.4 8.5 7.4 6.2 9.5 8.5 7.4 16.5 5.4 4.7 4.2 2.2 11.7 5.7 0.2 11.5 8.2 5.9 4.6 3.3 3.5 1.8 3.4 7.6 5.7 2.7 43.5 5.0 1.1 7.4 6.1 8.8 6.3 2.0 8.3 6.3 2.8 13.4 0.6 5.2 8.0 1.4 6.8 9.7 34.3 17.6 5.6 4.2 2.5 4.3 4.7 1.4 18.6 8.4 12.8 3.7 5.2 8.7 2.1 7.6 6.2 12.4 7.2 4.2 5.5 5.0 1.0 6.2 3.8 7.1 0.0 1.2 0.2 0.3 1.9 0.4 0.2 0.1 0.1 3.1 1.0 0.0 0.4 0.0 0.3 1.9 0.3 0.0 0.9 6.3 5.5 4.9 5.8 5.0 6.5 7.1 6.2 5.9 5.4 7.0 5.4 2.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.3 3.2 0.0 0.0 0.0 3.7 0.0 1.3 1.4 0.0 3.9 6.8 0.0 2.8 5.2 1.3 0.0 0.0 0.0 32.6 5.5 1.8 0.0 4.0 0.0 9.6 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.3 0.0 0.0 7.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.2 0.2 8.9 0.0 0.0 PLA2G1B "PLA2, PLA2A, PPLA2" ENSG00000170890 "Phospholipase A2 group IB" P04054 12 120322115-120327779 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid metabolism, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1519 "pancreas: 117705.6" "Cell type enriched" "Detected in many" 17 "Exocrine glandular cells: 20351.4" "Cancer enriched" "Detected in many" 185 "pancreatic cancer: 763.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.5;U-2 OS: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047822, HPA060803" Enhanced "Secreted to digestive system" NA NA 3900000 "Cluster 48: NK-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 1: Pancreatic cells - Digestion" "HPA047822: AB_2680169, HPA060803: AB_2684369" "unprognostic (1.28e-4)" "unprognostic (6.02e-2)" "unprognostic (1.84e-2)" "unprognostic (2.86e-2)" "unprognostic (2.74e-2)" "unprognostic (2.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (3.61e-2)" "unprognostic (1.27e-1)" "unprognostic (1.03e-1)" "unprognostic (2.80e-4)" "unprognostic (2.15e-1)" "unprognostic (1.97e-1)" "unprognostic (3.60e-1)" "unprognostic (8.61e-4)" 10.0 6.5 0.2 1.7 0.1 2.9 5.8 0.2 0.6 5.8 0.0 2.3 15.8 2.3 0.0 3.3 1.8 0.9 21.5 0.2 0.2 2.7 7.2 32.1 4.0 0.1 0.1 77.5 117705.6 0.0 4.4 6.0 0.2 4.4 0.3 0.7 21.3 0.0 1.9 3.4 7.7 0.1 0.1 3.0 8.7 4.3 0.1 0.3 1.5 0.0 0.0 1.3 1.9 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 1.9 0.2 0.2 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.6 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 12.8 91.5 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.8 1.3 0.4 0.0 0.8 0.0 0.0 0.0 0.2 0.2 1.9 24.3 10.6 0.4 0.1 1.1 1.2 0.0 0.1 20351.4 0.0 0.3 0.0 0.0 0.0 8.6 0.0 1.9 0.0 0.0 0.1 1.2 0.0 0.0 0.0 41.0 3.1 1.5 0.0 1.0 43.9 0.0 2.1 0.0 0.0 1142.1 1.7 3.4 0.1 0.2 4.1 7.6 1.0 0.0 0.0 0.0 3.4 0.5 0.2 0.0 0.1 0.0 0.3 12.5 1.2 0.1 PLSCR1 MMTRA1B ENSG00000188313 "Phospholipid scramblase 1" O15162 3 146515180-146544856 "Predicted intracellular proteins, Transporters" "Antiviral defense, Host-virus interaction" "DNA-binding, Host cell receptor for virus entry, Hydrolase, Nuclease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 291.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 319.8;BJ hTERT+ SV40 Large T+ RasG12V: 418.6;HHSteC: 292.9;SK-MEL-30: 569.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068923, CAB070421" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA Yes "Cluster 25: Monocytes - Inflammatory response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB070421: AB_11153452, HPA068923: AB_2686059" "unprognostic (7.88e-2)" "unprognostic (1.10e-1)" "unprognostic (5.34e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (3.35e-1)" "unprognostic (5.22e-2)" "unprognostic (7.73e-3)" "unprognostic (9.19e-3)" "unprognostic (6.93e-3)" "unprognostic (3.07e-3)" "unprognostic (1.10e-1)" "unprognostic (1.09e-3)" "unprognostic (5.26e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-1)" "unprognostic (1.63e-1)" 60.6 23.0 11.4 86.7 12.5 64.4 45.9 12.7 17.6 25.9 11.9 65.0 39.8 28.2 31.0 47.9 40.0 66.1 24.3 12.1 13.5 71.9 49.2 49.3 40.6 17.4 14.2 34.9 38.3 16.8 15.4 56.3 15.3 23.7 59.5 9.8 49.1 49.6 10.8 13.6 45.4 41.9 16.2 64.5 44.0 17.1 14.7 30.0 27.8 17.6 39.4 68.1 29.5 14.0 106.2 41.5 26.4 12.1 40.9 65.0 40.5 32.6 88.4 319.8 418.6 34.0 88.1 8.4 75.6 20.6 245.9 86.2 21.2 32.7 56.6 32.9 21.6 66.1 12.5 25.2 292.9 40.3 35.4 106.3 53.3 36.6 182.3 52.6 49.4 19.1 44.7 104.0 66.9 41.0 30.6 16.1 25.8 71.6 37.6 27.4 28.1 2.9 95.9 29.6 16.3 0.0 42.6 20.9 569.9 35.8 20.7 46.8 30.6 26.9 22.7 59.1 55.8 79.2 15.6 0.4 27.0 29.0 23.3 41.1 157.6 44.3 20.8 159.6 30.0 25.2 13.5 18.5 105.8 19.7 9.3 13.9 100.0 57.8 94.8 28.5 8.3 79.3 11.4 12.5 12.7 17.6 12.1 13.5 17.4 14.2 15.3 16.2 14.7 14.0 191.4 35.3 43.0 12.7 28.2 37.0 106.5 92.1 26.2 0.7 36.0 22.6 7.3 124.4 110.4 95.6 0.0 53.7 25.4 134.2 74.3 291.6 2.0 56.1 24.5 135.2 33.1 18.3 7.1 217.4 114.1 74.8 47.9 58.2 28.4 60.5 100.6 29.7 139.9 0.0 9.0 71.5 79.3 86.2 162.9 6.8 114.9 185.5 48.0 35.6 72.3 64.3 32.0 7.1 0.3 157.6 110.3 45.9 18.2 79.6 40.7 75.0 133.5 1.6 39.5 63.4 59.2 1.5 2.4 21.8 28.6 44.5 25.9 42.6 69.4 211.9 PMEPA1 "STAG1, TMEPAI" ENSG00000124225 "Prostate transmembrane protein, androgen induced 1" Q969W9 20 57648392-57711536 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Signal transduction inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 110.8" "Cell type enhanced" "Detected in many" "Ductal cells: 339.6;Muller glia cells: 325.9;Pancreatic endocrine cells: 827.5" "Cancer enhanced" "Detected in all" "prostate cancer: 157.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "naive B-cell: 6.3;plasmacytoid DC: 23.9" "Group enriched" "Detected in many" 8 "B-cells: 6.3;dendritic cells: 23.9" "Cell line enhanced" "Detected in many" "SiHa: 206.1;U-2 OS: 129.9;U-251 MG: 481.8;WM-115: 237.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072291 Supported Vesicles "Intracellular and membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 1: Pancreatic cells - Digestion" Vesicles "HPA072291: AB_2686509" "unprognostic (2.72e-3)" "prognostic unfavorable (2.45e-4)" "unprognostic (5.77e-2)" "unprognostic (1.73e-1)" "unprognostic (6.61e-2)" "unprognostic (2.11e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.73e-5)" "unprognostic (5.53e-1)" "unprognostic (1.32e-3)" "unprognostic (7.83e-3)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.87e-7)" "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (9.87e-3)" "prognostic unfavorable (7.60e-4)" 50.5 14.5 24.2 14.2 75.5 1.3 25.1 38.8 29.9 94.8 1.8 30.7 6.5 48.4 7.1 7.6 19.9 26.0 29.2 24.0 28.3 16.2 3.8 21.8 7.4 32.9 34.1 14.9 31.3 5.0 13.5 3.9 38.8 110.8 8.4 23.6 30.5 20.6 33.2 18.1 12.6 28.8 27.0 6.6 12.2 5.3 36.1 2.4 13.6 13.6 8.9 13.1 29.6 26.2 32.2 75.4 2.3 3.9 2.4 0.0 0.8 4.9 0.2 1.7 0.8 1.5 97.4 0.2 17.7 7.4 51.8 121.1 1.6 100.8 1.3 1.0 4.1 0.0 23.2 0.1 1.5 0.3 0.8 1.2 55.8 4.4 12.1 16.5 13.0 67.8 0.8 1.2 6.2 66.1 3.8 0.7 9.4 15.0 9.6 0.3 36.0 11.3 24.2 0.0 17.7 13.7 206.1 120.3 15.1 5.6 18.8 4.1 33.1 17.9 129.9 1.9 481.8 5.9 0.8 0.5 8.1 1.1 237.1 0.0 0.4 0.0 0.0 0.0 0.0 2.6 0.8 0.2 0.1 6.3 1.8 1.2 0.1 0.0 0.1 23.9 0.5 0.6 24.2 75.5 38.8 29.9 24.0 28.3 32.9 34.1 38.8 27.0 36.1 26.2 59.4 57.7 32.3 4.9 32.7 167.0 143.1 120.6 30.7 59.0 38.0 23.0 23.2 125.8 31.7 11.0 2.1 0.2 27.8 57.3 3.9 339.6 1.2 33.4 88.8 55.6 10.1 0.0 19.1 62.5 4.1 40.5 5.1 80.2 59.8 17.5 24.7 0.5 6.1 1.7 32.7 16.9 14.2 3.5 68.0 2.7 3.1 13.4 32.0 31.9 5.8 325.9 0.0 17.6 9.0 827.5 54.2 21.8 25.3 203.1 6.2 2.7 10.1 11.5 72.3 43.8 155.2 0.2 8.8 10.0 178.4 0.1 17.8 9.1 19.3 87.5 PNLIP PL ENSG00000175535 "Pancreatic lipase" P16233 10 116545931-116567855 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2058 "pancreas: 444687.5" "Cell type enriched" "Detected in some" 8 "Exocrine glandular cells: 4086.8" "Cancer enriched" "Detected in some" 4854 "pancreatic cancer: 2731.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA062430, HPA062494" Enhanced "Secreted to digestive system" NA NA 14000000 "Cluster 25: Pancreas - Digestion" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "HPA062430: AB_2684761, HPA062494: AB_2684782" "unprognostic (2.05e-2)" "unprognostic (4.46e-2)" 13.8 3.1 0.0 10.5 0.0 1.1 8.9 0.0 0.0 7.2 0.0 3.8 64.8 9.1 0.4 4.8 1.5 0.0 78.2 0.0 0.0 3.0 10.2 2.1 16.9 0.0 0.0 216.0 444687.5 0.0 2.5 24.4 0.0 4.5 0.0 0.0 71.7 0.0 2.9 4.6 34.0 0.0 0.0 3.8 28.2 2.3 0.0 0.0 2.0 0.0 0.0 1.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.5 0.0 0.0 0.3 0.0 0.0 0.1 4086.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 14.5 0.0 0.0 0.5 0.1 507.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PNLIPRP1 PLRP1 ENSG00000187021 "Pancreatic lipase related protein 1" P54315 10 116590385-116609175 "Metabolic proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 2343 "pancreas: 10825.1" "Cell type enriched" "Detected in some" 10 "Exocrine glandular cells: 688.3" "Cancer enriched" "Detected in single" 476 "pancreatic cancer: 32.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA 340000 "Cluster 25: Pancreas - Digestion" "Cluster 16: U-266 - Nucleosome" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (1.21e-1)" "unprognostic (4.08e-3)" "unprognostic (1.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.76e-2)" "unprognostic (1.41e-1)" "unprognostic (1.46e-1)" "unprognostic (1.49e-1)" 1.7 0.2 0.0 0.2 0.0 0.3 0.6 0.0 0.0 0.9 0.0 0.2 2.1 0.3 0.0 0.4 0.1 0.0 2.0 0.0 0.0 0.2 0.8 0.2 0.4 0.0 0.0 4.6 10825.1 0.0 0.5 0.8 0.0 0.4 0.1 0.0 2.7 0.0 0.2 0.4 1.1 0.0 0.0 0.4 1.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.8 0.0 0.0 0.1 0.0 0.0 0.0 688.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 3.4 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.1 66.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.3 PRR5-ARHGAP8 ENSG00000248405 "PRR5-ARHGAP8 readthrough" 22 44702233-44862706 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Astrocytes: 4.9;Collecting duct cells: 5.5;Pancreatic endocrine cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.0;CACO-2: 2.1;HEK 293: 2.7;MCF7: 2.1;U-266/70: 6.8" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 7: Kidney - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (1.83e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" "unprognostic (5.52e-2)" "unprognostic (3.65e-2)" "unprognostic (6.61e-3)" "unprognostic (3.29e-2)" "unprognostic (1.77e-2)" "unprognostic (2.35e-1)" "unprognostic (2.75e-2)" "unprognostic (2.53e-2)" "unprognostic (6.47e-3)" "unprognostic (9.28e-8)" "unprognostic (8.64e-2)" "unprognostic (9.91e-2)" "unprognostic (2.41e-2)" "unprognostic (3.45e-1)" 0.5 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.3 0.2 0.2 0.7 0.5 0.1 0.1 0.6 0.6 0.5 0.0 0.1 0.1 1.5 0.2 0.4 0.2 0.1 0.2 0.0 0.8 0.4 0.5 0.2 0.1 0.8 0.3 0.0 0.7 0.8 0.0 0.6 0.4 0.0 0.0 1.0 0.4 0.1 0.1 0.0 1.4 0.0 0.2 0.3 0.3 0.1 1.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.3 0.0 0.0 2.1 0.3 0.0 0.1 0.0 0.0 0.7 0.5 1.4 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.6 0.1 0.7 0.2 0.0 0.0 0.9 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 3.2 1.5 4.9 0.0 0.4 1.0 0.2 0.0 0.0 0.6 0.3 0.1 0.0 0.8 5.5 0.0 0.7 0.1 0.6 1.9 1.9 0.0 0.6 0.1 0.0 1.2 0.0 0.9 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.9 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.3 0.1 0.2 0.5 0.9 PRSS1 TRY1 ENSG00000204983 "Serine protease 1" P07477 7 142749468-142753076 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1923 "pancreas: 341429.7" "Cell type enriched" "Detected in some" 28 "Exocrine glandular cells: 57138.3" "Cancer enriched" "Detected in many" 224 "pancreatic cancer: 1920.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "OE19: 10.6;RPMI-8226: 4.5;U-2 OS: 2.8" "CAB025487, CAB025538, HPA062452, HPA063471" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" NA NA 100000000000 "Cluster 35: T-regs - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" Vesicles "Endoplasmic reticulum" "CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017" "unprognostic (6.55e-5)" "unprognostic (5.28e-1)" "unprognostic (7.58e-2)" "prognostic unfavorable (6.41e-6)" "unprognostic (8.26e-2)" "prognostic favorable (7.05e-4)" "unprognostic (1.35e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-1)" "prognostic favorable (4.91e-4)" "unprognostic (3.12e-1)" 45.2 9.9 0.0 4.7 0.0 0.0 25.7 0.0 0.0 19.9 0.0 11.2 54.5 8.9 0.8 15.2 5.6 0.0 51.0 0.0 0.0 9.6 29.7 6.4 6.5 0.0 0.0 177.5 341429.7 0.1 10.3 13.9 0.0 15.2 0.0 0.0 44.2 4.2 8.9 12.1 12.7 0.0 0.0 13.4 77.1 6.9 0.0 0.0 6.4 0.0 0.0 4.7 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 100.7 0.0 0.1 0.0 3.6 0.0 0.0 0.0 57138.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 119.4 0.6 0.0 0.0 0.0 1985.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.2 0.2 PRSS2 TRY2 ENSG00000275896 "Serine protease 2" P07478 7 142760398-142774564 "Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 452 "pancreas: 239420.0" "Cell type enriched" "Detected in some" 11 "Exocrine glandular cells: 108258.7" "Cancer enriched" "Detected in many" 72 "pancreatic cancer: 3463.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basophil: 4.1;T-reg: 2.9" "Group enriched" "Detected in many" 8 "granulocytes: 4.1;T-cells: 2.9" "Cell line enhanced" "Detected in some" "OE19: 21.0;RPMI-8226: 67.5;U-2 OS: 15.2" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" NA NA 890000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 25: Pancreas - Digestion" "Cluster 25: RPMI-8226 - Immune response" "Cluster 1: Pancreatic cells - Digestion" Vesicles "Endoplasmic reticulum" "HPA062452: AB_2684768, HPA063471: AB_2685017" "prognostic favorable (2.32e-4)" "unprognostic (3.80e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-3)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-3)" "unprognostic (1.48e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (3.50e-1)" "unprognostic (5.36e-3)" "unprognostic (1.18e-1)" 65.1 12.5 0.1 0.2 0.1 3.2 25.4 0.0 0.1 27.6 0.0 12.6 358.5 11.4 0.0 18.2 9.6 0.1 25.0 0.0 0.0 9.4 32.2 8.2 1.3 0.0 0.0 64.9 239420.0 0.0 13.4 8.1 0.0 17.2 0.0 0.0 25.4 0.9 10.1 11.3 529.2 0.1 0.0 16.9 54.7 8.6 0.0 0.9 8.3 0.0 0.0 7.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.4 4.4 0.5 0.0 0.0 0.0 1.9 0.0 21.0 0.0 0.0 0.0 67.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.9 3.8 0.0 2.9 0.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.9 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 378.7 0.0 0.4 0.1 11.4 0.0 0.0 0.0 108258.7 0.0 0.3 4.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 348.9 0.0 0.0 0.0 0.0 9565.7 8.9 0.0 0.1 0.0 60.0 0.1 0.0 0.0 0.0 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 85.4 0.2 PTF1A "bHLHa29, p48, PTF1-p48" ENSG00000168267 "Pancreas associated transcription factor 1a" Q7RTS3 10 23192312-23194245 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "pancreas: 104.2" "Group enriched" "Detected in some" 4 "Early spermatids: 2.1;Exocrine glandular cells: 4.8;Spermatocytes: 3.8" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.6;pancreatic cancer: 1.2" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" CAB022612 Approved Nucleoplasm NA NA "Cluster 25: Pancreas - Digestion" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "CAB022612: " "unprognostic (2.02e-1)" "unprognostic (1.85e-1)" "unprognostic (4.49e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.6 1.4 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.6 0.4 0.0 0.0 0.0 0.0 0.8 0.6 0.1 104.2 0.0 0.2 0.0 0.8 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.5 0.0 1.9 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.6 1.4 0.6 0.4 0.8 0.6 0.8 0.5 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.0 0.4 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PVR "CD155, HVED, Necl-5, NECL5, PVS, Tage4" ENSG00000073008 "PVR cell adhesion molecule" P15151 19 44643798-44666162 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 4.5;intermediate monocyte: 4.5;myeloid DC: 3.8;non-classical monocyte: 5.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.8;monocytes: 5.5" "Cell line enhanced" "Detected in many" "TIME: 175.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012568, HPA064739" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Secreted - unknown location" NA NA 720000000 "Cluster 7: Monocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Vesicles, Plasma membrane" "HPA012568: AB_1846248, HPA064739: " "unprognostic (2.90e-3)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.36e-1)" "unprognostic (2.34e-1)" "unprognostic (7.89e-2)" "unprognostic (2.45e-3)" "unprognostic (3.06e-2)" "prognostic unfavorable (9.30e-4)" "unprognostic (9.05e-3)" "unprognostic (1.69e-1)" "unprognostic (2.09e-3)" "unprognostic (2.64e-3)" "unprognostic (1.69e-1)" "unprognostic (4.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-3)" "prognostic unfavorable (2.75e-4)" 13.9 17.5 10.2 7.1 9.1 5.1 9.6 9.0 10.0 8.7 9.3 10.3 12.5 13.9 5.2 8.4 11.8 6.2 28.5 9.0 16.6 13.6 30.7 19.4 2.7 9.7 11.0 12.5 14.0 10.3 17.3 12.5 12.4 9.7 8.8 5.4 9.9 6.4 19.0 7.1 11.1 10.5 7.4 4.6 12.3 5.8 14.9 2.5 10.6 6.2 2.8 9.1 8.5 7.9 58.8 52.1 5.6 25.0 8.6 9.7 7.4 96.7 38.8 40.7 45.8 31.9 28.2 0.1 50.6 43.7 60.2 44.4 24.3 51.1 31.7 7.8 27.1 8.8 40.3 23.3 43.7 4.1 22.2 10.6 28.0 40.9 82.5 49.7 50.7 6.6 4.3 0.5 23.4 7.8 4.2 5.8 12.5 30.1 31.7 0.1 23.2 5.0 111.8 25.5 21.2 22.9 66.3 54.3 14.7 7.2 22.8 12.5 175.3 39.0 52.8 33.7 78.2 0.3 6.3 0.2 35.3 23.4 24.6 0.2 4.5 0.0 0.1 4.5 0.0 0.0 0.0 0.2 3.8 0.0 0.2 0.1 1.1 0.7 5.5 0.5 0.0 1.7 10.2 9.1 9.0 10.0 9.0 16.6 9.7 11.0 12.4 7.4 14.9 7.9 11.1 16.0 25.2 2.3 1.6 3.6 16.0 6.9 4.0 5.7 4.7 3.4 14.4 14.3 12.2 1.8 2.1 2.9 0.2 18.5 3.9 37.9 10.5 5.4 6.3 20.4 13.1 2.1 11.4 35.3 34.8 7.7 13.7 11.6 1.3 6.5 7.9 41.1 8.4 1.7 13.7 11.3 2.0 8.9 7.5 14.3 5.6 6.8 1.8 5.6 17.2 1.8 2.1 6.0 4.6 69.6 18.0 15.8 0.2 14.4 10.8 5.7 2.8 3.4 0.0 23.8 10.4 10.4 1.5 5.8 5.5 1.0 0.9 10.8 12.7 7.4 RDX DFNB24 ENSG00000137710 Radixin P35241 11 109864295-110296712 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 155.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 484.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000263, HPA000763, CAB037312" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 38000000 "Cluster 2: Granulocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane" Nucleoplasm "CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (3.85e-1)" "unprognostic (2.74e-2)" "unprognostic (6.93e-2)" "unprognostic (9.82e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.91e-2)" "unprognostic (6.91e-2)" "unprognostic (1.32e-3)" "unprognostic (6.47e-2)" "unprognostic (4.14e-3)" "unprognostic (5.43e-2)" "unprognostic (4.40e-1)" "unprognostic (1.24e-1)" "unprognostic (1.08e-3)" 40.3 155.0 38.0 17.4 57.7 12.0 16.4 50.0 42.7 32.1 32.8 15.2 6.8 28.8 12.9 27.4 19.7 27.2 41.0 35.1 44.7 50.2 68.5 48.8 11.4 52.7 48.2 52.8 52.7 33.2 7.6 35.3 54.3 25.4 11.1 19.2 20.8 26.0 82.1 11.9 7.4 35.0 45.1 26.6 15.0 33.7 47.7 14.3 45.7 59.7 14.6 27.1 10.1 77.6 69.6 35.3 137.3 54.8 78.8 87.4 79.3 85.8 47.6 54.3 59.2 99.7 115.4 0.1 127.4 104.7 84.9 61.5 77.3 80.4 80.5 41.9 44.2 51.5 107.7 74.1 73.6 19.0 33.2 89.7 45.6 68.0 120.1 89.3 149.8 11.1 73.5 29.5 127.0 120.0 11.0 15.6 44.0 4.0 58.4 31.2 96.8 30.1 68.1 33.5 37.2 40.5 148.5 65.9 52.7 102.5 85.0 29.9 92.6 89.5 66.8 43.9 67.4 9.5 17.3 65.9 34.2 11.3 210.9 29.5 14.8 22.0 11.6 12.5 15.5 11.5 10.2 8.8 12.8 8.3 6.8 5.8 2.0 17.6 9.9 10.3 22.0 8.4 38.0 57.7 50.0 42.7 35.1 44.7 52.7 48.2 54.3 45.1 47.7 77.6 248.8 484.0 98.8 53.5 30.0 56.1 51.8 124.6 56.9 85.9 47.4 45.7 159.3 70.1 77.9 75.4 43.8 122.1 21.6 17.7 109.5 128.1 15.5 109.1 117.2 289.2 22.2 104.8 27.1 423.4 189.8 88.4 19.9 135.3 67.2 132.0 319.2 260.1 85.1 101.0 57.6 7.3 61.1 103.2 59.9 43.6 275.2 71.6 72.9 42.2 135.4 77.0 36.0 68.3 229.4 134.3 22.1 266.7 36.1 65.9 0.1 236.9 52.2 94.8 124.9 74.0 143.8 73.9 257.4 52.8 40.5 227.3 29.2 229.9 11.8 45.9 REG1A "PSP, PSPS, PSPS1, PTP, REG" ENSG00000115386 "Regenerating family member 1 alpha" P05451 2 79120362-79123409 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "pancreas: 103906.5" "Cell type enriched" "Detected in some" 5 "Exocrine glandular cells: 115721.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 1268.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 12.3;EFO-21: 18.3;HDLM-2: 15.2;NB-4: 11.0;OE19: 10.7;RPMI-8226: 32.5;SH-SY5Y: 12.5;U-2 OS: 31.1;U-251 MG: 10.8;U-266/84: 13.3" "CAB025138, HPA045549, HPA045579" Enhanced "Secreted to digestive system" NA NA 68000000 "Cluster 25: Pancreas - Digestion" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "CAB025138: , HPA045549: AB_2679365, HPA045579: AB_2679374" "unprognostic (1.89e-1)" "unprognostic (2.91e-2)" "unprognostic (3.39e-1)" "unprognostic (1.45e-1)" "unprognostic (2.10e-1)" "unprognostic (1.63e-1)" "unprognostic (5.52e-2)" "unprognostic (3.54e-3)" "unprognostic (5.53e-2)" "unprognostic (5.54e-2)" 26.8 5.8 0.0 198.7 0.0 20.7 9.9 0.0 0.0 10.9 0.0 96.5 7597.3 5.3 0.0 9.3 6.4 96.6 10.2 0.0 0.0 93.0 15.9 4.5 7.5 0.0 0.0 25.6 103906.5 0.0 8.5 3.4 0.0 6.1 283.0 0.0 9.4 0.1 4.3 28.1 5638.4 178.1 0.0 8.5 945.9 3.9 0.0 0.0 4.0 0.0 0.4 3.2 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.5 10.7 0.0 0.0 0.0 32.5 0.0 0.0 1.4 12.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 31.1 2.0 10.8 0.0 13.3 5.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.0 25.5 1.9 1549.8 0.1 0.1 0.0 12.7 5.3 0.0 0.0 115721.8 0.0 0.9 692.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1813.1 0.0 0.0 0.0 0.1 0.0 17.0 0.0 0.0 507.5 0.0 0.0 0.0 0.0 22774.8 732.4 0.0 0.2 0.0 5100.1 20.8 0.0 0.0 0.0 0.0 51.7 0.0 0.4 0.0 0.0 0.0 0.6 0.0 5419.7 0.0 REG1B "PSPS2, REGH, REGI-BETA, REGL" ENSG00000172023 "Regenerating family member 1 beta" P48304 2 79085023-79088019 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "pancreas: 39745.3" "Cell type enriched" "Detected in some" 4 "Exocrine glandular cells: 36125.0" "Cancer enriched" "Detected in some" 5 "pancreatic cancer: 201.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.3;HDLM-2: 4.1;RPMI-8226: 3.0;U-2 OS: 15.7;U-251 MG: 3.9;U-266/84: 3.8" "HPA045549, HPA045579" Supported "Secreted to digestive system" NA NA 32000000 "Cluster 25: Pancreas - Digestion" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "HPA045549: AB_2679365, HPA045579: AB_2679374" "unprognostic (4.08e-1)" "unprognostic (1.09e-1)" "unprognostic (3.51e-3)" "unprognostic (9.20e-2)" 14.6 2.1 0.0 35.8 0.0 9.8 3.3 0.0 0.1 3.9 0.0 17.3 738.0 2.0 0.0 3.5 2.1 0.4 3.3 0.0 0.0 2.6 5.5 1.7 1.7 0.0 0.0 2.1 39745.3 0.0 3.1 0.1 0.0 2.0 108.1 0.0 3.1 0.0 1.6 16.1 2754.3 112.1 0.0 3.2 5.0 1.5 0.0 0.0 1.7 0.0 0.0 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.1 3.9 0.0 3.8 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 86.7 0.0 0.0 0.0 3.3 1.8 0.0 0.0 36125.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.6 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 178.3 0.0 0.0 0.0 0.0 7978.5 174.7 0.0 0.0 0.0 3101.3 0.1 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 178.8 0.0 REG3A "HIP, PAP, PAP1, PBCGF, REG-III, REG3" ENSG00000172016 "Regenerating family member 3 alpha" Q06141 2 79157003-79159753 "Plasma proteins, Predicted secreted proteins, Transporters" "Acute phase, Inflammatory response" Antimicrobial "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 61 "intestine: 6743.6;pancreas: 12212.2" "Group enriched" "Detected in some" 11 "Exocrine glandular cells: 1988.6;Pancreatic endocrine cells: 5382.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 710.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 17.6;EFO-21: 15.8;HDLM-2: 15.4;NB-4: 17.7;RPMI-8226: 24.6;SH-SY5Y: 14.6;U-2 OS: 28.5;U-251 MG: 11.0;U-266/84: 15.1" "HPA047894, HPA048334, HPA060705" Supported Approved Cytosol "Secreted to digestive system" NA NA 23000000 "Cluster 25: Pancreas - Digestion" "Cluster 24: NB-4 - Immune response" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346" "unprognostic (2.43e-2)" "unprognostic (2.12e-1)" "unprognostic (3.62e-2)" "unprognostic (1.42e-1)" 18.5 10.0 0.0 13.3 0.0 0.2 0.6 0.0 0.0 0.3 0.0 19.2 5180.0 2.9 0.0 1.4 0.2 24.9 1.0 0.0 0.0 2.6 2.0 0.5 4.9 0.0 0.0 0.9 12212.2 0.0 2.1 0.1 0.0 0.5 0.0 0.0 2.1 0.0 0.6 0.4 6743.6 0.2 0.0 1.3 156.5 0.9 0.0 0.0 0.6 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.1 0.4 0.0 0.0 0.0 24.6 0.0 0.0 1.8 14.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.5 5.4 11.0 0.0 15.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 152.8 7.7 0.0 0.0 3.0 0.0 0.0 0.0 1988.6 0.0 0.0 189.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 130.2 0.0 0.0 0.0 6.8 0.0 1.4 0.0 0.0 55.8 0.0 0.0 0.0 0.0 5382.1 32.5 0.0 0.2 0.0 215.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 315.9 0.0 REG3G "LPPM429, PAP1B, UNQ429" ENSG00000143954 "Regenerating family member 3 gamma" Q6UW15 2 79025686-79028505 "Predicted secreted proteins" "Acute phase, Inflammatory response" Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "pancreas: 3517.1" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 184.9;Pancreatic endocrine cells: 53.5;Proximal enterocytes: 39.4" "Cancer enriched" "Detected in many" 13 "pancreatic cancer: 71.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047894, HPA048334, HPA060705" Uncertain Approved Cytosol "Secreted to digestive system" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346" "unprognostic (3.29e-1)" "unprognostic (2.20e-1)" "unprognostic (1.29e-1)" "unprognostic (8.82e-2)" "unprognostic (7.20e-3)" "unprognostic (5.64e-2)" 1.0 46.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.3 2.4 0.1 165.7 0.3 0.3 0.0 0.2 0.0 0.0 6.0 0.4 0.1 0.0 0.0 0.0 0.2 3517.1 0.0 0.3 1.1 0.0 0.1 0.0 0.0 0.3 1.3 0.2 0.1 37.0 1.5 0.0 0.2 0.4 57.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.0 0.0 0.1 0.0 0.0 0.0 184.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 6.2 0.6 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 53.5 0.0 0.7 0.0 0.4 39.4 2.2 0.0 0.0 0.0 0.0 0.2 1.3 1.2 0.0 0.0 0.0 0.0 0.9 5.4 0.0 RND1 "ARHS, Rho6, RHOS" ENSG00000172602 "Rho family GTPase 1" Q92730 12 48857145-48865870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 131.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 205.5;Ductal cells: 220.6;Exocrine glandular cells: 147.1;Pancreatic endocrine cells: 350.9" "Cancer enhanced" "Detected in many" "liver cancer: 16.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "SK-BR-3: 67.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077800 Supported "Vesicles,Plasma membrane,Actin filaments" NA NA "Cluster 30: Non-specific - Translation" "Cluster 15: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Vesicles, Plasma membrane, Actin filaments" "HPA077800: AB_2686854" "unprognostic (5.60e-2)" "unprognostic (3.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.16e-1)" "unprognostic (6.90e-2)" "unprognostic (1.32e-3)" "unprognostic (3.59e-2)" "unprognostic (7.43e-2)" "unprognostic (2.21e-3)" "unprognostic (2.97e-1)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (8.38e-3)" "unprognostic (6.18e-2)" "unprognostic (6.60e-2)" "unprognostic (3.35e-3)" 9.6 0.8 24.4 2.6 26.9 1.8 5.6 18.9 40.6 1.6 15.4 4.8 2.4 3.9 1.0 3.1 2.7 14.5 7.3 26.8 20.4 4.4 131.8 37.9 1.0 21.4 23.6 1.2 2.8 2.4 8.0 1.2 21.9 6.5 1.9 1.7 3.9 0.8 1.0 1.6 2.6 2.4 19.9 0.8 23.4 0.9 22.1 2.4 15.4 0.6 2.3 14.0 2.7 23.2 1.1 7.9 3.8 2.0 0.8 0.0 0.6 0.0 0.4 1.2 1.3 4.9 1.7 6.0 1.4 0.0 0.4 0.1 3.1 0.3 0.7 1.8 1.9 0.8 0.0 3.0 0.4 1.8 1.1 0.0 0.2 0.6 0.8 0.0 2.0 3.9 0.2 6.0 0.0 10.2 0.9 0.5 8.9 13.6 0.5 1.9 0.4 2.6 1.1 1.5 0.0 1.0 0.2 67.7 0.3 9.1 6.9 0.4 0.2 0.0 0.7 0.0 0.9 2.9 5.4 10.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 24.4 26.9 18.9 40.6 26.8 20.4 21.4 23.6 21.9 19.9 22.1 23.2 28.9 28.9 205.5 5.9 8.5 11.5 8.4 14.1 9.1 2.5 37.5 25.4 3.8 18.6 27.5 1.8 8.4 1.1 9.0 21.7 0.0 220.6 0.4 4.5 2.0 87.3 31.5 2.7 10.6 147.1 0.7 10.5 55.5 12.6 15.2 0.8 6.1 10.9 1.2 0.0 2.7 11.4 18.3 0.8 24.1 0.0 0.0 6.6 14.2 1.0 6.4 3.0 0.0 7.1 1.0 350.9 42.2 0.4 6.5 19.5 11.1 1.7 7.7 3.6 0.0 5.8 16.7 0.8 1.6 4.3 10.5 1.5 9.9 0.6 5.4 8.6 SCTR ENSG00000080293 "Secretin receptor" P47872 2 119439843-119525301 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 26.6;pancreas: 68.2" "Group enriched" "Detected in some" 6 "Alveolar cells type 2: 54.4;Ductal cells: 92.0;Exocrine glandular cells: 93.8;Pancreatic endocrine cells: 41.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 15.3" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 5 "basophil: 1.5" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.5" "Cell line enriched" "Detected in single" 5 "Karpas-707: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA007269 Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 2: Karpas-707 - Immune response" "Cluster 1: Pancreatic cells - Digestion" "HPA007269: AB_1856640" "unprognostic (1.51e-1)" "unprognostic (2.22e-1)" "unprognostic (4.99e-2)" "unprognostic (5.82e-2)" "unprognostic (1.71e-1)" "unprognostic (4.12e-2)" "unprognostic (1.68e-1)" "unprognostic (1.09e-1)" "unprognostic (1.68e-2)" "unprognostic (9.08e-2)" "unprognostic (7.35e-2)" "unprognostic (2.38e-2)" "unprognostic (6.11e-3)" "unprognostic (1.65e-3)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (4.38e-2)" 0.3 0.4 0.3 0.2 0.3 0.3 0.0 0.6 1.2 0.0 0.3 0.1 26.6 0.2 0.2 0.3 0.4 0.4 0.3 0.4 0.4 12.5 0.4 8.6 0.1 0.3 0.2 0.4 68.2 0.1 0.2 0.1 0.4 0.0 0.0 2.4 0.0 0.0 0.2 0.2 3.8 0.0 0.2 0.3 4.5 0.5 0.6 0.1 0.9 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.6 1.2 0.4 0.4 0.3 0.2 0.4 0.2 0.6 0.4 0.0 0.0 54.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 3.4 0.0 1.8 5.5 0.0 0.0 0.0 0.1 11.7 92.0 4.5 0.0 0.2 0.1 2.4 0.0 3.0 93.8 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.7 5.0 4.1 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.0 1.0 1.6 0.3 0.0 0.0 0.7 41.9 0.0 0.0 0.0 0.1 0.1 0.5 0.0 1.9 0.0 0.0 0.6 0.3 0.9 0.0 0.0 0.3 0.4 0.0 0.1 0.0 SDC4 "amphiglycan, ryudocan, SYND4" ENSG00000124145 "Syndecan 4" P31431 20 45325288-45348424 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 410.9" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 515.9;Pancreatic endocrine cells: 476.4;Suprabasal keratinocytes: 472.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 512.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005716, CAB013240" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 320000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 15: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" "Plasma membrane" "CAB013240: AB_2533250, HPA005716: AB_1080160" "unprognostic (1.34e-2)" "unprognostic (1.80e-1)" "unprognostic (1.71e-2)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (5.93e-2)" "unprognostic (2.68e-1)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.97e-1)" "prognostic favorable (2.44e-7)" "unprognostic (3.00e-1)" "unprognostic (2.18e-1)" "prognostic favorable (2.67e-4)" "unprognostic (7.42e-2)" 68.0 73.1 90.3 26.3 116.8 10.1 113.1 90.2 120.7 53.0 68.5 102.6 37.8 53.0 11.8 124.3 76.6 72.2 65.9 66.4 90.2 166.9 410.9 168.3 9.8 120.5 127.8 26.3 90.3 34.7 43.2 27.3 95.4 53.0 62.6 35.1 103.7 45.9 101.5 190.4 42.4 53.8 89.9 32.3 140.1 47.1 151.9 8.2 51.1 35.4 35.2 124.7 68.7 71.4 162.1 20.7 11.1 0.8 269.2 164.3 474.4 201.5 273.0 222.9 158.6 242.7 400.0 0.2 88.1 255.4 224.5 203.1 8.2 512.2 269.0 46.7 7.4 4.9 15.8 95.8 292.4 1.0 8.2 223.1 336.5 92.4 223.2 123.3 29.9 3.7 8.2 0.5 130.5 159.9 0.2 14.2 20.4 139.9 63.1 0.3 99.7 0.6 367.7 211.7 4.3 15.6 277.2 169.4 51.4 125.2 123.1 9.7 56.4 169.4 141.4 17.3 131.8 8.5 6.7 0.7 266.2 16.4 103.2 1.5 1.6 0.4 0.7 0.6 2.1 0.3 2.0 0.8 1.5 0.3 0.4 0.5 0.8 0.7 0.6 1.4 4.4 0.7 90.3 116.8 90.2 120.7 66.4 90.2 120.5 127.8 95.4 89.9 151.9 71.4 21.9 291.7 391.2 106.7 3.8 373.7 322.2 352.8 75.1 14.5 208.8 90.6 59.3 245.9 218.4 189.4 12.5 38.9 7.8 174.3 64.6 296.0 1.2 116.6 20.8 16.0 55.1 7.4 0.2 515.9 230.0 43.0 170.7 179.0 13.9 10.8 11.4 260.6 18.8 0.0 0.3 131.9 160.7 19.3 106.0 3.8 4.1 39.5 76.5 5.6 33.0 10.0 0.0 3.5 1.8 476.4 121.7 5.3 2.1 284.2 59.0 153.8 178.6 23.6 0.0 34.9 33.5 1.8 2.5 170.9 472.8 67.5 16.8 3.2 90.7 423.9 SDR42E1 HSPC105 ENSG00000184860 "Short chain dehydrogenase/reductase family 42E, member 1" Q8WUS8 16 81988855-82011481 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 9.2" "Cell type enhanced" "Detected in many" "Ductal cells: 10.0;Ionocytes: 10.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.3;NK-cells: 2.0;T-cells: 2.2" "Cell line enhanced" "Detected in some" "HaCaT: 9.5;hTCEpi: 12.1;MCF7: 8.3;RT4: 20.6;SCLC-21H: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014388 Uncertain NA NA "Cluster 37: B-cells - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 15: RT4 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "HPA014388: AB_1851226" "unprognostic (2.09e-1)" "unprognostic (4.90e-1)" "unprognostic (9.52e-3)" "unprognostic (3.81e-1)" "unprognostic (3.46e-1)" "unprognostic (1.14e-2)" "unprognostic (1.38e-1)" "unprognostic (2.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.51e-2)" "unprognostic (3.96e-2)" "unprognostic (4.93e-4)" "unprognostic (4.90e-7)" "unprognostic (2.18e-1)" "unprognostic (1.82e-1)" "unprognostic (3.21e-2)" "unprognostic (8.27e-2)" 0.5 0.1 0.0 0.9 0.1 0.4 4.4 0.0 0.1 1.2 0.1 2.4 5.6 1.3 1.9 3.6 1.7 1.1 0.6 0.0 0.2 1.9 1.8 1.6 1.3 0.1 0.1 0.3 3.2 2.1 1.3 0.3 0.1 1.7 1.7 0.0 3.1 0.9 0.0 9.2 4.7 1.1 0.0 0.8 2.6 1.1 0.2 1.6 1.9 0.0 2.4 2.3 2.4 0.0 3.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.9 0.0 1.8 0.0 0.4 9.5 0.0 6.5 0.0 0.0 0.6 0.0 1.7 0.0 0.3 0.0 0.0 0.3 12.1 1.5 5.9 0.0 0.0 0.0 1.6 0.0 0.8 8.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 2.5 20.6 8.2 0.0 0.2 4.3 0.0 0.2 0.1 0.0 0.2 0.0 4.3 0.0 0.0 4.0 5.9 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 1.1 2.3 0.7 1.2 0.1 1.0 2.2 1.6 0.0 2.0 0.0 0.1 1.5 0.9 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.2 0.0 1.0 0.0 1.1 0.0 2.7 5.9 3.5 6.1 6.2 0.0 5.8 3.9 2.6 7.2 3.3 1.8 0.0 0.6 1.1 2.7 3.9 10.0 1.3 2.8 0.7 0.5 2.4 0.4 0.0 7.5 0.2 0.4 1.1 3.2 0.0 0.4 0.0 3.7 0.0 0.0 0.0 6.0 10.2 0.0 0.3 2.0 0.0 0.2 1.8 0.0 0.0 0.0 1.0 0.0 0.1 6.3 4.5 0.0 1.1 3.8 9.7 2.9 3.6 0.0 0.0 0.0 0.5 8.4 6.2 5.6 9.1 0.3 1.2 0.1 4.1 4.4 SERPINI2 "MEPI, PANCPIN, PI14, TSA2004" ENSG00000114204 "Serpin family I member 2" O75830 3 167441789-167479004 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 133 "pancreas: 1370.0" "Cell type enhanced" "Detected in some" "Astrocytes: 37.5;Exocrine glandular cells: 93.4;Respiratory ciliated cells: 22.9" "Cancer enriched" "Detected in some" 6 "pancreatic cancer: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "THP-1: 9.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 8.7" "Secreted to digestive system" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 25: Pancreas - Digestion" "Cluster 43: THP-1 - Innate immune response" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (1.88e-2)" "unprognostic (2.23e-3)" "unprognostic (1.14e-1)" "unprognostic (5.27e-2)" "unprognostic (1.17e-2)" "unprognostic (1.29e-2)" "unprognostic (1.11e-2)" "unprognostic (2.04e-1)" "unprognostic (3.13e-1)" "unprognostic (1.76e-5)" "unprognostic (5.35e-2)" "unprognostic (4.16e-2)" 0.1 0.1 3.7 0.0 2.9 0.4 0.1 4.4 1.5 0.2 10.2 0.1 1.0 0.2 0.2 0.2 3.9 0.0 0.5 2.5 3.7 0.2 0.0 1.0 0.1 9.6 7.7 0.5 1370.0 0.0 0.4 0.0 7.1 0.2 0.0 0.0 0.4 0.0 0.0 0.1 1.9 0.1 9.4 0.2 0.3 0.1 4.3 0.0 0.0 0.2 0.1 0.1 0.1 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.7 2.9 4.4 1.5 2.5 3.7 9.6 7.7 7.1 9.4 4.3 5.8 0.0 0.0 1.1 37.5 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 5.9 0.1 0.1 0.0 0.0 3.6 93.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 1.2 0.0 0.0 2.0 0.9 4.8 0.0 0.0 0.0 0.0 0.7 0.0 22.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 SFRP5 SARP3 ENSG00000120057 "Secreted frizzled related protein 5" Q5T4F7 10 97766751-97771999 "Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "choroid plexus: 98.7;heart muscle: 78.7;intestine: 36.4;pancreas: 143.2" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 273.1" "Cancer enriched" "Detected in many" 4 "pancreatic cancer: 30.4" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 4 "naive CD8 T-cell: 3.6" "Lineage enriched" "Detected in single" 4 "T-cells: 3.6" "Cell line enhanced" "Detected in some" "A549: 2.5;CACO-2: 12.4;RPMI-8226: 4.5;SCLC-21H: 2.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 8 "spinal cord: 120.7" "Secreted in other tissues" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 39: CACO-2 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (2.63e-4)" "unprognostic (3.03e-3)" "unprognostic (6.74e-2)" "unprognostic (3.43e-2)" "unprognostic (9.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" "unprognostic (3.19e-1)" "unprognostic (2.85e-1)" "unprognostic (8.83e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (4.51e-9)" "unprognostic (1.67e-2)" "unprognostic (1.57e-1)" "unprognostic (9.17e-2)" "unprognostic (1.62e-1)" 2.9 9.6 2.8 0.3 3.9 0.3 2.4 1.6 0.6 3.5 98.7 36.4 29.8 1.8 2.2 2.0 2.2 4.1 78.7 5.6 7.5 0.4 8.8 3.4 0.3 3.6 8.3 0.6 143.2 0.0 0.9 0.0 3.6 6.8 0.5 0.2 2.8 4.0 1.3 3.1 26.3 0.4 1.6 0.1 10.5 0.8 14.7 0.1 1.0 2.9 0.1 3.2 4.9 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 4.5 0.0 0.0 2.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.8 0.0 0.2 2.8 3.9 1.6 0.6 5.6 7.5 3.6 8.3 3.6 1.6 14.7 0.2 0.0 3.2 3.6 0.3 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 7.8 273.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.1 0.6 0.0 0.0 0.2 16.8 0.0 3.2 0.0 0.0 0.0 0.0 2.2 0.7 0.0 0.0 0.3 1.3 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.2 3.3 2.5 0.0 0.0 0.0 37.8 0.0 0.0 0.2 0.0 1.2 0.4 0.1 5.9 0.0 0.0 0.0 0.1 0.0 0.5 0.0 SPHK1 SPHK ENSG00000176170 "Sphingosine kinase 1" Q9NYA1 17 76376584-76387860 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 105.4;Muller glia cells: 165.1;Pancreatic endocrine cells: 101.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 127.6;TIME: 108.9;U-251 MG: 142.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "olfactory bulb: 5.7" "HPA022829, HPA028761" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane, Cytosol" "HPA022829: AB_1857438, HPA028761: AB_10600814" "unprognostic (1.04e-1)" "unprognostic (6.30e-2)" "unprognostic (1.09e-2)" "unprognostic (8.66e-2)" "unprognostic (2.25e-2)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (9.32e-3)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (8.99e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.14e-6)" "unprognostic (1.39e-1)" "unprognostic (4.82e-2)" "unprognostic (8.29e-2)" "unprognostic (1.10e-3)" 18.9 4.1 4.0 10.5 3.0 17.3 18.0 2.1 3.9 11.0 2.3 7.0 1.9 6.7 3.9 23.8 9.4 11.9 17.5 2.9 3.9 21.4 3.8 24.3 8.1 4.0 4.1 4.3 14.4 4.8 4.9 2.5 4.5 7.3 1.1 8.4 19.9 1.5 3.2 15.6 7.0 3.2 2.3 5.0 6.7 5.8 8.5 3.5 10.6 0.8 4.1 11.3 13.1 3.9 36.9 3.7 15.2 0.8 7.6 7.0 15.8 82.6 54.0 67.8 40.8 19.4 3.9 1.8 7.4 61.0 28.9 7.7 11.7 105.4 16.4 1.6 6.2 0.5 28.3 127.6 16.6 1.3 2.9 13.6 2.1 105.9 41.3 28.8 66.0 3.7 17.3 0.2 13.5 46.6 3.5 0.6 0.9 8.2 29.7 2.5 4.1 2.8 3.7 0.5 2.0 3.6 8.3 0.9 74.4 9.1 3.0 5.1 108.9 105.8 20.8 82.3 142.1 1.7 0.4 1.6 80.5 6.5 16.1 1.5 1.9 0.0 0.7 0.9 0.2 0.0 0.1 0.2 0.5 0.1 0.0 0.1 0.2 0.0 0.2 4.8 0.0 0.8 4.0 3.0 2.1 3.9 2.9 3.9 4.0 4.1 4.5 2.3 8.5 3.9 22.0 0.0 0.0 1.0 2.8 12.6 57.0 18.6 2.8 1.5 31.1 29.1 5.3 47.1 6.6 1.8 0.0 1.2 9.1 1.0 0.0 105.4 0.2 15.3 13.5 51.2 0.0 22.3 0.5 12.7 16.9 27.5 3.1 60.7 7.0 0.4 4.2 0.2 30.1 33.7 1.6 2.4 6.1 8.9 45.4 1.4 3.7 39.9 12.4 1.0 61.5 165.1 3.1 0.0 0.1 101.8 1.2 19.9 3.5 68.9 0.8 2.5 2.0 3.9 0.0 17.3 54.3 0.0 9.5 6.7 10.7 1.4 4.2 0.8 0.4 27.0 SPINK1 "PCTT, PSTI, Spink3, TATI" ENSG00000164266 "Serine peptidase inhibitor Kazal type 1" P00995 5 147824572-147831671 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 36 "pancreas: 53063.4" "Group enriched" "Detected in many" 9 "Exocrine glandular cells: 50621.7;Pancreatic endocrine cells: 16750.7" "Cancer enhanced" "Detected in many" "pancreatic cancer: 513.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "CACO-2: 417.2;RT4: 1139.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026366, HPA027498" Enhanced "Secreted to digestive system" NA NA 8000000 "Cluster 25: Pancreas - Digestion" "Cluster 15: RT4 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "CAB026366: , HPA027498: AB_10603115" "unprognostic (1.05e-1)" "unprognostic (1.00e-1)" "unprognostic (9.96e-3)" "unprognostic (3.55e-1)" "unprognostic (6.12e-3)" "unprognostic (1.79e-4)" "unprognostic (8.34e-3)" "unprognostic (2.43e-1)" "unprognostic (2.66e-1)" "unprognostic (1.88e-1)" "unprognostic (3.82e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (5.44e-7)" "unprognostic (7.98e-2)" "unprognostic (2.07e-1)" "prognostic favorable (2.15e-5)" 8.8 1.5 0.1 36.4 0.1 6.8 4.1 0.3 1.2 3.1 0.3 428.2 394.4 5.5 0.8 2.9 1.3 111.9 12.0 0.2 0.2 142.5 491.8 2.7 2.7 0.1 0.1 25.6 53063.4 0.0 1.9 3.2 0.2 4.4 441.3 0.6 12.8 1.4 1.2 21.1 403.9 14.1 0.0 2.5 1475.2 0.9 0.3 0.4 1.0 0.0 0.3 995.6 10.8 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 417.2 0.3 0.1 6.8 0.0 0.8 0.9 2.2 0.0 0.0 3.9 0.0 0.0 0.0 107.0 0.3 0.0 3.9 0.0 2.1 0.0 3.0 5.8 0.0 0.0 0.0 0.3 0.0 0.3 0.8 1.3 2.1 138.9 0.8 0.8 0.0 2.5 0.0 1139.0 0.5 1.7 0.0 0.2 0.1 5.4 0.1 0.0 0.0 0.1 13.7 1.1 3.8 2.2 5.9 3.0 16.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 1.2 0.2 0.2 0.1 0.1 0.2 0.0 0.3 0.6 0.0 0.0 3.6 0.0 9.7 0.0 15.1 0.3 0.0 0.0 5.5 0.8 0.1 1451.2 11.1 377.0 0.0 0.0 0.0 280.8 86.1 1286.7 0.1 0.3 0.4 9.4 517.2 18.7 1.0 50621.7 0.1 1.9 1580.5 5.0 4.5 2.0 39.3 3385.8 0.1 0.0 0.2 2087.4 0.0 30.9 0.0 0.2 0.0 13.7 0.0 0.0 269.8 0.0 0.0 0.0 0.1 16750.7 563.8 0.0 1.3 173.5 1457.1 1.6 0.7 0.0 0.0 0.0 43.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1365.3 649.1 SPR SDR38C1 ENSG00000116096 "Sepiapterin reductase" P35270 2 72887382-72892158 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 85.3;Exocrine glandular cells: 81.1;Proximal tubular cells: 91.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 8.3;intermediate monocyte: 2.4;myeloid DC: 8.9" "Group enriched" "Detected in many" 11 "dendritic cells: 8.9;monocytes: 8.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039505 Uncertain Supported Nucleoplasm,Cytosol NA NA 180000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "HPA039505: AB_10795466" "unprognostic (4.09e-1)" "unprognostic (1.22e-1)" "unprognostic (7.72e-3)" "unprognostic (1.97e-1)" "unprognostic (2.46e-2)" "unprognostic (1.06e-2)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-2)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (7.50e-3)" "unprognostic (2.87e-1)" "unprognostic (1.43e-3)" "unprognostic (1.95e-1)" 25.9 50.8 26.0 7.6 27.2 0.6 20.0 27.2 61.4 14.5 39.6 36.4 23.4 13.4 36.9 19.7 26.3 11.9 44.4 26.8 30.0 44.2 99.8 15.9 3.2 27.9 31.5 12.2 63.5 38.4 10.9 6.8 29.8 26.2 32.5 3.1 31.2 16.7 43.9 9.1 22.0 11.5 27.9 9.6 42.1 7.3 28.5 2.4 20.5 25.4 5.1 25.2 13.7 28.0 47.5 130.9 0.6 20.0 51.2 18.5 31.8 21.4 31.8 16.0 15.0 84.0 48.0 34.5 25.4 26.1 80.6 43.9 58.1 35.1 13.3 10.0 43.7 51.7 30.8 87.4 19.1 8.2 13.6 16.7 38.7 17.6 19.7 32.7 42.6 25.4 54.0 6.8 21.4 100.5 3.3 31.1 10.9 139.9 118.7 0.0 82.8 20.3 85.8 73.4 8.0 14.6 39.6 89.7 31.0 16.9 40.4 9.9 52.8 17.4 42.2 30.5 38.7 7.2 16.9 2.3 25.0 17.6 31.0 0.0 8.3 0.7 0.3 2.4 0.3 0.0 0.1 0.1 8.9 0.0 0.1 0.3 0.0 0.0 0.9 0.9 0.0 2.4 26.0 27.2 27.2 61.4 26.8 30.0 27.9 31.5 29.8 27.9 28.5 28.0 13.8 12.8 7.3 0.3 1.1 8.4 23.0 14.8 20.5 0.7 22.2 16.5 46.2 38.6 10.8 42.3 0.0 18.1 0.4 85.3 21.5 56.9 0.3 12.5 4.2 16.7 11.4 6.6 0.7 81.1 10.6 13.9 26.0 6.7 4.5 8.4 17.2 62.9 42.1 1.7 0.4 39.6 12.2 6.0 7.4 1.5 9.3 9.7 14.2 1.9 20.8 13.8 0.0 0.0 0.3 43.3 50.4 5.7 1.4 33.9 71.0 91.6 11.2 0.7 6.6 8.3 8.6 0.4 10.2 17.8 6.5 4.4 1.9 8.7 57.8 15.6 SPRR5 ENSG00000283227 "Small proline rich protein 5" A0A1B0GTR4 1 152947154-152949258 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 24 "skin 1: 115.2" "Cell type enhanced" "Detected in single" "Exocrine glandular cells: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HaCaT: 2.0;hTCEpi: 5.3" NA NA "Cluster 61: Skin - Cornification" "Cluster 30: Epithelial cell lines - Translation" "Cluster 1: Pancreatic cells - Digestion" 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 115.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRRD "HC/HCC, SRR1L" ENSG00000100104 "SRR1 domain containing" Q9UH36 22 26483877-26494658 "Predicted intracellular proteins" "Biological rhythms, Heme biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 49.0;Late spermatids: 54.9;Pancreatic endocrine cells: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002945 Uncertain Approved Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA002945: AB_1079265" "unprognostic (3.25e-1)" "unprognostic (3.01e-2)" "unprognostic (1.65e-2)" "unprognostic (1.47e-1)" "unprognostic (1.33e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (9.00e-2)" "unprognostic (8.51e-3)" "unprognostic (2.49e-2)" "unprognostic (4.50e-3)" "unprognostic (3.93e-2)" "unprognostic (2.63e-1)" "unprognostic (2.70e-1)" "unprognostic (1.03e-1)" "unprognostic (1.76e-3)" "unprognostic (2.96e-1)" 5.0 3.5 8.4 4.1 8.8 6.2 6.2 10.4 9.7 5.5 6.2 6.0 3.6 6.3 6.1 5.3 5.5 3.7 7.6 8.7 8.0 6.4 6.9 5.3 5.6 8.2 8.2 7.1 5.5 6.7 5.1 5.3 7.7 6.8 5.2 5.8 4.9 7.2 19.6 6.0 3.9 7.0 8.1 5.4 4.9 4.8 8.6 5.7 10.5 17.1 7.3 5.5 4.2 8.6 10.7 6.3 10.6 10.9 10.8 6.5 6.1 7.4 10.4 14.7 13.5 6.2 4.6 23.6 5.1 9.7 7.4 9.5 16.6 15.6 14.3 12.2 16.5 10.4 5.5 10.1 7.6 23.1 7.8 6.2 13.4 10.5 16.4 9.7 12.9 13.8 17.2 14.5 9.7 9.2 10.4 7.3 6.6 11.7 7.9 23.3 13.2 17.0 9.7 7.6 11.2 7.6 8.5 7.6 19.7 8.8 9.1 9.0 9.9 11.3 37.2 6.4 13.1 9.5 8.3 19.4 7.7 9.4 15.0 0.3 0.5 0.2 0.7 0.4 1.0 1.1 0.8 1.0 0.5 0.6 1.1 1.2 0.4 0.9 0.4 0.4 0.2 0.3 8.4 8.8 10.4 9.7 8.7 8.0 8.2 8.2 7.7 8.1 8.6 8.6 12.1 0.0 6.4 3.6 10.6 29.7 16.2 7.5 3.4 13.0 10.0 10.5 3.0 12.8 5.9 1.8 2.1 13.3 5.9 3.7 9.8 24.9 22.4 5.8 10.6 11.2 4.8 46.9 3.1 49.0 22.9 8.9 7.7 8.9 11.4 15.1 11.0 15.4 14.1 13.5 3.0 4.5 2.0 3.8 8.6 54.9 7.2 8.6 8.8 1.0 6.1 9.8 10.3 3.5 1.9 48.9 2.4 9.1 10.4 12.1 3.4 19.9 3.2 9.3 6.6 12.6 10.3 17.8 12.9 7.7 31.8 16.7 9.1 21.7 5.9 14.7 STK38L "KIAA0965, NDR2" ENSG00000211455 "Serine/threonine kinase 38 like" Q9Y2H1 12 27243968-27325959 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 49.9;granulocytes: 80.7;monocytes: 33.0" "Cell line enhanced" "Detected in all" "HDLM-2: 157.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038623, HPA051324" Approved Approved Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA038623: AB_10967059, HPA051324: AB_2681442" "unprognostic (2.14e-2)" "unprognostic (1.01e-1)" "unprognostic (9.94e-2)" "unprognostic (2.43e-2)" "unprognostic (2.02e-1)" "unprognostic (1.76e-1)" "unprognostic (3.33e-2)" "unprognostic (4.68e-2)" "unprognostic (5.56e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (5.82e-4)" "unprognostic (1.16e-1)" "unprognostic (3.41e-2)" "unprognostic (1.09e-1)" "unprognostic (1.95e-1)" "unprognostic (5.05e-2)" "unprognostic (1.05e-2)" 23.9 11.6 6.5 21.6 8.6 17.2 14.0 6.9 11.1 17.2 6.4 28.9 12.9 27.1 7.5 22.7 15.1 25.7 44.9 6.7 8.6 12.9 12.5 12.3 12.4 8.1 7.5 7.0 12.3 26.9 7.2 15.7 8.4 20.2 21.2 6.6 13.8 15.0 8.8 10.8 14.3 33.3 7.6 12.0 18.6 11.2 9.5 17.8 9.2 16.4 14.8 24.6 15.5 6.8 12.0 15.7 40.1 17.7 18.6 12.4 30.8 7.7 11.5 4.8 6.5 19.8 8.5 29.3 17.7 6.4 13.6 21.9 19.0 13.4 7.2 157.8 17.3 18.7 17.5 10.0 15.5 43.7 19.7 14.7 13.3 17.6 21.7 29.3 38.1 36.8 21.2 21.1 9.7 8.3 28.5 46.3 49.6 31.2 25.4 10.6 47.8 22.4 6.8 22.0 6.7 22.3 33.1 19.9 13.3 38.6 9.8 14.0 16.4 15.5 13.9 23.7 20.3 7.7 8.1 29.1 8.0 19.9 6.7 16.3 33.0 60.8 10.0 28.4 7.0 11.6 7.7 9.8 49.9 9.3 9.4 7.6 80.7 11.6 22.4 21.2 10.8 14.7 6.5 8.6 6.9 11.1 6.7 8.6 8.1 7.5 8.4 7.6 9.5 6.8 24.4 19.2 16.2 32.7 20.8 35.4 36.3 88.2 22.2 12.7 16.2 14.7 76.0 10.0 33.7 9.2 2.1 11.0 21.7 33.6 9.8 49.8 23.1 12.5 15.3 26.2 19.2 15.4 57.2 40.1 9.1 19.7 15.3 14.9 17.7 10.9 24.3 14.5 28.8 10.1 37.5 33.8 18.3 36.4 73.7 5.9 6.5 45.7 21.4 37.5 46.2 8.1 14.4 42.3 16.0 70.5 26.3 12.0 22.8 24.8 9.2 16.2 11.9 7.9 19.7 8.6 41.1 12.1 13.4 20.5 32.0 27.8 15.7 9.7 23.0 42.0 STOML1 "FLJ36370, hUNC-24, SLP-1, STORP" ENSG00000067221 "Stomatin like 1" Q9UBI4 15 73978926-73994622 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042353 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 65: Brain - Ion transport" "Cluster 18: U-2197 - ECM organization" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA042353: AB_10797387" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (7.76e-2)" "unprognostic (4.54e-3)" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.78e-1)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.30e-3)" "unprognostic (2.26e-3)" "unprognostic (2.14e-1)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.67e-2)" 11.4 17.3 33.0 6.5 33.7 4.5 10.4 22.0 38.5 9.8 17.1 11.0 5.9 9.1 5.6 9.4 7.3 6.3 23.6 36.8 32.4 8.6 13.2 10.2 5.6 34.6 30.5 8.5 10.1 7.8 16.6 7.5 36.8 9.9 3.6 3.1 8.3 8.8 18.6 9.4 7.9 7.7 26.5 7.9 9.5 13.1 32.6 8.1 13.6 8.9 3.8 11.8 9.2 28.4 5.8 10.8 6.4 8.8 12.7 8.0 5.4 18.3 7.1 9.8 8.3 3.2 31.4 5.8 28.3 14.9 7.3 18.9 6.1 12.9 3.1 19.4 6.6 6.1 10.0 3.6 12.5 4.0 4.6 14.3 9.9 15.4 14.5 8.1 9.3 13.1 14.6 10.9 14.3 8.8 7.6 2.9 3.1 8.9 8.6 4.5 6.5 8.9 20.7 6.3 12.1 7.9 8.4 10.9 11.9 4.0 9.1 4.4 14.3 22.4 7.2 25.8 24.9 10.6 5.8 3.0 20.6 12.1 11.6 1.0 4.1 2.5 5.3 7.7 4.4 4.5 4.3 7.0 6.5 5.6 8.7 9.2 2.1 8.0 18.2 11.5 8.1 5.5 33.0 33.7 22.0 38.5 36.8 32.4 34.6 30.5 36.8 26.5 32.6 28.4 15.2 0.0 4.1 7.2 5.3 3.2 3.7 7.2 1.8 13.1 7.0 4.8 10.8 2.8 5.8 7.3 6.2 13.0 3.5 8.9 1.9 25.1 1.0 2.8 6.2 7.7 10.2 4.2 6.9 19.0 8.6 11.4 12.8 5.4 4.5 8.5 5.0 5.1 10.8 16.8 8.1 7.3 4.1 3.3 2.2 2.6 9.0 3.3 3.6 2.8 2.5 11.9 2.1 7.5 4.1 20.8 4.9 11.7 3.4 6.8 12.6 4.8 2.7 14.0 6.6 7.5 9.7 20.8 7.8 4.7 2.0 5.6 4.1 13.7 5.6 3.3 SYCN "FLJ27441, INSSA1, SYL" ENSG00000179751 Syncollin Q0VAF6 19 39202825-39204263 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1004 "pancreas: 28361.5" "Cell type enriched" "Detected in some" 7 "Exocrine glandular cells: 4000.5" "Cancer enriched" "Detected in single" 842 "pancreatic cancer: 369.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA047654 Enhanced "Intracellular and membrane" NA NA 920000 "Cluster 25: Pancreas - Digestion" "Cluster 1: Pancreatic cells - Digestion" "HPA047654: AB_2680112" "unprognostic (8.02e-2)" 4.5 0.8 0.0 0.4 0.0 0.0 2.5 0.0 0.1 2.6 0.0 0.9 4.0 0.9 0.2 1.5 0.6 0.0 4.5 0.0 0.0 1.0 3.0 0.5 0.6 0.0 0.0 11.2 28361.5 0.0 0.9 1.6 0.0 1.6 0.0 0.0 4.0 0.0 0.8 1.6 1.8 0.0 0.0 1.2 2.2 28.2 0.0 0.0 0.5 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 4.4 0.0 0.0 0.3 0.0 0.0 0.0 4000.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 1.2 0.5 0.0 0.0 9.8 0.0 0.0 0.0 0.0 506.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.6 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TAPBP TAPA ENSG00000231925 "TAP binding protein" O15533 6 33299694-33314387 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 168.7;Karpas-707: 140.8;U-266/70: 140.5" "Low region specificity" "Detected in all" HPA007066 Approved NA NA 20000 "Cluster 49: Eosinophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 1: Pancreatic cells - Digestion" "HPA007066: AB_1857769" "prognostic favorable (2.76e-4)" "unprognostic (1.43e-2)" "unprognostic (7.01e-2)" "unprognostic (1.98e-2)" "unprognostic (1.59e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.21e-2)" "prognostic favorable (6.29e-4)" "unprognostic (1.67e-2)" "unprognostic (2.37e-1)" "unprognostic (3.63e-1)" "unprognostic (1.61e-2)" "unprognostic (3.82e-1)" "unprognostic (1.19e-2)" "unprognostic (1.21e-1)" "unprognostic (6.54e-3)" 47.3 73.1 2.4 28.5 4.8 25.0 43.1 1.9 2.8 40.1 1.2 66.7 52.3 38.2 13.3 57.3 43.8 10.5 63.7 2.9 1.8 67.4 107.5 82.1 21.2 2.7 3.2 33.3 48.2 14.9 38.8 18.7 2.0 64.3 19.6 4.1 61.9 17.2 26.7 54.0 81.9 23.1 1.9 129.0 52.1 16.2 2.0 24.4 59.1 6.5 36.7 45.0 43.4 2.4 3.3 1.2 6.3 26.1 20.3 25.6 92.9 18.5 88.1 42.5 57.1 0.1 168.7 48.1 38.1 41.3 92.2 2.9 0.3 30.3 15.8 125.5 4.1 19.1 9.9 24.8 0.2 20.4 63.0 51.7 20.6 0.8 8.2 37.8 0.4 16.0 1.5 140.8 14.7 19.6 51.9 44.1 0.5 0.0 6.3 2.8 0.4 1.3 35.5 1.2 8.6 0.6 0.6 2.4 23.7 3.7 1.4 0.9 45.5 89.4 18.6 1.3 2.0 140.5 117.4 46.2 58.6 38.8 58.8 159.7 87.9 172.1 137.3 121.6 117.0 97.1 99.7 114.3 90.0 86.0 76.2 109.9 151.3 159.6 139.0 102.9 85.9 150.5 2.4 4.8 1.9 2.8 2.9 1.8 2.7 3.2 2.0 1.9 2.0 2.4 116.8 125.0 102.1 22.5 186.6 77.0 93.3 148.2 66.6 34.7 82.0 64.1 73.9 84.4 105.8 71.7 33.3 46.9 223.7 259.6 13.7 256.4 1.9 64.0 52.4 99.1 84.6 58.0 25.9 282.9 85.9 63.9 105.5 78.4 91.9 65.9 75.0 143.7 119.7 20.2 15.0 174.6 83.4 124.3 128.0 9.2 33.2 131.9 119.2 30.9 229.3 34.7 195.7 23.6 8.7 215.5 172.4 32.0 194.9 130.4 283.2 33.1 113.3 30.4 32.9 39.3 57.6 1.2 0.6 53.6 56.3 49.1 163.7 66.4 162.3 141.0 TBC1D22B "C6orf197, dJ744I24.2, FLJ20337" ENSG00000065491 "TBC1 domain family member 22B" Q9NU19 6 37257772-37332970 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027908, HPA027909, HPA027910" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203" "unprognostic (9.83e-2)" "unprognostic (5.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (8.15e-5)" "unprognostic (2.70e-1)" "unprognostic (1.45e-1)" "unprognostic (2.29e-2)" "unprognostic (1.44e-1)" "unprognostic (9.48e-2)" "unprognostic (6.06e-3)" "unprognostic (3.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.53e-3)" "unprognostic (9.87e-2)" "unprognostic (2.71e-1)" "unprognostic (3.19e-1)" "unprognostic (9.73e-2)" 5.8 12.1 8.3 5.1 8.4 18.3 5.7 8.3 8.2 7.9 8.8 6.5 7.9 6.4 7.4 14.1 8.2 5.9 7.4 8.3 8.0 8.6 6.1 8.0 5.8 7.7 8.1 9.4 12.8 10.7 6.7 6.0 7.9 8.2 7.7 7.7 11.8 5.5 15.0 15.2 8.5 6.7 7.1 7.2 7.5 10.0 8.5 13.5 7.7 7.8 7.1 7.5 9.3 8.1 13.2 5.5 9.9 10.9 9.1 9.1 14.2 7.2 15.0 13.2 16.2 12.6 8.5 12.3 7.4 9.2 17.9 8.9 12.7 11.6 14.8 19.9 10.4 19.5 9.0 17.2 13.0 11.1 15.9 7.8 16.6 13.0 15.4 12.6 18.9 20.4 22.5 3.1 9.6 11.9 16.6 8.4 13.0 15.0 5.1 10.7 9.1 9.6 13.6 9.5 13.0 8.4 7.9 11.2 14.3 13.3 8.2 19.7 18.4 8.0 12.2 5.5 9.6 11.1 12.4 80.8 5.5 16.5 12.6 1.4 2.6 4.4 2.3 3.5 2.7 1.7 2.6 2.3 4.0 2.0 2.8 2.4 1.1 3.0 1.5 1.1 1.9 2.6 8.3 8.4 8.3 8.2 8.3 8.0 7.7 8.1 7.9 7.1 8.5 8.1 4.1 3.2 5.6 17.9 6.3 8.2 8.5 7.5 8.0 5.0 6.0 3.7 5.8 7.2 10.1 1.8 4.2 6.3 4.6 15.1 3.9 12.3 5.6 10.6 3.6 4.9 1.8 10.5 20.3 15.4 9.2 4.2 3.1 8.1 5.7 5.0 3.6 3.9 5.8 0.0 22.0 4.9 10.2 4.4 7.8 5.0 3.1 4.1 1.8 6.5 6.0 3.6 6.2 14.1 24.1 15.0 6.8 1.2 5.6 10.0 11.2 9.0 15.8 4.5 0.0 4.2 3.6 6.5 6.4 10.8 15.9 6.7 6.6 3.2 6.3 11.2 TCN1 "TC1, TCI" ENSG00000134827 "Transcobalamin 1" P20061 11 59852800-59866489 "Plasma proteins, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "salivary gland: 776.3" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 52.0;Cholangiocytes: 62.9;Club cells: 94.9;Exocrine glandular cells: 372.3;Glandular and luminal cells: 84.7;Urothelial cells: 61.0" "Cancer enriched" "Detected in many" 4 "pancreatic cancer: 124.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 149 "basophil: 2374.2" "Lineage enriched" "Detected in many" 1592 "granulocytes: 2374.2" "Cell line enriched" "Detected in some" 21 "OE19: 159.0" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 4000000 "Cluster 18: Basophils - Vesicular transport" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" "prognostic favorable (1.90e-4)" "unprognostic (1.17e-1)" "unprognostic (5.89e-2)" "unprognostic (3.61e-3)" "unprognostic (2.49e-2)" "unprognostic (5.28e-3)" "unprognostic (4.52e-3)" "unprognostic (3.11e-3)" "unprognostic (1.13e-1)" "unprognostic (7.56e-2)" "unprognostic (9.07e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (1.56e-8)" "unprognostic (2.50e-1)" "unprognostic (8.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.76e-2)" 0.1 0.2 0.0 0.7 0.0 190.7 5.4 0.0 0.2 31.7 0.0 0.2 9.6 3.1 0.0 23.0 1.4 173.8 0.1 0.0 0.0 0.1 0.4 1.4 0.3 0.0 0.0 0.0 5.3 108.5 0.2 0.5 0.0 1.2 0.8 0.0 776.3 0.0 0.1 0.9 1.0 0.0 0.0 4.5 76.3 0.3 0.0 1.3 0.0 0.0 0.9 15.5 10.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 2.2 0.0 0.8 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 159.0 7.5 0.0 0.2 0.0 1.5 0.0 0.0 0.0 7.3 0.0 1.6 0.0 0.0 3.0 0.1 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 2374.2 0.0 0.3 0.0 0.1 0.2 0.2 0.3 0.0 0.2 0.1 0.2 0.4 15.9 0.1 1.4 0.1 0.3 4.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 19.2 52.0 0.0 0.0 21.9 4.2 0.2 62.9 94.9 23.9 0.0 0.0 0.5 0.3 0.0 23.7 0.4 2.2 8.0 0.4 0.0 0.0 0.1 372.3 0.0 0.1 3.6 84.7 0.0 0.0 0.0 0.3 0.2 0.0 0.1 1.2 12.2 0.6 0.3 0.0 0.3 0.9 0.0 0.0 0.7 0.0 0.0 0.5 0.0 46.5 0.0 0.0 0.1 5.0 0.0 0.3 11.7 0.0 0.0 0.0 2.5 0.0 0.0 6.0 0.1 0.0 0.5 0.0 0.2 61.0 TEAD2 "ETF, TEF-4, TEF4" ENSG00000074219 "TEA domain transcription factor 2" Q15562 19 49340595-49362457 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 51.1;Early spermatids: 76.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "memory B-cell: 1.7;naive B-cell: 2.7" "Lineage enriched" "Detected in single" 27 "B-cells: 2.7" "Cell line enhanced" "Detected in many" "AF22: 135.3;AN3-CA: 147.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066292, HPA069963" Supported Nucleoplasm NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA066292: AB_2685651, HPA069963: AB_2686222" "unprognostic (2.69e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-1)" "unprognostic (1.03e-2)" "unprognostic (8.58e-3)" "unprognostic (4.39e-1)" "prognostic unfavorable (8.66e-4)" "unprognostic (2.91e-1)" "unprognostic (4.47e-3)" "unprognostic (1.11e-1)" "unprognostic (3.96e-3)" "unprognostic (1.24e-1)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" "unprognostic (1.08e-1)" "unprognostic (1.31e-1)" "unprognostic (6.78e-2)" 32.8 17.8 7.5 15.4 7.1 0.2 31.6 6.6 7.9 41.8 16.2 50.4 7.6 39.6 12.4 11.0 34.2 15.5 55.5 7.5 6.8 34.5 11.9 35.7 9.0 8.7 8.3 33.5 26.8 19.4 9.2 17.7 7.7 26.5 11.2 3.4 18.5 22.7 12.9 10.7 18.5 38.4 7.6 14.8 31.3 26.6 8.3 3.1 16.9 22.1 7.3 27.2 24.4 6.6 12.5 28.6 135.3 147.6 14.2 20.8 24.3 22.8 23.9 25.6 29.7 2.3 6.8 1.2 29.6 38.5 13.1 13.9 37.5 7.7 14.1 0.1 17.5 0.0 27.2 19.3 24.6 0.1 0.3 24.8 17.8 17.4 8.4 50.6 92.1 0.1 22.0 0.0 36.1 15.3 0.0 0.2 45.4 35.2 36.2 0.0 40.8 0.2 23.3 0.2 0.2 82.0 38.1 5.6 10.1 46.1 40.5 3.5 55.0 45.9 28.1 9.9 1.8 0.1 0.1 4.8 1.7 0.6 18.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 7.1 6.6 7.9 7.5 6.8 8.7 8.3 7.7 7.6 8.3 6.6 26.1 3.2 3.2 0.0 3.8 3.3 6.9 5.9 8.6 0.4 21.1 9.5 1.0 8.6 3.4 12.9 0.0 0.6 0.4 1.3 1.9 51.1 76.6 7.3 20.7 29.5 7.1 3.2 0.1 26.2 23.7 15.0 9.7 6.5 0.0 14.7 21.4 2.8 0.6 0.0 0.1 6.6 8.2 0.9 3.6 29.6 15.2 0.7 5.4 1.9 0.0 15.9 0.0 0.0 0.1 22.7 4.9 22.2 0.1 7.2 0.1 0.2 1.2 0.4 32.9 7.6 28.7 2.1 2.4 2.0 1.6 1.2 0.5 4.4 6.8 2.8 TEN1 "C17orf106, FLJ39785" ENSG00000257949 "TEN1 subunit of CST complex" Q86WV5 17 75979240-76000586 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 55.1;Exocrine glandular cells: 88.9;Pancreatic endocrine cells: 89.1;Proximal tubular cells: 89.0;Suprabasal keratinocytes: 52.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA065069 Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA065069: AB_2685418" "unprognostic (1.61e-1)" "unprognostic (1.16e-1)" "unprognostic (3.34e-2)" "unprognostic (1.07e-1)" "unprognostic (3.02e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-3)" "unprognostic (2.95e-1)" "unprognostic (2.85e-2)" "unprognostic (9.03e-2)" "unprognostic (8.61e-3)" "unprognostic (3.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.94e-1)" "unprognostic (2.85e-4)" 21.0 27.7 10.1 14.8 10.4 32.2 21.9 10.4 12.7 19.4 11.8 18.9 22.7 16.8 11.8 43.4 15.2 15.9 16.7 10.0 10.8 27.4 49.5 20.7 18.7 10.8 11.4 16.1 32.8 12.8 22.3 11.5 11.7 28.1 9.5 3.4 27.8 10.2 12.1 46.3 25.7 7.8 10.5 23.3 26.9 13.3 11.0 6.7 20.1 7.8 12.9 16.2 25.0 11.5 19.2 15.1 12.1 16.6 16.5 21.6 32.7 12.3 18.4 21.5 21.9 18.6 32.3 25.0 20.4 15.0 22.4 18.1 7.7 18.6 6.3 13.8 24.8 28.7 21.3 21.0 19.8 18.6 45.7 19.4 25.8 11.8 12.3 18.0 29.0 14.6 12.4 24.2 12.8 31.8 23.9 40.3 11.8 19.4 25.6 21.7 12.0 22.7 27.5 33.5 23.8 40.1 9.6 83.5 16.3 9.3 43.4 28.8 15.9 41.7 24.0 17.8 28.3 25.3 10.1 14.2 22.4 13.2 13.3 81.8 53.7 33.4 40.0 52.5 33.3 60.8 31.6 34.0 48.5 49.2 23.7 28.4 32.7 45.3 29.2 52.8 37.9 36.3 10.1 10.4 10.4 12.7 10.0 10.8 10.8 11.4 11.7 10.5 11.0 11.5 14.0 0.0 4.2 0.0 13.0 39.0 0.0 55.1 5.2 0.0 39.2 32.8 0.0 0.0 23.4 5.5 0.0 0.0 21.7 0.1 39.2 39.5 0.0 12.4 13.0 10.2 0.0 0.8 0.0 88.9 0.1 8.8 2.6 19.0 2.5 16.9 0.0 0.0 0.1 0.0 0.0 0.2 34.6 0.0 39.9 0.0 0.0 19.7 30.2 0.0 37.2 0.0 0.0 0.0 0.0 89.1 0.0 0.0 7.9 0.0 0.0 89.0 8.7 0.0 0.0 0.1 12.9 0.0 0.0 6.1 52.7 0.0 9.4 24.4 0.0 0.1 TESC "CHP3, FLJ20607, TSC" ENSG00000088992 Tescalcin Q96BS2 12 117038923-117099479 "Predicted intracellular proteins" "Differentiation, Protein transport, Transport" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 329.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 183.0;Erythroid cells: 222.9;Exocrine glandular cells: 481.2;Gastric mucus-secreting cells: 316.0;Late spermatids: 319.3;Pancreatic endocrine cells: 215.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 261.1" "Lineage enriched" "Detected in all" 5 "monocytes: 261.1" "Cell line enhanced" "Detected in many" "HMC-1: 398.5;NB-4: 675.1;OE19: 288.1;U-937: 221.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053200 Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 24: NB-4 - Immune response" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm Cytosol "HPA053200: AB_2682079" "unprognostic (4.53e-3)" "unprognostic (5.98e-2)" "unprognostic (6.50e-2)" "unprognostic (2.23e-3)" "unprognostic (6.31e-2)" "unprognostic (2.05e-3)" "unprognostic (4.98e-3)" "unprognostic (3.35e-1)" "unprognostic (4.35e-1)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (7.43e-2)" "unprognostic (1.69e-2)" "unprognostic (8.65e-2)" "unprognostic (2.57e-1)" "unprognostic (1.56e-2)" "unprognostic (5.67e-3)" 8.1 46.5 17.4 10.3 36.8 118.8 8.9 16.4 25.4 4.3 15.7 3.8 7.2 3.9 121.9 3.3 4.0 36.1 71.5 26.5 15.0 26.5 4.9 10.2 8.0 17.8 15.0 5.3 102.4 9.4 26.7 10.2 18.2 9.8 2.8 0.5 329.9 19.7 5.1 9.7 7.3 2.8 14.8 11.9 138.4 31.1 15.5 7.4 10.7 8.1 10.3 29.3 5.3 18.9 0.2 97.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 4.3 13.8 4.7 0.0 0.2 0.6 8.1 0.0 0.0 37.5 19.2 115.5 9.8 78.1 0.0 49.2 398.5 0.1 0.0 0.0 0.0 0.0 0.0 18.5 54.0 0.9 0.0 2.2 95.5 675.1 9.0 288.1 0.0 0.4 0.0 52.4 56.5 15.0 17.0 6.1 0.1 0.1 3.6 0.9 0.0 53.9 0.0 0.0 1.7 0.2 0.4 17.0 38.2 0.0 0.1 221.8 0.5 0.0 51.0 51.5 7.0 67.9 0.4 5.5 2.4 9.1 35.8 13.1 0.3 3.8 12.6 11.6 261.1 2.6 3.5 19.0 17.4 36.8 16.4 25.4 26.5 15.0 17.8 15.0 18.2 14.8 15.5 18.9 35.6 0.0 0.0 5.9 16.2 2.7 0.3 0.4 1.8 0.8 5.5 67.1 58.3 183.0 0.9 12.9 0.0 0.4 21.1 0.2 74.3 159.5 106.5 1.3 0.7 43.6 1.8 222.9 26.1 481.2 0.6 7.9 316.0 3.2 71.1 1.2 1.8 0.5 48.0 0.0 2.0 1.5 0.0 17.9 6.1 319.3 3.1 30.6 72.9 8.4 41.0 0.2 25.7 2.5 1.5 215.6 0.9 3.4 25.8 3.5 0.2 6.1 0.0 1.5 144.7 1.9 68.4 63.0 20.3 0.5 2.0 1.2 28.3 66.7 2.3 1.3 TMED6 "MGC23911, p24g5, p24gamma5" ENSG00000157315 "Transmembrane p24 trafficking protein 6" Q8WW62 16 69343250-69351786 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 298.9" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 28.3;Exocrine glandular cells: 36.6;Pancreatic endocrine cells: 12.8;Paneth cells: 10.6;Proximal tubular cells: 19.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 15.5;OE19: 7.4" HPA012532 Approved NA NA "Cluster 32: T-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 1: Pancreatic cells - Digestion" "HPA012532: AB_1858065" "unprognostic (6.85e-2)" "unprognostic (1.42e-1)" "unprognostic (6.31e-3)" "prognostic favorable (7.74e-5)" "unprognostic (9.84e-3)" "unprognostic (7.57e-2)" "unprognostic (2.40e-1)" "unprognostic (1.20e-1)" "unprognostic (7.94e-2)" "unprognostic (3.74e-1)" "unprognostic (2.94e-2)" "unprognostic (4.76e-2)" "unprognostic (4.58e-3)" "unprognostic (9.71e-2)" "unprognostic (1.50e-1)" "unprognostic (1.36e-1)" "unprognostic (4.52e-3)" 0.5 0.6 0.1 0.7 0.3 1.1 0.6 0.8 0.7 2.5 0.1 4.3 12.5 0.9 18.1 0.4 22.5 0.7 0.4 0.3 0.0 16.1 5.5 1.9 1.3 0.1 0.1 0.6 298.9 0.1 0.2 0.4 0.1 0.7 7.8 1.0 0.5 2.4 0.3 1.0 7.7 0.5 0.1 0.9 61.2 0.4 0.2 0.2 0.5 0.0 0.6 0.3 0.2 0.4 0.6 1.6 1.4 1.0 0.1 0.0 0.9 2.0 0.1 0.0 0.3 2.2 0.8 4.2 0.7 0.0 0.6 1.1 0.2 0.2 0.4 0.6 1.7 2.1 0.6 15.5 0.1 2.7 0.9 0.2 0.8 0.1 0.3 0.8 0.1 1.9 1.4 0.5 0.3 1.6 1.1 2.9 1.9 7.4 1.4 2.3 1.2 1.6 0.4 1.7 3.2 1.3 2.7 0.9 1.0 0.5 0.5 1.7 1.9 2.2 1.3 0.8 1.4 1.4 1.3 4.5 1.2 2.2 0.7 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.7 0.3 0.0 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.0 0.5 1.3 0.5 0.0 0.1 0.1 0.6 0.5 0.5 0.3 0.2 1.5 0.1 1.8 2.1 0.1 0.0 5.0 0.0 6.6 0.1 28.3 0.7 0.4 8.4 3.2 1.4 36.6 0.0 0.1 9.7 5.0 1.3 0.1 0.4 4.7 0.3 0.0 0.8 2.6 0.0 0.8 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.5 1.0 12.8 10.6 0.0 0.3 0.3 8.0 19.1 0.4 0.6 0.0 0.5 0.2 0.1 0.1 0.6 0.0 0.1 0.5 0.1 7.0 0.2 TMEM14A "C6orf73, PTD011" ENSG00000096092 "Transmembrane protein 14A" Q9Y6G1 6 52671113-52686588 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A-431: 253.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072536 Approved Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 15: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Endoplasmic reticulum" "HPA072536: AB_2686531" "unprognostic (6.75e-2)" "unprognostic (3.65e-2)" "unprognostic (2.04e-1)" "unprognostic (8.10e-3)" "unprognostic (3.55e-2)" "unprognostic (1.06e-1)" "unprognostic (8.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.45e-1)" "unprognostic (2.56e-3)" "unprognostic (8.88e-2)" "unprognostic (1.17e-1)" "unprognostic (3.52e-2)" "unprognostic (9.60e-2)" "unprognostic (5.44e-2)" "unprognostic (3.37e-1)" "unprognostic (2.64e-1)" 20.7 46.8 51.9 13.6 52.7 10.3 24.9 52.7 78.4 25.8 72.6 25.3 38.3 27.7 36.4 36.2 31.3 25.0 16.5 53.3 62.6 51.5 106.4 18.0 19.7 55.1 50.5 39.8 36.2 22.2 24.2 16.1 55.8 36.4 25.9 31.4 21.7 21.6 4.4 13.9 35.4 26.4 52.5 13.7 40.8 17.2 55.0 15.5 28.6 8.5 23.9 24.4 26.2 55.4 253.4 37.5 27.3 77.6 73.1 56.0 23.1 50.0 68.0 45.2 69.5 57.8 63.5 30.8 54.2 63.1 94.9 93.9 61.3 83.7 75.3 125.0 50.1 45.6 57.4 95.7 24.0 23.6 54.7 50.5 57.8 49.5 11.1 59.5 61.7 38.9 9.8 85.4 54.1 51.3 46.4 26.9 16.2 165.9 64.7 36.0 38.8 24.5 88.5 48.1 141.4 68.5 55.6 44.2 97.1 33.9 68.0 44.8 45.8 62.0 83.3 24.5 81.3 40.9 37.1 46.6 87.4 14.8 50.7 23.3 0.5 16.4 38.4 0.1 24.8 54.6 48.7 40.4 19.4 36.0 36.9 39.4 2.1 11.0 0.1 35.2 66.5 30.3 51.9 52.7 52.7 78.4 53.3 62.6 55.1 50.5 55.8 52.5 55.0 55.4 28.6 25.6 17.6 13.1 23.4 48.4 61.9 183.5 56.9 20.4 71.3 72.4 17.4 54.3 90.1 51.5 8.4 56.1 27.5 22.6 64.6 108.1 1.4 31.2 33.3 37.3 33.5 32.8 50.3 140.9 150.8 62.4 50.0 26.3 25.4 46.5 38.6 138.7 47.0 5.0 45.7 53.1 77.3 7.0 56.6 2.5 43.5 10.9 88.9 16.9 4.9 27.1 16.5 15.1 15.5 74.7 25.2 50.0 18.6 48.5 77.4 152.7 85.5 13.2 6.6 38.6 60.7 4.3 41.2 139.5 38.2 15.5 30.9 22.0 51.7 69.3 TMEM51 "C1orf72, FLJ10199" ENSG00000171729 "Transmembrane protein 51" Q9NW97 1 15152532-15220478 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 87.0;Exocrine glandular cells: 74.1;Pancreatic endocrine cells: 71.0;Urothelial cells: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014547, HPA019441" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "HPA014547: AB_1858121, HPA019441: AB_2670142" "unprognostic (1.21e-1)" "unprognostic (1.84e-1)" "unprognostic (8.74e-2)" "unprognostic (1.89e-2)" "unprognostic (3.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.47e-2)" "unprognostic (7.81e-3)" "unprognostic (7.84e-2)" "unprognostic (1.39e-1)" "unprognostic (3.00e-2)" "unprognostic (8.91e-2)" "prognostic favorable (8.16e-8)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (5.58e-2)" "unprognostic (1.67e-3)" 5.0 20.5 8.1 8.8 8.1 0.8 5.5 18.1 10.6 16.0 7.4 19.8 22.8 5.3 7.3 17.6 11.3 21.2 5.8 8.0 7.4 36.0 4.0 14.2 4.8 9.4 8.6 21.3 45.1 12.9 7.0 10.8 8.5 15.7 10.7 0.4 10.4 15.3 1.7 8.4 20.1 7.9 8.2 7.0 30.2 2.6 8.8 2.2 4.8 3.0 5.0 30.3 18.1 9.1 42.7 22.4 12.5 3.0 2.1 4.5 0.0 4.8 20.1 14.5 19.6 29.6 46.8 0.0 15.4 3.2 20.7 40.2 4.3 15.7 8.2 0.1 11.1 1.0 1.2 29.8 17.8 0.0 39.7 1.4 13.7 18.9 20.6 9.3 13.6 1.7 6.5 0.1 7.5 14.7 0.0 0.1 2.3 33.7 8.4 5.9 8.0 7.4 37.0 43.3 1.9 37.0 4.0 16.2 40.6 7.5 2.3 4.5 9.5 15.0 13.2 6.6 15.2 0.4 0.6 0.1 14.8 0.6 18.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 8.1 8.1 18.1 10.6 8.0 7.4 9.4 8.6 8.5 8.2 8.8 9.1 2.7 0.0 2.6 19.9 1.5 18.2 53.8 9.4 15.4 0.1 9.7 6.7 3.0 34.3 10.7 49.7 0.0 6.3 0.1 20.3 5.9 87.0 0.5 10.0 1.9 10.5 19.2 0.0 0.7 74.1 0.9 10.3 26.0 15.7 0.0 0.3 8.6 0.4 48.1 0.0 8.1 18.7 57.0 31.4 19.2 0.4 2.8 22.1 14.2 23.4 13.1 0.0 0.0 11.6 0.4 71.0 27.2 13.9 0.3 53.7 14.3 12.1 11.7 0.1 32.9 1.6 30.3 0.5 3.6 20.7 21.2 1.4 1.1 1.0 15.4 117.9 TMEM87B FLJ14681 ENSG00000153214 "Transmembrane protein 87B" Q96K49 2 112055269-112119318 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 89.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035183 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus, Vesicles" "HPA035183: AB_10600829" "unprognostic (3.19e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (4.28e-4)" "prognostic unfavorable (4.72e-4)" "unprognostic (4.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.07e-2)" "unprognostic (2.87e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.32e-1)" "unprognostic (5.35e-2)" "unprognostic (1.05e-1)" "unprognostic (3.25e-3)" 10.5 12.2 6.8 14.7 6.6 7.9 20.1 6.1 8.0 12.9 6.9 28.4 28.6 11.0 18.5 10.5 8.4 12.1 5.0 5.9 7.1 7.9 7.4 11.7 15.4 7.5 10.0 6.0 11.3 12.9 9.2 15.1 8.0 30.7 27.8 6.9 15.4 15.9 3.1 13.7 30.5 13.4 7.1 15.5 22.8 5.0 8.3 9.7 15.0 4.2 14.6 17.1 9.0 6.9 21.7 6.4 5.9 25.8 24.9 32.6 21.4 35.5 46.8 21.9 26.7 16.6 28.6 20.9 18.2 47.3 30.2 34.9 3.8 21.6 28.7 12.8 4.1 27.5 4.6 15.2 24.7 19.6 28.9 22.3 25.9 28.0 22.0 21.4 23.6 9.6 16.9 13.1 31.8 13.7 9.3 10.8 4.8 35.0 16.4 7.6 8.9 17.0 20.3 30.2 4.6 6.4 15.4 38.6 34.6 15.5 20.4 14.7 26.6 22.3 6.8 17.6 7.8 10.6 18.1 12.9 25.9 10.1 16.3 5.4 3.0 2.6 3.2 5.2 5.6 5.9 6.9 4.4 2.7 4.9 6.2 3.6 1.8 3.5 6.7 2.7 7.4 3.6 6.8 6.6 6.1 8.0 5.9 7.1 7.5 10.0 8.0 7.1 8.3 6.9 18.3 28.9 13.9 18.9 23.3 12.2 14.5 20.9 39.9 5.0 32.9 14.4 4.6 20.0 21.6 18.4 2.1 15.9 12.3 59.5 0.0 42.9 18.7 14.4 26.5 19.9 17.4 6.3 18.4 89.3 25.5 17.5 46.4 24.9 13.3 14.5 35.7 10.1 21.7 6.7 16.4 53.6 12.2 37.7 10.9 24.5 9.9 22.7 3.6 30.0 20.9 4.0 6.2 21.6 23.1 69.7 47.1 3.0 21.6 28.9 44.9 4.7 17.9 7.9 0.0 5.4 17.2 4.9 5.6 29.9 12.8 29.1 20.5 11.8 38.2 23.9 TNFAIP1 "B12, B61, BTBD34, EDP1, MGC2317" ENSG00000109079 "TNF alpha induced protein 1" Q13829 17 28335602-28347009 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 112.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 166.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013333, HPA014641" Uncertain Approved Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 39: CACO-2 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Nucleoli "HPA013333: AB_1858160, HPA014641: AB_1858159" "unprognostic (4.42e-1)" "unprognostic (1.54e-2)" "unprognostic (4.32e-2)" "prognostic unfavorable (7.48e-5)" "unprognostic (2.29e-1)" "unprognostic (4.97e-3)" "unprognostic (3.21e-1)" "unprognostic (1.94e-1)" "unprognostic (2.64e-2)" "unprognostic (1.31e-2)" "unprognostic (8.27e-3)" "unprognostic (1.43e-2)" "unprognostic (4.21e-3)" "unprognostic (2.49e-2)" "unprognostic (2.04e-1)" "unprognostic (4.09e-1)" "unprognostic (7.02e-2)" 36.1 30.4 32.4 19.3 31.1 8.1 30.3 28.5 32.0 22.0 38.6 19.9 17.7 21.7 14.9 39.6 19.2 28.9 46.7 30.9 29.1 35.9 54.8 40.9 17.0 30.3 30.1 17.4 37.6 23.0 17.5 44.7 29.4 20.5 16.9 26.3 23.9 20.5 23.3 29.0 17.7 30.9 28.9 50.2 25.4 17.2 35.7 22.0 24.0 23.8 19.5 35.1 23.4 28.9 43.3 61.3 40.2 28.4 34.3 30.1 39.0 50.4 62.4 60.6 47.6 166.1 25.8 8.7 34.4 67.0 29.4 49.1 22.3 86.9 46.5 24.0 28.0 7.7 66.0 24.2 45.9 13.5 12.5 38.9 99.7 47.7 37.0 56.9 71.7 17.4 20.0 12.8 28.8 25.8 25.6 7.4 9.3 36.4 22.3 11.3 50.8 15.5 89.5 45.9 29.3 31.7 62.3 102.5 25.8 55.8 42.9 11.4 76.4 44.2 43.7 34.4 39.3 20.8 18.7 9.3 34.3 9.0 28.5 1.7 7.2 9.5 6.5 7.0 7.7 5.3 4.7 5.9 9.3 3.9 4.5 5.5 2.5 9.1 8.7 4.5 4.3 5.0 32.4 31.1 28.5 32.0 30.9 29.1 30.3 30.1 29.4 28.9 35.7 28.9 66.6 38.5 12.9 5.5 4.6 24.6 47.5 32.0 12.5 25.6 18.2 11.9 21.8 20.0 17.5 22.0 16.7 31.5 6.2 14.3 23.5 60.5 40.1 23.0 13.9 62.4 17.4 7.4 11.7 82.5 34.9 13.5 12.8 30.2 7.0 14.0 60.3 29.5 11.0 11.8 7.5 11.0 10.2 12.5 12.1 6.9 7.8 7.0 0.0 9.4 30.1 10.0 4.1 7.1 7.2 112.9 15.1 7.9 7.1 46.9 13.6 16.9 20.2 9.8 13.1 10.9 22.3 5.4 5.6 15.9 28.4 69.2 5.0 18.1 9.7 43.0 TRIB3 "C20orf97, dJ1103G7.3, TRB3" ENSG00000101255 "Tribbles pseudokinase 3" Q96RU7 20 362835-397559 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 80.5" "Cell type enhanced" "Detected in many" "Ductal cells: 53.1;Hepatocytes: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 630.3;hTCEpi: 401.9;hTERT-HME1: 461.8;SK-MEL-30: 615.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015272, HPA055442" Approved Supported Nucleoplasm NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 18: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA015272: AB_1858269, HPA055442: AB_2682818" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (1.57e-1)" "unprognostic (2.25e-3)" "unprognostic (1.92e-1)" "prognostic unfavorable (1.70e-4)" "prognostic unfavorable (6.75e-5)" "unprognostic (1.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.24e-1)" "unprognostic (7.95e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.07e-13)" "unprognostic (7.62e-2)" "unprognostic (2.79e-2)" "unprognostic (2.31e-1)" "unprognostic (4.05e-3)" 8.0 16.4 5.6 4.0 5.4 16.1 7.8 6.0 6.7 4.4 6.5 4.4 1.3 2.9 3.0 20.5 2.2 2.6 4.0 5.1 6.5 9.9 80.5 15.4 6.5 5.5 5.5 3.2 17.3 13.3 15.2 8.4 5.6 7.8 2.2 2.7 10.4 3.0 1.8 13.6 5.3 1.8 4.4 12.1 10.2 1.4 6.7 5.6 38.2 0.5 5.9 4.8 5.3 4.4 80.9 41.6 5.1 11.9 13.7 17.9 33.7 23.9 65.8 23.0 47.5 86.7 40.0 35.3 22.2 22.5 102.3 62.6 22.6 107.7 21.4 12.4 16.2 27.5 8.9 144.2 630.3 71.5 12.7 73.3 401.9 43.5 461.8 16.2 45.1 86.1 97.3 155.2 2.3 77.3 4.2 87.0 11.8 122.8 133.0 15.2 7.1 77.1 27.0 33.3 14.7 23.0 5.6 192.2 615.5 7.2 55.7 185.6 24.6 11.7 20.6 0.3 36.2 52.3 73.9 63.5 10.5 61.4 43.6 5.1 6.4 1.4 13.2 4.9 9.4 21.0 12.3 15.3 6.7 13.8 13.7 9.8 4.4 10.2 2.6 2.8 9.7 7.8 5.6 5.4 6.0 6.7 5.1 6.5 5.5 5.5 5.6 4.4 6.7 4.4 7.9 3.2 1.5 0.3 9.3 6.8 10.9 20.3 3.4 6.8 12.7 8.3 1.6 11.5 8.5 1.8 4.2 14.1 4.0 3.4 0.0 53.1 0.0 0.2 1.6 15.8 1.2 5.7 2.2 22.7 6.4 3.9 0.0 2.6 5.1 0.5 6.8 38.4 6.4 0.0 3.1 8.8 6.1 3.3 4.4 0.0 1.8 3.0 7.2 0.0 4.2 1.0 14.4 1.0 0.6 24.0 1.9 1.5 10.0 12.2 0.0 0.1 2.9 7.0 6.6 6.5 6.9 2.4 3.1 4.0 5.4 7.1 5.7 3.5 2.2 6.7 TRIM47 "GOA, RNF100" ENSG00000132481 "Tripartite motif containing 47" Q96LD4 17 75874164-75878581 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 105.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 48.4;RPTEC TERT1: 36.0;U-266/70: 39.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014933 Uncertain Supported Cytosol NA NA "Cluster 13: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA014933: AB_10603219" "prognostic favorable (6.54e-4)" "unprognostic (8.42e-2)" "unprognostic (1.42e-1)" "unprognostic (2.42e-2)" "unprognostic (1.19e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (5.59e-5)" "unprognostic (2.08e-2)" "unprognostic (9.18e-3)" "unprognostic (2.74e-1)" "unprognostic (1.18e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (9.69e-5)" "unprognostic (3.94e-2)" "unprognostic (1.44e-2)" "unprognostic (3.01e-2)" "unprognostic (9.98e-2)" 20.6 10.3 43.4 6.5 45.1 0.3 17.7 39.9 68.1 20.4 38.8 31.9 9.0 29.2 3.9 19.1 17.6 7.6 26.7 41.7 42.3 39.2 17.8 18.9 4.3 50.1 46.8 7.2 18.0 5.8 8.8 2.6 43.1 16.8 4.5 0.8 24.4 4.9 6.8 19.9 19.6 6.1 41.5 28.9 17.4 7.4 53.0 1.8 12.8 4.5 4.3 31.4 21.4 45.7 20.6 14.8 0.1 0.1 3.2 3.4 0.5 0.8 1.6 1.1 0.9 2.8 10.2 0.0 12.9 0.7 10.1 23.4 3.7 5.5 0.1 13.2 9.4 0.1 10.2 28.3 5.3 0.1 0.1 2.8 1.5 2.3 2.0 1.0 10.1 1.6 2.2 30.3 0.6 3.5 2.0 0.3 1.6 7.9 29.1 1.5 1.8 48.4 36.0 0.7 5.8 0.4 6.1 29.1 8.4 0.8 3.5 0.6 15.6 18.0 11.3 1.8 7.1 39.2 12.1 2.5 7.8 0.0 1.7 0.0 0.0 1.4 1.7 0.0 4.6 2.4 4.0 2.2 0.1 2.1 2.6 1.7 0.0 2.2 0.0 1.2 5.4 0.6 43.4 45.1 39.9 68.1 41.7 42.3 50.1 46.8 43.1 41.5 53.0 45.7 34.3 16.0 5.4 26.4 5.2 18.0 39.8 34.8 34.1 6.0 20.8 23.4 4.8 40.0 13.8 16.5 0.0 0.5 2.6 30.2 19.6 67.5 0.5 13.6 17.7 39.6 8.4 1.3 1.9 76.6 1.4 33.7 22.4 12.6 22.2 17.1 43.5 11.4 63.5 0.0 1.4 12.5 57.0 9.1 14.5 1.0 34.2 8.2 42.7 8.4 2.6 10.3 0.0 5.5 5.8 105.2 4.7 19.2 12.5 57.0 42.0 66.3 16.7 0.9 32.9 14.5 36.4 1.0 2.2 22.1 15.9 0.8 7.9 2.0 11.8 19.2 TRPV6 "CaT1, ECAC2" ENSG00000165125 "Transient receptor potential cation channel subfamily V member 6" Q9H1D0 7 142871208-142885745 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 38.3;prostate: 23.5;salivary gland: 69.3" "Cell type enhanced" "Detected in many" "Cholangiocytes: 18.6;Collecting duct cells: 27.6;Cytotrophoblasts: 17.0;Ductal cells: 80.1;Early spermatids: 25.9;Late spermatids: 37.3" "Cancer enriched" "Detected in many" 5 "prostate cancer: 16.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 9.6;HaCaT: 18.0;RT4: 30.7;SK-BR-3: 23.5;T-47d: 52.8" "Low region specificity" "Detected in single" HPA062864 Approved NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 6: T47d - Mammary gland" "Cluster 1: Pancreatic cells - Digestion" "HPA062864: AB_2684885" "unprognostic (9.85e-2)" "unprognostic (1.60e-2)" "unprognostic (6.29e-2)" "unprognostic (8.72e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (5.43e-2)" "unprognostic (3.50e-1)" "unprognostic (4.56e-2)" "unprognostic (3.89e-2)" "unprognostic (3.27e-2)" "unprognostic (8.49e-2)" "unprognostic (9.39e-3)" "unprognostic (1.69e-1)" "unprognostic (7.17e-3)" "unprognostic (3.53e-2)" 0.0 0.0 0.5 0.0 0.6 0.1 4.2 0.6 1.1 0.5 0.6 0.1 8.1 0.1 0.3 2.7 0.2 8.2 0.1 0.5 0.6 5.2 0.9 0.2 0.0 0.6 0.6 0.0 38.3 1.5 0.5 11.9 0.8 23.5 0.0 0.0 69.3 1.6 0.0 6.4 2.2 0.0 0.6 0.0 4.5 1.2 0.6 0.0 1.8 0.0 0.2 0.4 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 1.9 0.1 0.0 23.5 0.6 0.9 52.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 1.1 0.5 0.6 0.6 0.6 0.8 0.6 0.6 0.6 0.0 3.2 0.0 0.0 0.0 0.5 1.1 0.2 5.2 0.6 2.4 2.0 1.9 18.6 1.4 27.6 0.0 17.0 0.1 0.1 0.0 80.1 25.9 0.7 0.2 0.2 0.0 0.0 0.1 3.3 0.8 0.2 3.6 1.6 0.0 0.0 0.4 0.0 1.6 3.3 0.1 0.3 0.0 0.0 0.0 37.3 0.9 0.2 0.0 0.0 2.0 0.7 0.0 0.0 6.8 8.9 0.1 0.0 0.0 10.6 0.1 0.3 0.7 0.2 0.0 1.0 0.3 0.3 0.4 4.3 1.8 6.0 0.0 0.0 0.2 3.1 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451465-69507666 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 125.8;Ductal cells: 125.2;Exocrine glandular cells: 189.3;Pancreatic endocrine cells: 193.4;Paneth cells: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "MAIT T-cell: 19.5" "Lineage enriched" "Detected in many" 6 "T-cells: 19.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 154.7;EFO-21: 211.3;MCF7: 168.0;OE19: 153.2;PC-3: 266.8;SK-BR-3: 134.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044657, HPA071160" Approved Approved "Nuclear bodies,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Nuclear bodies, Plasma membrane" "Vesicles, Cytosol" "HPA044657: AB_10967927, HPA071160: " "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavorable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 70.1 5.3 22.8 15.3 37.6 1.0 61.0 35.0 34.1 16.4 14.9 62.5 38.8 32.6 8.5 10.8 24.6 27.4 16.9 23.6 25.4 25.9 4.6 34.4 8.7 36.9 33.4 3.4 20.0 3.2 6.6 28.1 33.7 34.5 39.4 3.1 26.6 24.7 17.9 10.6 38.8 31.3 30.0 26.7 75.3 9.5 34.5 3.6 14.5 5.6 7.5 46.0 14.9 62.4 51.3 103.9 2.1 0.3 2.3 0.0 12.0 0.2 1.9 2.6 6.8 45.1 154.7 0.0 211.3 2.3 9.2 101.2 7.2 11.5 3.0 42.1 20.4 2.9 3.5 10.0 1.1 0.1 1.8 2.2 3.1 1.4 1.5 7.5 39.4 20.5 1.1 0.0 1.2 168.0 0.6 0.9 2.6 153.2 266.8 4.0 2.1 2.0 29.7 92.9 34.5 13.2 0.6 134.8 17.9 17.3 59.3 2.2 34.5 0.2 0.8 0.1 17.5 1.2 6.1 1.0 1.1 0.1 0.2 0.0 0.0 0.0 2.3 0.0 19.5 0.0 3.1 2.8 3.3 0.0 1.0 0.2 0.0 0.1 0.0 0.2 1.1 0.5 22.8 37.6 35.0 34.1 23.6 25.4 36.9 33.4 33.7 30.0 34.5 62.4 108.8 32.1 6.9 4.9 1.5 3.6 10.9 59.6 2.2 2.9 45.1 15.6 1.7 31.5 29.5 29.5 6.2 2.0 1.6 125.8 3.9 125.2 27.9 25.5 3.8 48.4 40.2 8.0 1.7 189.3 11.9 8.2 71.4 36.6 1.3 2.5 10.4 0.1 25.3 1.7 1.0 106.7 36.7 8.5 16.1 6.6 0.6 9.8 28.4 15.0 15.6 44.7 0.0 11.1 75.3 193.4 120.9 0.0 0.2 50.4 68.3 1.8 27.6 1.5 13.1 39.7 26.8 4.3 18.5 2.9 3.1 3.0 3.9 7.5 66.3 29.6 TSPAN17 "FBX23, FBXO23, TM4SF17" ENSG00000048140 "Tetraspanin 17" Q96FV3 5 176647387-176659054 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030447 Approved NA NA "Cluster 35: T-regs - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 1: Pancreatic cells - Digestion" "HPA030447: AB_2673484" "unprognostic (1.70e-2)" "unprognostic (7.92e-2)" "unprognostic (2.91e-1)" "unprognostic (3.47e-2)" "unprognostic (3.97e-2)" "unprognostic (3.71e-3)" "unprognostic (1.21e-3)" "unprognostic (3.82e-1)" "unprognostic (2.30e-1)" "unprognostic (3.60e-1)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.41e-2)" "unprognostic (7.11e-3)" "unprognostic (2.32e-1)" "unprognostic (4.50e-1)" "unprognostic (1.46e-1)" 13.3 40.5 23.0 16.3 24.3 58.2 12.9 18.6 26.2 14.1 21.3 18.0 15.9 12.1 8.4 24.5 13.0 14.7 28.3 24.5 20.1 30.2 20.6 17.7 17.6 18.7 20.0 11.4 26.3 18.2 23.5 12.3 20.6 17.5 13.9 20.8 15.9 10.4 41.6 17.1 17.9 13.3 19.4 22.0 21.1 20.9 21.5 7.0 14.1 25.8 15.2 18.4 13.9 20.6 48.9 48.3 31.8 58.2 43.0 36.8 49.4 35.8 52.0 51.7 51.3 15.0 54.6 21.8 63.5 62.0 106.9 36.4 15.9 83.2 31.6 161.0 33.5 8.3 20.9 17.7 39.1 17.7 29.3 44.0 46.2 41.3 24.9 35.2 71.6 16.6 41.8 22.8 53.1 80.2 3.8 7.8 25.6 47.3 52.5 18.8 27.0 12.1 48.3 35.5 47.9 33.9 38.8 44.6 49.6 26.4 36.7 22.4 56.2 55.9 57.5 42.5 45.8 12.9 17.9 9.7 61.1 37.6 33.3 0.0 2.4 0.6 3.8 2.4 3.1 1.1 2.9 6.2 2.4 1.8 1.9 2.7 0.3 3.0 3.9 0.6 7.5 2.8 23.0 24.3 18.6 26.2 24.5 20.1 18.7 20.0 20.6 19.4 21.5 20.6 11.3 12.8 9.8 5.5 8.0 2.9 11.3 10.7 10.2 23.7 11.5 4.8 16.0 17.2 10.2 11.0 12.5 1.0 11.4 31.1 5.9 37.2 0.8 10.3 6.7 14.1 14.4 51.1 9.5 56.7 18.8 10.5 20.9 12.1 0.0 25.7 10.8 13.5 15.2 1.7 4.2 18.3 14.2 12.4 4.1 1.3 6.8 9.7 7.2 6.5 12.9 7.1 16.5 2.0 3.5 46.6 21.5 7.2 6.6 17.5 29.1 14.6 6.2 24.8 0.0 4.7 11.7 1.9 2.5 12.0 5.4 1.2 14.2 41.1 25.0 13.5 TSPAN2 "FLJ12082, TSN2, TSPAN-2" ENSG00000134198 "Tetraspanin 2" O60636 1 115048011-115089503 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.4;intestine: 55.4" "Cell type enhanced" "Detected in many" "Ductal cells: 35.3;Enteroendocrine cells: 39.4;NK-cells: 40.2;Prostatic glandular cells: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 109.0;neutrophil: 109.8" "Group enriched" "Detected in many" 4 "granulocytes: 109.8;NK-cells: 86.2" "Cell line enhanced" "Detected in many" "EFO-21: 58.8;hTERT-RPE1: 16.9;U-937: 26.9" "Region enhanced" "Detected in all" "white matter: 842.5" "Low region specificity" "Detected in many" "HPA015640, HPA073306" Uncertain Enhanced Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA015640: AB_1858405, HPA073306: " "unprognostic (4.56e-2)" "unprognostic (6.86e-2)" "unprognostic (2.60e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (1.57e-3)" "unprognostic (1.64e-1)" "unprognostic (9.73e-6)" "unprognostic (6.06e-3)" "unprognostic (3.07e-2)" "unprognostic (4.74e-2)" "unprognostic (7.66e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (8.48e-7)" "unprognostic (5.40e-2)" "unprognostic (1.59e-1)" "unprognostic (1.48e-3)" "unprognostic (7.80e-3)" 7.2 1.8 3.5 10.1 1.9 20.8 4.5 0.9 1.4 10.7 1.3 55.4 5.4 47.4 7.5 14.6 22.2 7.4 7.4 1.0 3.6 8.4 0.8 6.5 1.4 5.4 4.1 2.9 2.9 10.2 2.1 3.0 5.7 15.4 12.0 2.0 3.0 28.3 2.8 2.0 11.0 42.7 2.1 3.8 13.8 1.1 5.7 2.7 2.7 5.2 1.1 24.7 8.0 1.2 15.1 0.3 1.2 0.0 0.0 0.2 0.1 2.1 1.0 2.4 3.8 3.1 9.5 0.0 58.8 3.5 3.3 2.2 1.9 0.0 2.7 3.1 1.2 0.5 1.1 0.0 0.2 0.1 0.0 0.0 0.4 0.7 0.0 16.9 0.1 11.1 0.0 0.9 0.0 0.8 8.2 1.3 13.8 3.2 1.6 0.1 0.8 0.0 0.4 5.8 3.0 4.5 3.5 1.6 0.2 8.2 0.3 0.6 0.2 0.2 5.7 0.4 14.1 12.5 0.4 0.1 0.1 26.9 6.9 109.0 9.1 55.8 17.4 0.2 5.6 0.6 20.5 22.6 4.1 0.3 3.4 17.0 109.8 86.2 0.1 3.8 3.3 13.1 3.5 1.9 0.9 1.4 1.0 3.6 5.4 4.1 5.7 2.1 5.7 1.2 18.7 0.0 0.6 0.3 1.4 8.0 23.2 10.9 1.8 2.5 1.5 7.6 9.6 0.0 4.4 11.0 0.0 1.4 19.9 0.1 0.0 35.3 12.2 14.3 0.9 16.3 39.4 3.0 2.8 2.4 4.3 4.0 0.5 16.3 0.0 2.0 6.4 0.0 0.7 0.0 5.4 1.3 4.1 0.6 3.7 4.6 0.6 3.0 3.6 2.8 2.7 0.0 40.2 1.5 0.2 10.9 0.0 3.0 3.3 30.0 0.0 1.3 10.7 0.4 6.6 1.4 16.2 0.1 0.9 0.2 2.7 0.3 17.2 0.1 1.4 21.6 TUBB3 "beta-4, CFEOM3, CFEOM3A, FEOM3" ENSG00000258947 "Tubulin beta 3 class III" Q13509 16 89921392-89938761 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 313.3" "Cell type enhanced" "Detected in some" "Astrocytes: 20.2;Ductal cells: 28.7;Excitatory neurons: 37.9;Exocrine glandular cells: 21.4;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 45.1;Pancreatic endocrine cells: 49.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "naive B-cell: 2.5" "Lineage enriched" "Detected in single" 9 "B-cells: 2.5" "Cell line enhanced" "Detected in many" "A549: 421.3;SCLC-21H: 424.9;SH-SY5Y: 433.8" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA 89000000 "Cluster 24: B-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 1: Pancreatic cells - Digestion" Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (7.08e-2)" "unprognostic (3.37e-4)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (8.01e-2)" "unprognostic (3.12e-2)" "unprognostic (4.04e-3)" "unprognostic (1.12e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (7.57e-2)" "unprognostic (1.27e-3)" "unprognostic (3.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.91e-2)" 5.7 24.8 99.4 12.1 93.3 3.4 2.1 100.5 127.6 3.3 0.0 18.4 3.7 9.7 0.2 3.6 2.3 8.8 5.5 88.6 313.3 13.3 0.9 4.1 7.1 208.8 132.7 3.9 3.2 0.4 55.1 1.8 266.2 3.0 2.6 24.8 10.6 0.4 0.6 5.2 8.0 12.7 74.2 1.3 7.2 38.0 183.4 1.0 2.5 0.3 5.2 7.3 5.3 82.5 30.1 421.3 152.6 173.9 17.9 170.8 6.8 181.0 31.0 105.8 48.2 57.2 53.5 89.6 93.6 136.8 74.3 112.1 148.9 26.7 26.3 22.7 15.5 0.7 32.5 383.7 6.0 0.0 67.6 98.4 7.9 161.9 14.0 136.8 88.4 5.9 9.2 2.5 122.3 288.6 1.2 31.5 274.3 11.2 237.3 0.1 54.1 9.5 131.8 8.1 424.9 433.8 251.2 4.4 137.1 27.5 15.0 1.9 110.9 142.8 156.9 197.3 185.3 1.4 19.6 35.2 150.2 11.5 260.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 99.4 93.3 100.5 127.6 88.6 313.3 208.8 132.7 266.2 74.2 183.4 82.5 0.4 0.0 0.0 20.2 0.0 0.0 0.0 0.0 3.4 1.8 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 28.7 8.2 0.5 2.6 3.8 4.9 0.0 37.9 21.4 0.7 6.1 27.0 0.7 0.0 0.0 0.0 0.0 0.2 5.0 45.1 0.1 0.0 0.0 0.0 16.8 0.3 0.2 0.0 9.4 0.0 0.3 0.0 16.1 9.2 49.2 0.0 0.4 0.4 0.0 0.0 0.1 0.0 1.4 0.0 0.0 5.1 0.2 0.4 3.0 0.0 1.0 0.1 0.0 0.2 0.0 UBD FAT10 ENSG00000213886 "Ubiquitin D" O15205 6 29555515-29559732 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 151.3" "Group enriched" "Detected in many" 7 "Ductal cells: 534.8;Exocrine glandular cells: 273.8;monocytes: 151.9;Pancreatic endocrine cells: 510.6" "Cancer enhanced" "Detected in all" "liver cancer: 75.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "Hep G2: 63.9;RT4: 52.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043710 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "Nucleoli fibrillar center" "HPA043710: AB_2756303" "unprognostic (2.99e-3)" "unprognostic (4.16e-2)" "unprognostic (6.37e-2)" "unprognostic (2.61e-2)" "unprognostic (3.93e-2)" "unprognostic (3.53e-3)" "unprognostic (1.60e-1)" "unprognostic (9.47e-2)" "unprognostic (1.44e-2)" "prognostic favorable (7.35e-4)" "unprognostic (1.28e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (4.04e-2)" "unprognostic (6.02e-2)" "unprognostic (8.40e-2)" "unprognostic (1.21e-2)" 4.2 0.4 0.3 35.6 0.4 0.0 8.6 0.3 0.7 1.7 0.3 13.3 4.2 1.9 1.2 8.3 4.7 0.9 0.6 0.3 0.3 23.2 25.4 10.9 87.5 0.4 0.3 1.2 27.3 1.7 1.4 0.0 0.3 11.9 19.0 0.0 14.6 1.3 0.4 1.8 31.1 1.2 0.3 22.9 27.1 0.8 0.3 90.2 3.0 0.1 151.3 25.8 1.7 0.3 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 63.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 52.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.9 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.7 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.2 3.2 3.1 0.0 0.7 0.1 0.1 2.3 16.5 0.0 1.9 1.9 0.0 21.5 13.3 0.0 0.0 0.0 0.1 6.9 1.9 534.8 0.0 0.3 0.2 7.1 3.6 0.0 0.0 273.8 0.0 2.2 13.3 0.2 0.0 0.0 0.7 0.3 0.1 0.0 0.0 5.2 6.1 0.3 0.0 0.0 0.0 1.2 0.0 0.0 151.9 0.0 0.0 0.0 0.0 510.6 8.3 0.0 0.0 0.5 49.1 1.1 9.7 0.0 0.0 0.0 3.4 0.0 0.0 2.2 0.0 0.0 0.2 0.0 11.1 0.1 UGDH ENSG00000109814 "UDP-glucose 6-dehydrogenase" O60701 4 39498755-39528311 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" "Allosteric enzyme, Oxidoreductase" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 137.7" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 345.5;Hepatocytes: 231.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 509.6;Hep G2: 595.9;U-2197: 375.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034444, HPA036656, HPA036657" Enhanced Supported Nucleoplasm Yes No 1300000 "Cluster 46: Basophils - DNA binding" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360" "unprognostic (1.22e-2)" "unprognostic (1.62e-1)" "unprognostic (2.73e-2)" "unprognostic (3.96e-2)" "unprognostic (5.54e-2)" "unprognostic (1.63e-1)" "unprognostic (8.78e-3)" "unprognostic (6.07e-2)" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (6.86e-2)" "prognostic unfavorable (5.51e-10)" "unprognostic (2.48e-1)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "unprognostic (4.97e-2)" 48.5 27.8 6.2 29.5 7.3 2.4 32.0 9.4 9.2 31.5 18.1 96.5 45.3 29.1 10.6 34.1 29.6 40.5 16.0 5.9 8.3 37.5 137.7 19.0 13.3 7.4 7.7 30.0 33.7 23.1 7.8 38.4 8.0 35.6 73.3 14.3 16.8 14.0 6.7 9.9 41.1 23.5 7.6 11.5 47.4 6.8 8.4 10.3 27.8 9.5 14.5 54.4 17.1 9.7 36.0 509.6 58.4 76.2 181.5 185.3 51.3 102.7 113.8 94.5 84.8 76.2 115.5 25.4 63.0 133.3 94.5 33.5 56.0 29.5 95.8 32.1 13.0 26.2 65.4 595.9 72.7 34.1 25.3 64.4 14.9 160.2 49.8 78.9 59.3 20.9 34.1 17.3 67.9 89.8 29.4 34.4 53.1 194.0 46.4 48.3 95.0 22.0 53.7 120.0 31.2 46.7 69.2 37.9 45.3 41.4 21.0 27.0 85.9 97.9 49.1 375.8 54.2 42.1 33.3 23.3 86.9 25.8 56.6 30.0 20.9 19.7 23.2 18.4 37.8 18.8 18.8 24.9 19.0 18.4 16.1 19.4 3.8 42.3 11.2 22.5 13.5 18.8 6.2 7.3 9.4 9.2 5.9 8.3 7.4 7.7 8.0 7.6 8.4 9.7 19.1 25.6 27.6 4.6 14.1 116.1 73.4 19.5 43.9 7.5 115.8 62.0 8.9 24.3 25.4 20.2 14.6 21.3 12.9 207.8 70.5 54.7 1.1 78.3 53.8 25.4 113.3 9.1 10.6 345.5 78.8 145.7 184.0 64.8 35.5 11.1 20.7 231.3 17.8 10.1 12.6 114.5 12.2 20.2 33.3 1.6 33.2 12.7 30.2 7.5 19.9 7.3 9.2 46.3 12.8 195.8 112.2 29.0 21.3 127.3 81.4 79.6 65.7 9.2 32.9 39.0 57.5 6.5 5.5 102.2 40.1 29.0 11.7 12.4 152.4 86.4 UNC5CL "MGC34763, ZUD" ENSG00000124602 "Unc-5 family C-terminal like" Q8IV45 6 41026895-41039221 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 37.1;kidney: 58.6;liver: 52.8;pancreas: 36.2;stomach 1: 23.6" "Group enriched" "Detected in many" 6 "Cholangiocytes: 30.0;Collecting duct cells: 22.0;Ductal cells: 25.7;Exocrine glandular cells: 68.6;Gastric mucus-secreting cells: 36.7;Hepatocytes: 30.0;Pancreatic endocrine cells: 19.8;Proximal enterocytes: 37.3;Proximal tubular cells: 41.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "OE19: 44.8;RPTEC TERT1: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA015725 Enhanced Approved Centrosome NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" Centrosome "HPA015725: AB_2669283" "unprognostic (1.10e-2)" "unprognostic (3.59e-2)" "unprognostic (1.60e-1)" "unprognostic (2.57e-1)" "unprognostic (7.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.16e-1)" "unprognostic (8.55e-3)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" "unprognostic (9.30e-2)" "unprognostic (2.35e-1)" "unprognostic (2.31e-1)" "unprognostic (1.19e-1)" "unprognostic (5.60e-6)" 1.2 1.0 1.3 1.0 1.6 0.9 1.6 1.3 1.7 1.5 1.2 3.1 37.1 1.1 0.3 1.3 1.9 9.2 1.2 1.3 1.3 58.6 52.8 2.1 1.0 1.7 1.4 1.5 36.2 0.3 0.8 0.4 1.6 1.5 1.3 0.8 1.7 0.6 0.7 1.9 29.4 0.4 1.4 3.3 23.6 2.2 1.5 2.7 1.6 0.2 0.7 1.1 1.1 2.3 0.5 0.2 0.6 0.9 0.2 0.1 0.6 0.0 0.1 0.0 0.0 7.0 0.1 0.1 2.5 0.0 0.0 0.2 0.1 0.2 0.1 1.1 1.3 0.6 0.0 3.8 0.1 0.3 0.2 0.1 0.6 0.0 0.4 0.1 0.0 2.8 0.5 0.4 0.0 0.1 0.9 2.3 0.2 44.8 0.2 0.9 0.1 0.5 13.0 0.0 0.6 0.6 0.0 0.0 1.3 0.7 0.1 0.2 0.2 0.0 0.4 0.3 0.1 4.3 2.3 0.6 0.0 1.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.3 1.6 1.3 1.7 1.3 1.3 1.7 1.4 1.6 1.4 1.5 2.3 0.3 3.2 1.1 4.2 1.3 0.8 0.6 0.4 0.6 0.6 1.0 1.0 0.8 30.0 0.3 22.0 4.2 0.4 1.8 2.3 3.9 25.7 2.4 0.6 0.3 0.4 1.2 0.4 0.3 68.6 0.8 0.5 36.7 1.6 0.0 0.3 1.4 30.0 0.3 1.7 0.2 5.0 0.0 0.8 0.3 0.4 0.3 0.8 1.8 0.0 0.8 0.2 2.1 0.0 3.5 19.8 3.1 0.7 0.3 0.6 37.3 41.8 0.9 0.3 0.0 0.3 0.4 0.9 0.8 0.5 0.1 0.8 1.0 0.1 5.4 0.4 VNN1 Tiff66 ENSG00000112299 "Vanin 1" O95497 6 132680849-132714055 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "gallbladder: 89.2;intestine: 136.3;liver: 218.7" "Cell type enhanced" "Detected in many" "Cholangiocytes: 50.1;Ductal cells: 244.2;Hepatocytes: 70.6;Pancreatic endocrine cells: 98.0;Proximal enterocytes: 61.7" "Cancer enhanced" "Detected in many" "liver cancer: 41.5" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "classical monocyte: 13.7;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 80 "dendritic cells: 5.0;granulocytes: 8.5;monocytes: 13.7" "Cell line enhanced" "Detected in some" "A-431: 2.5;CAPAN-2: 2.5;EFO-21: 8.7;HBEC3-KT: 2.3;LHCN-M2: 2.5" "Region enhanced" "Detected in single" "white matter: 2.4" "Not detected" "Not detected" "HPA046103, HPA064145" Approved Approved Vesicles "Intracellular and membrane" NA NA 980000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Vesicles "HPA046103: , HPA064145: AB_2685197" "unprognostic (9.53e-2)" "unprognostic (5.01e-2)" "unprognostic (9.95e-2)" "unprognostic (1.35e-3)" "unprognostic (6.11e-2)" "unprognostic (1.16e-2)" "unprognostic (2.20e-1)" "unprognostic (4.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (4.62e-1)" "prognostic unfavorable (2.52e-4)" "unprognostic (2.26e-2)" "unprognostic (4.42e-2)" "unprognostic (2.16e-1)" "unprognostic (2.34e-1)" 2.7 0.6 0.3 3.1 0.6 9.4 1.1 0.5 1.5 1.0 0.0 6.2 136.3 8.9 0.2 0.6 2.6 89.2 0.6 0.2 0.3 21.7 218.7 4.7 2.5 0.6 0.3 0.3 1.4 0.1 0.1 2.7 1.2 0.3 1.8 1.0 2.3 0.2 0.3 0.9 79.5 0.9 0.2 10.1 1.5 0.5 0.5 0.6 0.4 1.1 2.5 1.6 0.7 0.9 2.5 0.0 0.3 0.1 0.0 0.7 0.5 0.2 0.2 0.0 0.0 0.0 2.5 0.1 8.7 0.0 0.4 0.0 0.0 2.3 0.6 0.0 0.0 0.1 0.1 1.4 1.3 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 1.1 0.5 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.3 3.0 13.7 0.0 0.0 8.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.0 8.5 0.0 11.9 0.2 0.0 3.8 0.3 0.6 0.5 1.5 0.2 0.3 0.6 0.3 1.2 0.2 0.5 0.9 0.0 0.0 3.0 0.0 0.3 1.3 0.2 14.9 0.0 0.0 1.2 0.4 0.2 50.1 11.4 1.8 0.0 0.1 0.2 12.5 0.0 244.2 0.0 7.6 4.1 0.2 0.0 0.0 0.0 19.4 0.1 0.3 4.6 39.6 0.0 0.0 1.1 70.6 18.1 0.0 0.0 11.2 22.4 12.0 3.9 0.0 0.0 23.1 0.0 0.0 17.6 0.0 0.0 0.0 0.0 98.0 1.6 0.0 0.5 6.6 61.7 21.9 16.0 0.0 0.0 0.4 1.1 0.1 0.0 0.1 0.1 0.1 0.5 0.0 2.0 14.7 WDR25 "C14orf67, MGC4645" ENSG00000176473 "WD repeat domain 25" Q64LD2 14 100376418-100530303 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003113 Uncertain Approved Nucleoplasm "Secreted to blood" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA003113: AB_2215263" "unprognostic (5.31e-2)" "unprognostic (5.76e-3)" "unprognostic (2.28e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (7.36e-4)" "unprognostic (1.79e-2)" "unprognostic (6.62e-2)" "unprognostic (3.94e-3)" "unprognostic (2.44e-2)" "unprognostic (1.37e-2)" "prognostic favorable (3.89e-5)" "unprognostic (1.01e-2)" "unprognostic (1.73e-1)" "unprognostic (7.30e-2)" "unprognostic (7.51e-2)" 6.4 10.0 7.6 2.5 7.8 4.1 6.5 8.0 9.5 8.1 8.1 6.7 3.2 7.9 4.2 4.5 6.8 3.0 6.6 7.4 7.5 7.0 8.6 5.8 3.6 7.6 7.6 6.6 12.9 3.5 11.3 3.3 8.5 7.9 2.5 4.5 5.7 3.6 10.7 5.7 4.8 2.7 7.0 5.7 6.5 7.4 7.3 5.6 9.1 4.5 2.3 7.9 5.4 7.8 3.5 6.1 4.2 15.6 6.7 6.2 3.5 6.4 10.2 7.3 7.4 2.9 6.5 5.1 7.9 5.0 2.0 6.2 4.0 7.8 3.8 5.0 2.9 3.4 6.9 4.9 12.2 4.0 3.8 9.3 9.2 5.3 7.9 6.4 5.3 5.9 4.2 7.3 4.8 13.5 6.0 4.4 3.2 4.2 10.7 4.3 5.9 3.6 5.6 2.8 9.8 10.3 5.2 1.9 9.0 4.0 7.2 1.4 9.2 2.8 3.2 10.8 3.7 4.9 2.6 2.5 9.7 3.0 5.4 34.0 16.4 24.6 8.6 14.6 8.7 13.0 11.1 9.1 14.3 8.5 11.7 8.6 8.7 5.6 16.3 11.0 12.0 12.2 7.6 7.8 8.0 9.5 7.4 7.5 7.6 7.6 8.5 7.0 7.3 7.8 7.1 0.0 6.4 12.1 5.1 3.2 4.3 8.6 0.6 8.8 5.5 6.1 2.6 0.0 6.9 3.7 10.4 8.4 6.7 6.3 9.8 12.7 9.2 13.8 6.7 8.8 5.4 11.0 17.8 33.6 4.7 6.2 8.2 8.5 3.8 3.9 5.0 8.7 6.9 5.0 16.9 9.0 14.2 5.6 4.0 6.3 6.8 3.7 5.4 16.9 5.4 14.0 5.2 14.6 19.1 13.3 3.8 11.3 6.3 3.3 7.5 17.9 11.8 16.2 13.1 4.5 7.2 15.6 17.0 2.8 3.0 7.0 5.0 9.2 7.1 3.0 YDJC ENSG00000161179 "YdjC chitooligosaccharide deacetylase homolog" A8MPS7 22 21628089-21630064 "Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 82.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA061005 Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA061005: AB_2684412" "unprognostic (5.34e-2)" "unprognostic (2.30e-1)" "unprognostic (3.96e-1)" "unprognostic (2.29e-1)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (9.84e-4)" "unprognostic (9.35e-2)" "unprognostic (7.08e-2)" "unprognostic (8.09e-3)" "unprognostic (1.24e-1)" "unprognostic (9.86e-2)" "unprognostic (4.90e-3)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (9.60e-2)" "prognostic favorable (8.98e-5)" 2.2 4.1 4.3 1.2 4.2 0.7 2.8 3.8 7.5 3.5 3.7 4.4 1.9 4.0 1.6 7.2 4.4 0.3 2.8 4.3 3.9 8.0 6.6 2.8 0.5 4.7 4.1 3.8 9.7 1.4 3.3 0.5 4.3 4.9 1.2 0.4 4.6 1.5 2.0 5.7 4.9 0.8 4.1 5.0 5.6 3.2 4.1 0.6 6.1 0.0 2.6 4.6 4.3 4.7 8.3 1.5 0.1 1.2 2.4 1.8 8.8 3.5 2.5 2.7 3.7 0.7 3.5 7.4 12.6 0.9 1.9 6.8 5.0 8.3 4.5 6.5 23.8 9.7 1.5 12.3 4.2 18.7 8.5 3.5 13.1 2.4 21.1 2.6 5.9 10.0 82.4 1.5 2.3 10.5 6.7 30.5 3.0 23.8 13.8 4.7 0.0 8.2 15.4 4.5 11.0 6.1 3.1 6.3 6.3 1.6 6.7 10.3 4.9 0.9 8.9 1.9 4.3 12.8 7.4 5.7 1.0 6.0 1.6 8.1 14.4 12.4 9.4 14.5 9.9 18.3 13.6 10.1 18.0 18.4 11.4 10.4 5.3 22.3 9.4 11.2 15.3 11.1 4.3 4.2 3.8 7.5 4.3 3.9 4.7 4.1 4.3 4.1 4.1 4.7 11.8 6.4 8.2 1.0 39.4 25.0 54.1 35.0 22.2 5.8 27.1 28.2 3.6 18.6 15.3 44.1 0.0 43.1 30.3 24.9 39.2 57.7 25.3 15.2 10.1 13.0 16.2 19.1 5.4 42.8 69.1 11.6 15.8 15.8 12.0 27.9 5.0 15.0 30.2 3.3 4.6 33.5 22.4 15.7 22.9 4.8 10.5 16.3 14.2 1.9 53.9 8.6 27.8 1.5 5.3 51.4 44.5 6.8 21.1 88.9 52.0 68.3 11.3 5.6 19.7 3.7 10.7 27.7 26.3 26.6 22.7 23.1 28.9 32.6 38.9 45.7 ZBED6CL C7orf29 ENSG00000188707 "ZBED6 C-terminal like" Q96FA7 7 150322639-150332721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 72.3;parathyroid gland: 25.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 8.4;Exocrine glandular cells: 13.3;Pancreatic endocrine cells: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 85.2;K-562: 34.5" "Low region specificity" "Detected in all" "HPA019724, HPA055805" Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 1: Pancreatic cells - Digestion" "Nuclear membrane" Vesicles "HPA019724: AB_1845756, HPA055805: AB_2682929" "prognostic favorable (9.48e-5)" "unprognostic (6.77e-2)" "unprognostic (2.06e-2)" "unprognostic (7.41e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.35e-2)" "unprognostic (2.49e-3)" "unprognostic (2.78e-2)" "unprognostic (3.12e-2)" "unprognostic (3.44e-1)" "prognostic favorable (2.44e-5)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.86e-2)" "unprognostic (7.82e-2)" "unprognostic (8.52e-3)" "unprognostic (1.50e-3)" 1.3 72.3 1.0 5.2 0.8 3.8 2.1 0.6 0.8 3.0 3.1 4.0 3.3 4.3 1.2 3.0 4.1 1.6 1.2 1.1 1.1 5.3 12.1 3.1 6.9 1.1 1.0 6.0 7.2 25.6 5.4 0.8 0.8 3.5 3.1 1.7 2.7 2.1 0.5 3.6 5.0 1.8 0.6 4.9 4.2 1.1 1.2 5.6 4.0 0.2 6.7 2.7 2.1 0.6 8.1 0.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.3 0.9 10.9 8.4 4.8 4.0 0.1 0.0 3.5 0.0 0.0 0.7 85.2 5.4 6.3 13.3 17.6 2.1 0.0 8.4 1.4 3.9 0.0 0.0 0.3 0.4 16.2 34.5 11.8 0.0 3.3 14.5 2.8 5.3 3.4 0.0 0.0 0.5 10.2 3.2 16.4 15.1 8.4 14.9 3.2 0.5 2.4 1.0 3.6 0.2 0.0 0.0 0.0 0.1 10.0 3.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.2 0.8 0.5 0.6 0.9 0.2 0.8 0.8 0.8 0.8 0.7 0.0 0.2 0.6 0.7 1.0 0.8 0.6 0.8 1.1 1.1 1.1 1.0 0.8 0.6 1.2 0.6 0.0 0.0 1.5 0.0 0.6 0.3 0.5 1.0 0.0 1.0 1.2 0.9 0.9 2.8 1.6 1.8 8.4 1.5 2.2 2.2 5.9 2.8 0.0 3.1 0.4 0.9 4.8 0.8 0.0 13.3 0.8 0.6 1.5 3.3 1.3 1.3 0.4 3.7 0.6 0.0 0.0 2.4 4.1 1.2 0.0 0.4 2.8 0.7 0.0 0.0 3.4 1.2 3.1 0.0 0.0 13.4 1.2 1.2 0.2 0.4 1.3 0.9 0.6 0.6 0.0 0.9 0.2 0.4 0.9 0.9 0.1 1.9 1.4 1.1 2.3 0.4